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ABSTRACT 
The early expression and role of cytokines in resistance to experimental 
Trypanosoma congolense infections in the highly susceptible BALBIc and relatively 
resistant C57BL/6 mice was studied. 
Higher levels of IL-4, IL-LO and IFN-y were detected in the plasma of infected 
BALB/c than in those of C57BLl6 mice. In contrast, plasma levels of TNF-a were higher 
in infected C57BLl6 than in BALB/c mice. IL-10 and IFN-y mRNA transcripts 
accumulated earlier and in higher concentrations in the spleens of susceptible than in those 
of resistant mice. TNF-a mRNA levels in the spleens were similar, but the hepatic TNF-a 
mRNA levels were higher in resistant than in susceptible mice on day 9. 
The patterns and kinetics of IL-4, IL-I0 and IFN-y spot-forming cells in the spleens 
were essentially similar but significantly higher numbers were detected in BALB/c than in 
C 5 7B L/6 mice. In contrast, unstimulated and concanavalin A- (Con A) stimulated 
splenocytes fiom BALB/c mice secreted dramatically high amounts of IL-4, IL-10 and 
IFN-y in cultures starting fiom day 4. Secretion of IL-4 by splenocytes from infected 
C57BL16 mice was undetectable throughout the period tested. Secretion of IL-10 and IFN- 
y became appreciable on day 6 but were down-regulated by day 8. Treatment of infected 
BALB/c mice with Berenil resulted in cure and caused a dramatic decline in the secretion 
of IL-I 0 and IFN-y by BALBIc splenocytes. 
Con A-induced proliferation of splenocytes from infected BALBk mice was 
progressively suppressed. This suppression was effectively reversed by anti-IL-l O or anti- 
IFN-y antibodies. Whereas in vivo administrations of anti-IL- 1 0 antibodies to B ALB/c 
mice early during infection oniy moderately prolonged their survival period, anti-IFN-y 
antibodies substantially shifted the phenotype of these susceptible BALB/c mice to a 
resistant-like phenotype. 
Most of the IL-4, IL-ID and IFN-y found in the infected BALBIc mice were 
produced by adherent Thy1.2TD4-8- splenocytes in synergy with adherent Thy1.2' cells. 
These adherent cells suppressed T and B cell responses. 
Infected BALB/c mice mounted an earlier IgM response to various antigens of T. 
congolense than C57BL/6 mice. In contrast, C57BL/6 mice made a strong and sustained 
IgGZa and IgG3 response to these antigens. It is hypothesized that enhanced resistance to 
T. congolense infection in mice is mediated by a TH 1 cell response. 
iii 
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1.0 LITERATURE REVIEW 
1.1 African Trypanosomes 
1.1.1 Introduction 
African trypanosomes are protozoal parasites that include the causative agents of 
important human and animal diseases. Trypsanosoma congolense, T. brucei and T. v i v a  
are the major species that primarily c a w  disease in domestic livestock. 
The occurrence of animal trypanosomiasis coincides with the distribution of their 
tsetse fly vectors. This includes large expanses of sub-Saharan Africa between latitudes 
14"N and 29"s. This area represents a vast region covering about 10 million square 
kilometers and 37 countries (Hursey and Slingenbergh, 1995). 
The economic impact of AFrican trypanosomiasis is enormous. It results in an 
estimated three million cattle deaths annually and the estimated direct production loss in 
cattle alone is between US$6,000 million and US$12,000 million per year (Hursey and 
Slingenbergh, 1995). It is projected that if the disease is controlled, the region could 
support a fkther 120 million cattle translating to an additional 1.5 million tons of meat 
annually (Nantulya, 1986). 
Several methods of control of trypanosomiasis are currently employed and include 
chemotherapy, breeding of resistant breeds of cattle, and measures directed against the 
insect vector. Other measures include bush clearing to eliminate the fly habitats, spraying 
with insecticides and trapping of the fly (Taylor, 1998). The efficacy of chemotherapy 
and chemoprophylaxis is hindered by the rapid evolution of drug-resistant trypanosomes 
and this has resulted in widespread outbreaks in cattle (Holmes and Scott, 1982, Leach 
and Roberts, 1981). Furthermore, the lack of development of new drugs and logistical 
difficulties in maintaining treatment regimes make this method of control unpopular. 
Measures directed against the tsetse fly vector such as destruction of the fly habitats by 
bush clearing and extensive spraying of insecticides have been effective. However, these 
measures are no longer desirable for ecological concerns and their deleterious effects to 
the environment. Sterilization of male flies in an attempt to reduce the degree of 
productive mating and hence the incidence of the vector has been attempted. The 
logistical problems in assessing the efficacy of this measure has lead to the failure of this 
scheme. Tsetse flies can be locally controlled by the use of traps (Dransfield et al.. 1990). 
Again, this method requires Frequent maintenance and the costs might be enormous. 
Vaccination has been considered to be the most desirable method of control. 
However, the ability of the African trypanosome to continually express antigenically 
distinct VSG genes (reviewed in Borst et al., 1997) reduces the likelihood of an effective 
VSG-based vaccine. Invariant parasite antigens are being sought as candidates for 
vaccine designs but only partial and minimal cross-protection has been reported so far 
(2c/lkunza et al., 1995). Most researchers therefore, have focused on understanding the 
parasite and host factors involved in either parasite or disease control. It is believed that 
understanding these mechanisms might be important in the design of appropriate 
immunotherapeutic interventions aimed at reducing the disease and pathology in infected 
livestock. 
Infections with African trypanosomes are associated with profound alteration of 
the immune system of the host. Many of these alterations may be important in the 
induction of the disease process as well as in control of parasitemia. Modulation of the 
immune system by the parasite might be advantageous for the parasite in subverting the 
host's immune responses and consequently its survival. Identification of mechanisms and 
molecules causing immunomodulations might make it possible to design appropriate 
strategies for intervention aimed at preventing certain immunopathologies and enhancing 
effective immune responses by the host against the parasite. 
1.1.2 Classification 
Trypanosornes are flagellated protozoal parasites that belong to the class 
Zoomastigophores, order Kinetoplastida, family Trypanosomatidae. Members of this 
order are elongate, slender and possess a single nucleus and a kinetoplast which is situated 
near the origin of a single flagellum. The pathogenic trypanosomes belong to the 
subgenus T~ypanosorna and have been divided into two sections on the basis of their life 
cycle in the insect vector and mode of transmission (Hoare, L 972). 
The section salivaria consists of groups that complete their developmental cycle 
within the salivary glands of the insect vector. Almost all of the species in this group are 
transmitted by tsetse flies (Giossinu spp) with the exception of T. equiperdurn and T. 
evansi that are transmitted venerally and mechanically respectively. Most members of 
this section are important pathogens either to man or to domestic animals. Because 
development takes place in the salivary glands, transmission occurs only by bite of the 
infected insect vector during a blood meal. The section salivaria consists of four 
subgroups namely Duftonella (T .  viva) ,  Nannornonas (i? congolense), Trypanorom (T .  
brucei brucei) and Pycnornonas (T. suis). 
Members of 
hindgut of the insec~ 
the section stercoraria complete their developmental cycle in the 
vector. As a result, they are passed out in the vector's feces or may 
be liberated if the vector is crushed. Infection occurs when the feces containing the 
infective metacyclic form of the parasite is rubbed into lesions or wounds produced by 
scratching the skin in response to irritation of the insect's bite. They may also actively 
penetrate punctures produced by the proboscis of the insect or the mucous membranes of 
the mouth if the animal licks up the insect feces. There are three subgroups in this section 
namely, Megatrypanurn ( T. theileri), Herpestoma ( T. le wisi, T. musculi) and 
Schirohypanum (T. cruzi). Most members of the section Stercoraria are relatively non- 
pathogenic, however, T. cruzi is of medical importance because it causes Chagas disease 
in man in South and Central America, 
1.1.3 Morphology and characterization 
African trypanosomes are characterized and distinguished on the basis of shape, 
size, position of the nucleus, location and size of the kinetoplast as well as host range and 
geographical distribution. Generally, they are elongate, spindle-shaped and possess a 
single flagellum originating fiom the basal body near the kinetoplast. The flagellum runs 
along the body fiom the posterior to the anterior end forming folds on the body pellicle 
known as the undulating membrane (Hoare, 1972). 
African trypanosomes range from 8-30pm in length. Trypanosoma congolense is 
a small organism and varies in length between 8 and 24 pm with a mean of 12.2-1 7.6 pn 
(Soltys and Woo, 1977). It has a central nucleus and a marginal kinetoplast. The 
undulating membrane is usually not well marked and movement appears sluggish under 
the microscope. T. congolense is usually monomorphic (Soltys and Woo, 1977). 
1.1.4 Life cycle 
l.l.4.l Development in insect vectors 
Almost all the pathogenic salivarian trypanosomes of livestock are transmitted 
cyclically by tsetse flies (Glossina spp). Trypanosoma congoZenre is capable of 
developing in all the three groups of this genus consisting of more than 34 species and 
subspecies (Hoare, 1972). The parasites are ingested by the female tsetse fly during a 
regular blood meal from an infected mammalian host. In the hindgut of the fly, the 
ingested parasites lose their VSG and undergo a series of developmental and 
morphological changes (reviewed by Stephen, 1986) resulting in multiplication. They 
migrate anteriorly through the cell linings of the gut wall and via the proventricular to the 
esophagus of the insect (Newton et al., 1973). From here, they migrate to the 
hypopharynx and transform into the epimastigote form (Newton, et al., 1957). The 
epimastigotes migrate to the mouth pads of the proboscis and transform into the effective 
metacyclic trypanosomes. This transformation is associated with the reappearance of the 
VSG which was lost in the midgut (Vickerman, 1974). The entire cycle of development 
in the Glossina may take From 7 (Nantulya et al., 1978) to 53 (Hoare, 1972) days 
depending on the species of the insect vector and ambient temperature. Once infected, the 
tsetse fly harbors the parasite and is able to transmit it for a considerable length of time 
and in certain instances, for life (Molyneux and Ashford, 1983). 
1.1 A.2 Development in mammalian hosts 
Infection of the mammalian host occurs by the deposition of the metacyclic 
trypanosomes in the saliva of the insect vector within the dermal connective tissue of the 
animal during a regular blood meal. Here, they multiply extensively as typical blood 
forms within a few days, producing a raised cutaneous swelling commonly referred to as 
chancre (Akol et al., 1982). These cutaneous trypanornastigotes eventually spread fiom 
the chancre via the blood and local lymph vessels and enter the blood stream. Certain 
blood stream forms of many species may invade the connective tissues of the animals, but 
this is not usually observed with T. con&lenre (Losos and Ikede, 1972). The length of 
the prepatent period is variable and depends on many factors including the number of 
infecting parasites, the route of inoculation and the genetic makeup of the host. Usually, 
parasitemia becomes apparent within 1-2 weeks after natural infection and may persist for 
months, occuring in waves, until the animal dies (Gray and Luckins, 1976). 
During the period of growth in the blood stream, certain changes in metabolism 
result in morphological plcornorphism among various subspecies of T. bnrcei (Opperdoes 
et al., 1 987). Morphological variants range fiom short, stumpy, usually non-dividing 
forms to long slender forms that are in a state of active cell division. Intermediate forms 
are also frequently observed and may represent a transition stage from long slender to 
stumpy form (Opperdoes et al., 1987). The slender forms predominate during the early 
logarithmic growth phase of infection (Lumsden, 1972) while the stumpy forms 
predominate during the phase of parasite remission (McLintock et al., 1990). It has been 
suggested that the transformation from slender dividing forms to the short stumpy non- 
dividing forms is necessary for cyclical development in the insect vector (Seed and 
Sechelski, 1989). Although Stephen (1986) reported morphological variants of T. 
congolense, the general agreement among workers is that I: congolense does not undergo 
physical transformation. 
1.1.5 Course of the infection 
The severity and clinical signs in animals following infection with pathogenic 
trypanosomes vary depending on the virulence of the infecting organisms and 
susceptibility of the host. Various strains within a species are capable of causing a wide 
range of clinical responses ranging from acute, chronic to asymptomatic carrier 
syndromes (Stephen, 1 970: Maxie et al., 1979). Also, even under similar environmental 
conditions, pronounced differences in susceptibility of individual animals within a 
homogenous population are observed (Ikede and Losos, 1972). 
In ruminants, acute infection with T. congolense is associated with intermittent 
fever, depression, anemia, subcutaneous edema of the mandible, and a prominent jugular 
pulse (Stephen, 1970; Losos, 1986). The appetite is depressed and there is rapid loss of 
weight. Death is most often related to severe anemia and circulatory collapse. Chronic 
syndromes may last for months and results in extreme emaciation and anemia. Profound 
lymphadenopathy commonly seen in infections with other species is not a common 
feature of T. congolense infection in cattle (Maxie et al., 1979; Wellde et al., 1974). 
1.1.6 Pathology 
There are no pathognomonic lesions in organs and tissues of animals that die of 
trypanosomiasis. Most lesions are either due to immunocomplexes or related to the 
circulatory disturbances resulting from anemia. Animals that died of acute syndrome 
have pale carcasses and variable atrophy of adipose and skeletal muscle tissues (Losos, 
1 986; Molyneux and Ashford, 1983). In chronic cases, there is extensive muscle wasting 
and marked enlargement of the spleen with very prominent white pulp Walli and 
Forsberg, 1979; Morrison and Murray, 1979). On histology, there are marked foci of 
necrosis in these organs and trypanosomes are found localized in the small blood vessels 
especially those of the heart and brain. 
The mechanisms of pathogenesis of trypanosomiasis have not been clearly 
established, but both trypanosome-derived substances and immune complexes of 
trypanosomal antigens and their antibodies have been implicated. Several biologically 
active trypanosome metabolites with inflammatory and complement activating properties 
have been purified from trypanosomes and are thought to be released from disintegrating 
intravascular parasites (Tizard and Holmes, 1976; Tizard et al., 1978; Nielsen et al., 
1979). Formation and deposition of immune complexes of trypanosome antigens and 
parasite-specific IgM or IgG and complement on the vascular and extravascular spaces of 
tissue could resuit in pathology (Mansfield, 1990). Such complexes have been detected in 
several tissues from infected animals and humans including brain, heart, skeletal muscle 
and kidney (Nagle et al., 1974; Facer et al., 1978; Lambert and Houba, 1974). It is 
believed that formation of imrnunocomplexes result from the repeated stimulation of the 
host immune system by the invariant antigens generated by the destruction of different 
variant populations during chronic infections (Mans field, 1 990). 
1.1.7 The variant surface glycoprotein (VSG) 
The plasma membrane of African trypanosomes is covered by a homogenous 
dense coat, the variant surface glycoprotein (VSG), composed of millions of glycoprotein 
molecules of a single molecular species. Purified VSG has a molecular weight of between 
53-65 KD and different VSGs of different variant antigen types (VATS) of the same 
seroderne may differ in their isoelectric points, amino acid composition and carbohydrate 
percentage (Cross, 1978; 1990). The VSG is only expressed by the infective metacyclic 
form in the insect (Vickerman, 1974) and it has been proposed that the VSG protects the 
metacyclic forms from lysis by the host's serum factors (Ghitto et al., 1979). 
The VSG molecules on a live trypanosome are packed as a dense array of rigid 
monomers or dimers thereby exposing similar N-terminal epitopes (Vickerman et al., 
1993). As a result of this repetitive nature, the VSG molecules induces strong T-cell 
independent immune responses (Mansfield, 1990). Thus, not all of the epitopes on the 
VSG are exposed to the host immune system on the live trypanosome. Also, although 
most of the carbohydrate determinants within the C-terminus are invariant, they are 
covered by the N-terminal variable amino acids and are therefore apparently not 
accessible to antibodies in an intact VSG on a live trypanosome (Cross, 1979). 
The VSG is anchored to the plasma membrane by the glycosyl- 
phosphatidyiinositol [GPI] (Ferguson et al.. 1 985; 198 8). Many proteins of eukaryotes 
are anchored to the plasma membrane by the GPI, including the decay-accelerating factor 
and Thy 1 antigen (McConville and Ferguson, 1993). The lipophospho-glycan and the 
glycoinositol-phospholipids of Leishmania (Thomas et al., 1992; McConville et al., 1990) 
and the epimastigote proteins of Trypanosoma cruzi (Bertello et al., 1995, Ferguson. 
1997) are also anchored by the GPI moiety. 
The biological significance of the GPI anchor of the VSG is not known as yet. 
One function, however, appears to be related to the release and shedding of the VSG. 
Trypanosomes contain GPI-specific phospholipase C, which when activated, causes the 
cleavage and release of the VSG fiom the plasma membrane (Fox et al., 1986; Hereld et 
al., 1988). In Mycobacterium ruberculosis, lipoarabinomannan (LAM), which is the 
major cell wall constituent, induces synthesis of monokines including IL-10 fiom 
monocytes (Barnes et al.. 1992). The major effective moiety of LAM that induces this 
monokine secretion was shown to be phosphatidylinositol (Barnes et al., 1992). 
Similarly, the glycolipids of M. tuberculosis have been shown to induce cytokine 
secretion by a subpopulation of double negative y6 and a p  T cells (Porcelli, et al., 1992; 
Beckman et al, 1994). These antigens were shown to be presented by non-classical MHC 
class 1 (CD1) molecules and are processed in a manner quite different fiom antigens 
presented by class I1 or class I pathways (Porcelli, et al., 1992; Beckman et al., 1994; 
Bendelac, 1997). It is conceivable that similar presentation of GPI-derived trypanosomal 
antigens occur during immune responses in animals infected with African trypanosomes. 
1.1.8 Antigenic variation 
In the host, the VSG due to its highly immunogenic nature, induces a strong 
humoral response that results in rapid elimination of all but a tiny proportion of the 
parasites. These tiny variant individuals give rise to a new population expressing a new 
population of VSG. The new variants multiply and the immune system raises another set 
of antibodies that eventually succeed in eliminating the majority of these variants. This 
results in a continuous cycle of undulating parasitemia (reviewed by Donelson and 
Turner, 1985; Barry, 1997). Thus, the undulating wave of parasitemia observed in 
infected animals is clearly a result of interactions between the host immune factors and 
the parasite. However, available evidence indicates that antibodies do not induce 
antigenic variation because antigenic variation has been observed in vitro (Doyle et al.. 
1980). But, it has been suggested that antibodies may select a variant that initiates a new 
population by its inability to quickly eliminate a particular new variant (Barry, 1997). It 
is estimated that coat switching occurs at a frequency of 10" - lo-' per cell division in 
established rodent strains, but at a much higher rate immediately after passage through 
insect vectors (Barry and Turner, 1 99 1). 
The parasite's ability to change its VSG coat relies on the presence of many VSG 
genes. It is estimated that each trypanosome contains more than 1000 genes, each of 
which is complete (Barry, 1997; Borst, 1997). The expression of a new VSG gene 
requires the transcription of the new gene at the expression sites located at the teleomeric 
positions of the chromosomes (Pays. 1989; Borst, 1997). Only one teleomeric site is 
active at a time (Pays et al., 1989) and the new gene copy at this site is known as the 
expression-linked copy (Barry et al., 1997). Activation and inactivation of expression 
sites appear to be due to infrequent stochastic events (Borst et al., 1997), since there are 
no sequence differences between the promoter regions of the active and inactive 
expression sites (Zomedijk et d., 1990). Antigenic switching occurs either by 
translocation of a basic copy of a new gene into an active expression site or by differential 
control of expression sites (Van der Ploeg et al., 1992; Borst et al., 1997). In order to be 
translocated, the basic copy of the VSG gene has to be duplicated (Van der Ploeg et al., 
1992). However, an already telorneric-linked VSG gene need not be duplicated but is 
converted into an active gene (Donelson and Turner, 1985). Other non-duplicational 
mechanisms of DNA rearrangements that lead to antigen switching include reciprocal 
exchange of trypanosome telomere (Delange et al., 1983; Pays et al., 1985) and 
recombinationd events (Donelson and Turner, 1 985). 
As previously stated, the precise molecular events that trigger the switch from one 
VSG gene to another are still not understood. Certainly, antigenic variation is 
advantageous to the parasite in the evasion of the host immune defenses. Because of the 
complexity and varied nature of these mechanisms, it is almost impossible to circumvent 
them and so highly unlikely that it will be feasible to develop an effective vaccine against 
blood stream trypanosomes. 
1.1.9 Common antigens 
These are the invariant antigens of trypanosomes that do not change fiorn one 
variant type to another during the course of infection. They include enzymes, structural 
and nuclear proteins, trypanosomal membranes and some receptors such as those for low 
density lipoprotein and transferrin (Pays et al., 1994), high density lipoprotein (Hadjuk et 
al.. 1994), TNF-a (Lucas et al., 1994) and IFN-y (Olsson et al., 1993). In addition, certain 
enzymes such as phospholipase C (Fox et al., 1986) and peptidases (Knowles et al., 1989) 
are common to all species of trypanosomes. The conservation of these enzymes suggests 
that they may be important for parasite survival and therefore might play some role in 
pathogenesis and/or evasion of host defense mechanisms. The carbohydrate rich C- 
terminal portion of the VSG is also considered as a common antigen and has been shown 
to show a high degree of sequence homology across members of a species (Rice-Fitch et 
al., 198 1 ). The flagellar pocket of African trypanosomes is not covered by the VSG and 
therefore is invariant among members of the same species. 
The invariant antigens are released after destruction of the parasite by anti-VSG 
antibodies or other immune factors. It has been suggested that these antigens may be 
involved in inducing pathology by forming immune complexes (Mansfield, 1990). 
However, in cattle infected with T. congolense, antibody responses to 33kd (Authie et al., 
1993a) and 69kd (Authie et al., 1993b; Boulange and Authie, 1994) invariant cysteine 
proteases have been associated with trypanotolerance. The trypanotolerant N'darna cattle 
infected with T. congolense made a superior IgG and low IgM antibody response to these 
invariant proteins (Authie et al., 1992; 1993a; 1993 b). In contrast, similarly infected 
trypanosusceptible Boran cattle mounted predominantly IgM but no IgGl response to 
these proteases. Crosses between N' darna and Boran cattle, which exhibit an intermediate 
susceptibility, had intermediate levels of these antibodies. In these studies, evidence was 
presented that the 33kd cysteine protease was either being released from the parasite or 
was accessible on living trypanosomes (Authie et al., 1993b). In another study in cattle. 
immunization with antigens derived from the flagellar pocket of T. brucei rhodesiense 
resulted in significant protection against a challenge with. T. congolense and T. v i v a  
(Mkunza et al., 1995). Although the mechanisms of protection in these animals were not 
studied, it is quite clear that they do not include immune responses to the VSG because 
the flagellar pockets are not covered by VSG. 
Thus, it is now clearly evident that the long-held notion that the common antigens 
of trypanosomes do not have any relevance for protection (Mansfield, 1990) may not be 
totally correct. On the contrary, immune responses to these antigens appear to influence 
the relative susceptibility or resistance during trypanosome infections in cattle. Detailed 
analysis of antibody responses to common antigens in mice is not yet known. 
1.2 Immunomodulation 
1.2.1 Polyclonal B-cell activation 
Polyclonal activation of B-cells is a prominent feature of Afiican trypanosome 
infections. There is a greatly increased concentration of serum IgM levels in infected 
animals (Houba et al., 1969; Clarkson, 1976). The elevated serum IgM levels result fkom 
the gross expansion of the B cells in the spleen and lymph nodes (Murray et al., 1974; 
Morrison et al., 1978; Morrison and Murray, 1979a). In humans, this elevated serum IgM 
level is used as an important diagnostic test for sleeping sickness in endemic areas of sub- 
Saharan Africa (Cunningham et al., 1967). 
Studies on the specificity of the serum antibodies produced in response to 
trypanosome infections have shown that both trypanosome antigen-specific and non- 
specific antibodies are produced, including autoantibodies. Antibodies to a variety of 
unrelated antigens including sheep red blood cells, pneumococcal polysaccharides and 
haptens (Kobayakwa et al., 1979; Hudson et al., 1976) have been detected in mice 
infected with T. brucei. As a result of these findings, it was postulated that African 
trypanosomes possess B cell mitogens that can cause polyclonal activation of B cells. 
Many workers have tried to purify a mitogen factor from trypanosomes. Esuruoso 
(1 976) demonstrated that the membranes of trypanosames were mitogenic for spleen cells 
of normal athymic and cyclophosphamide-treated mice in vitro. Similarly, whole or 
fractionated homogenates of trypanosomes have been reported to cause polyclonal 
activation of lymphocytes (Mansfield et al., 1976; Greenwood et al., 1978). The purified 
VSG molecules have also been reported to be mitogenic for B cells @iffey, 1983) and 
mice immunized with purified VSG have marked enlargement of B cell compartments in 
the spleen and an increase in serum IgM levels mostly due to the production of 
heterospecific antibodies (Diffley, 1983). 
Polyclonal activation may also be a consequence of binding of the VSG molecule 
linked to a C3 fragment to a complement receptor on B cells. Liu et al. (1 99 1 ; 1993) have 
shown that a soluble fragment of the VSG of T. congolense forms a covalent product with 
a breakdown component of C3 (VSG-C3b) in the presence of variant specific antisera. It  
is known that binding of an antigen by the B cell receptor and simultaneous cross-linking 
of the complement receptor 2 (CR.2) on B cells has a synergistic effect on B cell activation 
(Klaus and Humphrey, 1986; Tedder et al., 1997). 
The finding that the membranes of insect stages of trypanosomes (which do not 
possess VSG) do not cause polyclonal activation (Oka et al., 1988) suggests that 
bloodstream forms of African trypanosomes may induce polyclonal B cell activation as an 
evasion mechanism. Polyclonal B cell activation may prevent the maximum stimulation 
and proliferation of parasite-specific lymphocyte clones. In addition, because afXnity 
maturation does not occur during polyclonal B cell activation activation (Roitt et al., 
1997), selective proliferation and production of high affinity antibodies against the 
parasite is hence prevented. 
1.2.2 Immunosuppression 
One of the striking features of African trypanosomiasis in cattle, human and mice is 
profound suppression of the host immune system (reviewed by Roelants and Pinder, 
1984; Askonas, 1985; Sileghem et al., 1994a; Taylor, 1998). Suppressed B and T cell 
responses to trypanosome and non-trypanosome antigens have been documented in most 
hosts, with the exception of trypanoresistant wildlife (Mulla and Rickman, 1988). 
Generalized immunosuppression was observed in patients suffering from trypanosomiasis 
and was proposed to be the major cause of increased susceptibility of trypanosome- 
bearing individuals to opportunistic infections (Greenwood et al., 1973). Similarly, 
infections of cattle with T. v i v a  and T. congoleme cause suppression of antibody 
responses to a variety of vaccines (Rurangirwa et al., 1978; Ilemobade et al., 1982). Malu 
and Tabel (1986) reported suppressed antibody response to Brucella abortus in sheep 
infected with 7'. congolense. Similarly, in dogs, infections with T. congolense have been 
shown to suppress antibody response to Brucella abortus vaccine (Anene et al., 1986). 
Also, it has been reported that water buffaloes infected with T. evansi have an increased 
prevalence of brucellosis (Bajyana Songa et al., 1987). 
The suppression of both B and T cell responses have been demonstrated and 
studied in detail in laboratory rodent models. Various B cell functions have been shown 
to be suppressed in mice infected with African trypanosomes, including in vitro release of 
antibody measured by hemolytic plaque-forming assays (Murray et ai., 1974), mitogen- 
induced proliferation (Corsini et al., 1977; Jayawardena and Waksman, 1977), and 
production of antibodies (IgG and IgE) to Nippostrongylus braziliensis (Urquhart et al., 
1973). Various T cell responses are also severely affected including allogeneic graft 
rejection (Pearson et al., 1 978), delayed type hypersensitivity (Mansfield and Wallace, 
1984), mixed lymphocyte reaction (Pearson et al., 1978; 1978a; 1979; Roelants et al., 
1979a) and mitogen-induced proliferation (Jayawarden and Waksman, 1977, Pearson et 
al., 1978; 1978a; 1979; Morrison et al., 1978; Kar et al., 1979; Sileghem et al., 1989; 
l992b). 
Various mechanisms have been held responsible for immunosuppression in 
experimental murine trypanosomiasis and these operative mechanisms appear to be 
influenced by a number of factors including host, parasite species and the lymphoid 
compartment studied- 
1.2.2.1 Mechanisms of  immunosuppression 
Infections with African trypanosomes are associated with increases in total serum 
IgM levels and gross expansion of B cell populations (Murray et al.. 1974). Most of the 
serum IgM antibodies have heterophilic and autoimmune specificities (Hudson et al.. 
1976) and this has led to the postulate that trypanosomes possess a mitogen (i.e.molecule) 
which causes non-specific activation of B cells (Urquhart et al., 1973). As a consequence, 
a progressive depletion or exhaustion of antigen-reactive B cells due to poiyclonal 
activation would later result in suppression. Esuruosu (1976) first demonstrated the 
mitogenic capacity of T. brucei on B-cells in vitro. Mansfield et al. (1976) reported that 
extracts from T. brucei and T. congolense were stirnulatory for normal rabbit spieen cells 
and peripheral blood lymphocytes. However, such extracts failed to stimulate spleen cells 
From normal mice, rats or guinea pigs (Mansfield et al., 1976). Both polyclonal activation 
and immunosuppression were induced in vivo by the administration of trypanosome 
membrane fragments (Clayton et al., 1979; Sacks et d., 1982). 
Immunization of mice with purified VSG induces polyclonal activation but does 
not affect B cell proliferation (Diffley, 1983) indicating that polyclonal activation might 
be distinct fiom suppression of lymphocyte proliferation. Moreover, although parasite- 
unrelated immune responses are depressed, variant specific immune responses appear to 
be spared (Mansfield, 1 98 1; 1 990) and recovery of B cell function is very rapid following 
trypanocidal chemotherapy (Clayton et ai., 1 980). These observations are inconsistent 
with the concept of clonal exhaustion resulting fiom polyclonal activation. It is likely that 
polyclonal activation and immunosuppression are not necessarily conflicting hypotheses 
but might represent coexisting mechanisms. Thus, other mechanisms have been proposed 
as the cause of immunosuppression during experimental and natural African 
trypanosomiasis. 
1.2.2.2 Suppressor cells 
There is considerable evidence that antigen nonspecific suppressor cells present in 
the lymphoid compartments of trypanosome-infected animals are involved in 
immunosuppression (Jayawardena and Waksman, 1977; Corsini et al., 1977; Pearson et 
al., 1 W8a; 1979; Roelants et al., 1979; Wellhausen and Mansfield, 1979; 1980; Askonas, 
1985; Schleifer and Mansfield, 1993; Sileghem et al., 1994). The first evidence for the 
involvement of suppressor cells in trypanosome-induced immunosuppression was put 
fonvard by Jayawardena and Waksman (1977). Spleen cells fiom infected mice were 
shown to passively transfer unresponsiveness to spleen cells fiom uninfected mice. 
Adoptive transfer of spleen cells from infected mice suppressed both mitogen-induced 
proliferation (Jayawardena and Waksman, 1977) and in vitro PFC responses to SRBC 
(Eardley and Jayawardena 1978; Wellhausen and Mansfield 1979). Other investigators 
reported that peritoneal macrophages from T. brucei infected mice were also capable of 
passively transferring suppression to normal spleen cells (Corsini et al., 1977; Clayton et 
d., 1979). The involvement of suppressor cells in T. congolense-elicited suppression of 
Con A- and dlogeneic cell-induced proliferation of spleen cells from infected mice has 
also been reported (Pearson et al., 1 W8a; 1979). 
There is controversy as to the phenotype of the suppressor cells in the lymphoid 
organs of mice infected with trypanosomes. A potent suppressor T cell removable by 
treatment with anti-Thy l antibodies and complement has been postulated to act directly or 
indirectly by arming adherent macrophages to mediate suppression (Jayawardena and 
Waksman, 1977; Eardley and Jayawardena, 1977; Jayawardena et al., 1978). Other 
authors reported that peritoneal macrophages from T. brucei infected mice were 
potentially suppressive (Clayton et al., 1979; Groskinsky and Askonas, 1983; Askonas, 
1985). Wellhausen and Mansfield (1980) showed that suppressor cells in the spleen of 
mice infected with T. brucei-rhodesiense were adherent to nylon wool and plastic and 
were insensitive to treatment with anti-Thy1 serum and complement. Because the 
suppressor cell populations were insensitive to radiation and mitornycin C treatment but 
were inhibited by exposure to silica particles, these workers concluded that the suppressor 
cells were macrophages (Wellhausen and Mansfield, 1 979; 1 980). However, these 
authors failed to restore in vitro PFC responsiveness of infected spleen cells to SRBC by 
addition of indom&acin, an agent known to inhibit the activity of T-independent 
macrophage-mediated suppression, indicating that T cells might be indirectly involved. 
Pearson et al (1979) found that the suppressor cells in the spleens of T. 
congolense-infected mice were a sub-population of mitomycin C-sensitive Thy 1 ' cells 
that were not restricted by differences in the H-2 region. Because the suppressor cells 
were also present in the nylon wool-adherent cell populations, these workers concluded 
that macrophages were also involved in the induction of suppression (Pearson et al., 
1978a; 1979). Suppression of the lymph node compartment in mice infected with T. 
brucei appears to be mediated entirely by macrophage-like cells (Sileghem et al., 1987; 
1989; 1994). Depletion of Mac-1- fraction causes 100% reversal of suppression of 
proliferative responses to mitogens by lymph node cells whereas depletion of Thy1 * cells 
has no effect. However, in 7'. congolense infections in mice, unresponsiveness or 
suppressive activities are absent in lymph node cells (Kar et al., 1979). These 
contradictory results and conclusions about the nature of the suppressor cells could be 
attributed to the differences in the in v i m  systems, strains and species of the parasites as 
well as differences in mouse strains used by various groups. It appears that both 
suppressor T cells and macrophages are involved and mediate their suppressive activity 
via release of soluble factors (Roelants and Pinder, 1984; Sileghem, et al., 1994). 
1.2.2.3 Role of cytokines 
Suppression of lymph node T cells in mice infected with T. brucei results From 
suppression of IL-2 secretion and IL-2 receptor expression (Sileghem et al., 1987; 1989; 
1992a). Suppression of IL-2 secretion was shown to be caused by prostaglandins secreted 
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by suppressor macrophages (Sileghem et al., 1989), while the suppression of IL-2R 
expression was associated with endogenously produced IFN-y (Darji et al., 1993; 1996). 
In this system, interaction of macrophages with T. brucei rendered them stirnulatory for 
CD8- T cells, leading to IFN-y release by the latter cells (Darji et al., 1996). It was 
suggested that this cytokine then acts on the macrophages, leading to the release of a 
soluble factor associated with suppression of lymph node cell proliferative responses 
(Darji et al., 1996). The crucial role of IFN-y in this system was substantiated in vivo by 
treatment of trypanosome-infected animals with anti-IFN-y antibodies and subsequent 
abrogation of suppression in co-cultures of infected and uninfected splenocytes (Darji et 
al., 1996). 
Apart from EN-y, TNF-a has also been implicated in suppression of lymph node 
cells in T. brucei-infected mice (Lucas et al., 1993; Daji et al., 1996). In this system, it 
was suggested that membrane-bound TNF-a produced by macrophages following uptake 
of opsonized trypanosomes acts as a co-stirnulatory molecule in the sensitization of CD8- 
T cells for IFN-y production (Darji et al.. 1996). However, TNF-a has been shown to 
possess both static and lytic properties for T. brucei (Magez et al., 1993; 1997; Lucas et 
al., 1993; 1994). 
The role of IFN-y and TNFa in irnmunosuppression during T. congolense 
infections has not been studied. Also the role of interleukin-10, which is a potent 
inhibitory cytokine (Moore et al., 1 993), in African trypanosomiasis is unknown despite 
the fact that this cytokine has been shown to be involved in immunosuppression in other 
parasitic infections (Ding and Shevach, 1992; Denis and Ghadirian, 1993; Khan et al. 
1995). In cattle infected with T. congolense. IL-10 mRNA has been shown to be 
upregulated in the spleen, lymph nodes and PBMC of the trypanosusceptible Boran cattle 
(Taylor et al., 1996), and a suggestion-was made that IL-10 might be involved in 
immunosuppression in these animals (Taylor, 1998). 
1.2.2.4 Role of nitric oxide (NO) 
Production of high levels of NO have been observed in splenic and peritoneal 
macrophages of mice infected with T. brucei (Sternberg and McGuigan, 1992; Stemberg 
et al., 1994; Mabbot et al., 1995), and T. brucei rhodesiense (Schleifer and Mansfield, 
1993). This high level of NO was shown to mediate suppression of splenic T cell 
responses which could be partially reversed by N~-monomethyl-L-arginine (N%MA), a 
competitive inhibitor of arginine-dependent NO synthetase (Stemberg and McGuigan. 
1992; Schleifer and Mansfield, 1993). The production of immunosuppressive NO by 
splenic macrophages in mice infected with T. brucei is dependent on IFN-y and TNF-a 
(Schleifer and Mansfield, 1993). However, using lymph node cells from mice infected 
with T. brucei, Darji et al. (1996) failed to observe suppressive activity attributable to NO. 
There is as yet no report of NO mediating suppression of T cell proliferative responses in 
mice infected with T. congolense. However, in cattle infected with T. congolense and I: 
viva, production of NO by macrophages and monocytes is depressed and NO does not 
mediate the suppression of T cells observed in these animals (Taylor et al., 1996). It 
therefore appears that the role of NO in mediating suppression of T cell responses during 
trypanosomiasis may depend on the strain and species of parasites as well as the host. 
1.3 Resistance to African trypanosomes 
The degree of susceptibility or resistance of a host to most parasitic infections is 
generally a consequence of the host's immune response. However, many factors can act 
to modify the host's responses to the parasite. Some of these factors are related to the 
parasite while others are contributed by the host's non-immune defense mechanisms. The 
host's factors that determine resistance or susceptibility to African trypanosomes can be 
classified into non-specific and specific mechanisms. 
1.3.1 Non-specific mechanisms 
1.3.1.1 Inhibition of growth by human serum 
Trypanosoma brucei brucei and several other species non-pathogenic to man 
(including T. congolense, T. evansi and T. equiperdum) are lysed when incubated in the 
presence of human serum (reviewed by Hajduk et al., 1994). In contrast, the human 
pathogenic strains (T. b. rhodesiense and T. b. gombiense) are resistant to Iysis in human 
serurn. Recently, the lytic factor in human serum has been shown to be a protein related 
to haptoglobin which occurs as an apoprotein in an association with a minor subclass of 
high density lipoprotein (Hager and Hajduk, 1997). In another report, a large complex 
protein termed trypanosome lytic factor 2 was shown to be responsible for the lytic effect 
of human serum on T. brucei (Raper et al., 1996). It is believed that the trypanosome lytic 
factor binds to an as yet unidentified receptor on trypanosomes, and is then internalized, 
leading to trypanosome lysis (Hager and Hajduk, 1997). Resistant strains of T. brucei 
bind but do not internalize this lytic factor (Hager and Hajduk, 1997). 
The serum of cotton rats is lytic for T. v i v a  and as such these animals are 
refractory to infection with this parasite, even when challenged with very high numbers of 
trypanosornes (Hudson, 1972). This activity of cotton rat serum is specific only for T. 
v i v a  (Terry, 1957). The active molecule of cotton rat serum involved in lysis of T. v i v a  
is a protein of molecular weight 550 kD and has been referred to as "natural antibody" 
(Hudson, 1 972). 
1.3.1.2 Role of NO in resistance 
Peritoneal and splenic macrophages from mice infected with T. bmcei (Stemberg 
and McGuigan, 1992; Stemberg et ai., 1994) and T. rhodesiense (Schleifer and Mansfield, 
1993) produce large amounts of nitric oxide. Nitric oxide produced by activated murine 
macrophages is cystostatic for T. brucei and T. garnbienre in vitro (Vincendeau et al., 
1992). Also, mice infected with NO-treated parasites had an increased prepatent period 
and longer survival period when compared with groups infected with untreated parasites 
(Vincendeau and Daulouede, 199 1 ). Nitric oxide has been implicated in the microbistatic 
and microbicidal activities of macrophages against a variety of parasite targets, including 
intracellular protozoa, extracellular helminth larvae and extracellular pathogenic fungi 
(James and Hibbs, 1990). However, NO has been implicated in trypanosome-induced 
suppression of lymphoid cell proliferative responses (Sternberg and McGuigan, 1992; 
Schleifer and Mansfield, 1993) and inhibition of NO production has been reported to 
cause reduction in parasitemia in rnurine Trypanosoma brucei infection (Sternberg et al., 
1994). 
1.3.1.3 Role of complement in resistance 
Both the alternative and classical pathways of complement are activated during 
infection with African trypanosomes (Greenwood and Whittle, 1 980). Although 
clearance of trypanosomes by phagocytic cells does occur in the absence of complement 
(Ngaira et al., 1983), the efficiency of parasite clearance and immune complex removal is 
greatly enhanced by complement (Stevens and Moulton, 1978; Takayanagi et al., 1987). 
Trypanosomes coated with variant-specific antibody have been shown to activate 
complement via the alternative pathway (Diggs et al., 1980). Mice depleted of C3 by 
treatment with cobra venom factor exhibit severe impairment in the hepatic uptake of 
opsonized T. brucei brucei (MacAskiIl et al., 1980). However, partial depletion of C3 in 
mice infected with T. brucei brucei (Shirazi et al., 1980) or T. brucei rhodesiense 
(Dempsey and Mansfield, 1983) had no effect on the control of parasitemia or 
phagocytosis. 
Hypocomplementemia is a prominent feature of African trypanosomiasis in cattle 
(Tabel et al., 1982; Authie and Pobel, 1990), sheep (Malu and Tabel, 1986) and mice 
(Otesile et al., 199 1). Reduction in total hemolytic complement activity and C3 are more 
marked in the trypanosusceptible Zebu than trypanotolerant Baoule cattle (Authie and 
Pobel, 1990). Otesile et al. (1991) analysed the levels of proteins of the alternative 
pathway of the complement system in mice strains that differ in resistance to infection 
with T. congolense. They observed that the preinfection levels of factor H were 
significantly higher in the iesistant C57BLj6 mice than in the susceptible BALBIC mice. 
In addition, the amount of factor B in the plasma of infected mice during the later stages 
of infection was positively correlated with survival time and was higher in the 
trypanotolerant C57BL/6 mice. Similarly, Ogunremi et al. (1993) demonstrated that the 
activity of the alternative pathway of complement activation as measured by deposition of 
C3b was significantly higher in the plasma of resistant C57BW6 compared to susceptible 
BALBK mice infected with T. congolense. Although these reports would suggest an 
important role for complement in the resistance to trypanosomes, there is evidence that 
complement-mediated lysis of trypanosomes demonstrable in vitro may not play a 
significant role in resistance to trypanosomiasis in mice since no significant differences 
were observed in either the hepatic uptake of parasites (MacAskill et ai., 1980) or in the 
survival periods (Jones and Hancock, 1983) of C5-sufEcient and C5-deficient mice. 
1.3.2 Specific mechanisms 
1.3.2.1 Role of antibodies in resistance 
Ahican trypanosornes are extracellular parasites and therefore humoral immune 
responses are mostly mounted by the host during infection. The VSG of the 
trypanosomes is highly immunogenic and dominant immune responses are mounted 
against it. Most B-cell responses are mounted against the exposed N-terminal epitopes of 
the VSG molecule. These responses are both T cell-independent and T cell-dependent 
(Reinitz and Mans field. 1 990). 
The clearance of parasites from the blood of mice infected with T. brucei 
rhodesiense (Dempsey and Mansfield, 1983; Levine and Mansfield, 1984), T. brucei 
brucei (Black et d., 1986), T. congolense (MacAskill et al., 1983; Mitchell and Peanon, 
1986) and T. v i v a  (DeGee et al., 1982; Mahan et al., 1986) is associated with the 
appearance of parasite-specific antibodies. Several experiments have demonstrated the 
role of VSG-specific B-cell responses in protection. Passive transfer of VSG-specific 
antibody or primed B cells to immunocomprornised animals results in transfer of variant- 
specific immunity (Seed and Gam, 1966; Campbell and Phillips, 1976; Otesile and Tabel, 
1987). In contrast, passive transfer of T cells does not result in protection (Campbell and 
Phillips, 1976). Furthermore, mice rendered B cell-deficient by neonatal treatment with 
antiy chain specific antiserum are highly susceptible to T. brucei rhodesiense infections, 
whereas athymic nude mice can control their first wave of parasitemia (Campbell et al., 
1977; 1978). However, in a study of T. congolense infections in BALB/c mice, Otesile 
and Tabel (1987) concluded that variant-specific antibody is necessary, but not sufficient, 
for control of infection. 
The role of differences in antibody production in resistance to trypanosomes by 
different strains of mice has been extensively investigated. Morrison and Murray (1985) 
reported that the highly susceptible AJ mice produce little or no detectable antibody 
against the VSG during infection with T. congolense compared to the resistant C57BL 
mice. Because these mice had greatly increased numbers of plasma cells, they concluded 
that the lower antibody production in the kT mice was due to a defect associated with 
antibody secretion. Similar results were reported by Black et al. (1986) and Newson et al. 
(1990) in mice infected with T. brucei brucei. Spleen cells from resistant mice infected 
with T. brucei exhibited superior antibody synthesis and secretion in vitro compared to 
those from susceptible mice. However, when mice were immunized with non-multiplying 
trypanosomes or purified VSG, susceptible and resistant mice produced almost similar 
levels of anti-VSG antibodies with almost identical kinetics (Morrison and Murray, 1985; 
Pinder et al., 1986). Although Mitchell and Pearson (1983) reported superior qualitative 
and quantitative antibody response by the resistant mice following immunization with 
trypanosomal antigens, they also observed that the susceptible mice equally made a 
substantial antibody response to these antigens. In addition, when susceptible mice were 
treated with a trypanostatic (Newson et al., 1990) or trypanolytic (Black et al., 1986; 
Otesile and Tabel, 1987) drug, they mounted high antibody responses to the infecting 
variant organisms. 
Studies on the nature of antibody class associated with resistance in infected or 
immunized mice are equivocal. Some investigators reported that IgM antibodies were 
better in mediating trypanosome agglutination (Seed, 1977, Pinder et al., 1985) and 
neutralization of infectivity (Takayanagi and Enriquez, 1973). Seed (1 977) reported that 
IgG antibodies gave better passive protection against T. brucei gambiense, while 
Dempsey and Mansfield (1983) reported that both IgM and IgG were both protective 
against T. brucei brucei. Using a panel of monoclonal antibodies against the VSG of T. 
brucei rhodesiense, Hall and Esser (1 984) reported that antibody-mediated immunity 
against this parasite is not associated with any particular subclass of antibody. Both IgM, 
IgG, IgGZa, IgG2b, IgG3 and IgA subclasses were shown to mediate comparable immune 
clearance of trypanosomes. Nude mice which lack T helper cells, when infected with T. 
congolense, developed uncontrolled parasitemia and swived  for shorter period of time 
compared to thymus-intact litter mates (Morrison et al., 1978). These workers concluded 
that the enhanced susceptibility in these mice was due to lack of an IgG response against 
the parasite. In contrast, nude mice infected with either T. brucei rhodesieme (Campbell 
et al., 1978) or T. brucei brucei (Clayton et al., 1979) showed a reduced first peak 
parasitemia and relatively longer survival than thymus intact mates. Thus, there is no 
consensus on the relative importance antibody class in the control of pacasitemia in mice 
infected with trypanosomes. 
The overall effect of any antibody class will depend on many factors including its 
concentration, affinity, avidity and ability to activate complement or bind to macrophages 
(Roitt et al., 1985). Various classes of immunoglobulins have different effector functions 
related to their Fc portion. Removal of antibody-coated trypanosomes is primarily 
mediated by phagocytosis on the part of liver macrophages (MacAskill et al., 1980; 
Dempsey and Mansfield, 1983). It is therefore conceivable that parasites coated with IgG 
would be more readily cleared than those coated with IgM, since macrophages have high 
affinity receptors for the Fc of IgG. However, Ngaria et al., (1 983) has demonstrated 
adherence of trypanosomes to macrophages with subsequent phagocytosis in the presence 
of IgM antibodies, indicating that phagocytosis can be mediated by receptors on 
macrophages other than those for the Fc of IgG. The effectiveness of antibody may also 
be influenced by other factors including ability to mediate aggregation, neutralization, 
induce shedding of the VSG andlor activate complement to induce lysis. Takayanagi et 
al. (1993) observed that IgG3 caused aggregation of T. gambiense and their adherence to 
macrophages and suggested a role for this isotype in protection against T. gambiense 
infection. Similarly, an IgG3 monoclonal antibody against T. congolense caused rapid 
immobilization of this parasite in v i m  as well as parasite neutralization in vivo (Wei et 
al., 1993). It is conceivable that such immobilization in vivo would result in prolonged 
adherence of antibody-coated parasites to macrophages and thereby facilitate 
phagocytosis and clearance. 
Although resistant mice produce higher VSG-specific antibody levels than the 
susceptible mice during infection with crypanosomes, genetic analyses have shown that 
production of VSG-specific antibodies and overall resistance are distinct traits that 
segregate independently (DeGee and Mansfield, 1984; 1988; Seed and Sechelski, 1989; 
Ogunrerni and Tabel, 1995). Using bone marrow chimeras, DeGee and Mansfield (1984) 
showed that the ability to make an IgM anti-VSG antibody response is not linked to 
resistance. Irradiated susceptible mice adoptively reconstituted with bone marrow cells 
from H-2-cornpartible resistant mice made very good IgM anti-VSG antibody responses 
but were still susceptible to infection. They concluded that in addition to antibodies, 
resistance requires other factors associated with radioresistant cells. Similarly, Otesile 
and Tabel (1987) have shown that although antibodies were necessary for control of 
variant-specific parasitemia in susceptible mice infected with T. congolense, they were 
insufficient to mediate cure from the infection. These reports demonstrate that the longer 
survival period in resistant mice is due to anti-VSG antibody responses and at least, in 
part, to as yet unidentified additional factors which do not segregate with VSG-specific 
antibody responses. It has been suggested that among other factors, the degree of 
immunosuppression among resistant and susceptible mice is important (Black, 1985; 
Pinder et a]., 1986; Sileghern et al., 1994). 
Several reports have demonstrated similar as in mice, antibodies may be important 
in protection against bovine trypanosomiasis. Bovine macrophages can phagocytose 
trypanosomes in vitro in the presence of variant-specific antibodies (Takayanagi et al., 
1974; Ngaira et al., 1983). In addition, immunization of cattle with VSG or irradiated 
trypanosomes results in variant-specific immunity (Morrison et al., 1982; Wells et al., 
1982). 
As in mice, the trypanotolerant cattle breeds appear to produce a superior variant- 
specific antibody compared to the trypanosusceptible breeds (Chandler, 1958; Dwinger et 
al., 1992). However, Pinder et d. (1984, 1988) and Murray et al. (1982) did not find 
differences in the antibody responses between the resistant and susceptibile breeds. In 
one study, although no difference was observed between the tolerant and susceptible cattle 
in variant-specific antibodies to the infecting trypanosomes, later during the infection, 
tolerant cattle had higher titers of neutralizing antibodies than susceptible cattle (Akol et 
al., 1986). The differences among results fiom these experiments may be due to the 
difficulty in obtaining animals of homogenous immune status 6ee fiom mixed infections. 
Analysis of antibody classes indicate that resistant cattle produce more IgG 
antibodies against the VSG (Williams et al., 1996; Taylor et al., 1996) and invariant 
antigens (Authie et al., 1992; 1993a; 1993b) than susceptible cattle. In contrast? 
susceptible cattle made higher IgM responses to these antigens than resistant ones (Taylor 
et al., 1996; Williams et al., 1996). Superior IgG responses to the invariant antigens have 
been associated with enhanced resistance observed in the trypanotolerant cattle breeds 
(Authie et al., 1993a; 1993b; Agur and Mehr, 1997). Thus, while clear demonstration of 
antibody-mediated protection in cattle has not been shown, there appears to be an 
association between higher antibody production and resistance. 
13.2.2 Role of liver macrophages 
Several studies in rodent models of trypanosomiasis indicate that the mononuclear 
phagocytic system plays an important role in the elimination of trypanosomes fiom blood 
of infected animals (Takayanagi et al., 1974; MacAskill et al., 1980; Dempsey and 
Mansfield 1980). Mice infected with trypanosomes have greatly expanded mononuclear 
phagocytic system with macrophages fiom the liver, spleen, lymph nodes and bone 
marrow displaying morphological features of activation and increased activity (Murray et 
al., 1974). Antibody-coated trypanosomes are readily phagocytosed by mononuclear 
phagocytic cells of rodents (Takayanagi et al., 1974; MacAskill et al., 1 980). 
Several studies have shown that Kupffer cells of the liver are the major cells 
involved in the clearance of antibody-coated trypanosomes (MacAskill et al., 1980; 
Dempsey and Mansfield 1983; Albright et al., 1990). Injection of T. brucei brucei into 
mice immune to the infecting variant results in rapid sequesteration of the parasites within 
the Kupffer cells (Dempsey and Mansfield, 1983). Following phagocytosis. 
trypanosomes are rapidly destroyed within the phagolysosomes of the Kupffer cells 
(Mans field, 1990). 
The exact mode of attachment and uptake of antibody-coated trypanosomes by 
macrophages is not known. However, it is generally agreed that attachment of 
trypanosomes with subsequent phagocytosis by macrophages requires the presence of 
variant-specific antibody (Mosser and Roberts, 1982). Uptake of trypanosomes by 
monocytes occurs in the presence of IgM or IgG antibodies (Ngaira et al., 1983) 
indicating that both Fc receptor-independent and -dependent mechanisms may be 
operative. Binding of IgM antibodies to the VSG may lead to perturbations of the surface 
coat of the blood stream trypanosomes thereby exposing the plasma membranes. This 
exposes some carbohydrates which may serve as ligands for carbohydrate receptors on 
macrophages thereby facilitating phagocytosis. This theory is supported by the finding 
that the procyclic forms of trypanosomes (which do not have VSG on their membrane) 
readily adhere to macrophages (Mosser and Roberts, 1982) and are phagocytosed in vitro 
by monocytes in the absence of antibody (Abolarin et al., 1983). Binding of IgM 
antibodies to the surface of trypanosomes leads to complement activation via the 
alternative pathway (Diggs et al., 1980) resulting in the deposition of C3 cleavage 
products (Devine et al., 1986). Because macrophages have receptors for C3 cleavage 
products, trypanosomes coated with these molecules will be readily phagocytosed 
(Mans field, 1990). 
In cattle, indirect evidence suggests that phagocytosis may also be important in 
parasite clearance from the blood of infected animals. Trypanosomes coated with variant- 
specific antibodies were shown to adhere to the surface of monocytes (Ngaira et ai., 
1983). Furthermore, monocytes isolated from the peripheral blood of cattle infected with 
T. brucei or T. congolense were shown to require shorter periods of in vitro activation to 
bind and phagocytose opsonized parasites than those from uninfected cattle (Taylor, 
1998). This was interpreted to mean that monocytes of trypanosome-infected cattle have 
increased FcyR function compared to those from uninfected cattle. 
The overall contribution of parasite clearance trypanotolerance is equivocal. 
Kamanga-Sollo et al. (199 1) reported that antibody-coated trypanosomes adhere better to 
mononuclear cells from N'Dama than to those from Boran cattle. Kissling et al. (1982) 
observed that the blood of uninfected N'Dama cattle contains a greater number of 
neutrophils and has higher phagocytic activity than that of Zebu cattle. This phagocytic 
activity was W e r  increased in T. congolense infected N'Dama, but not Boran, cattle 
(Kissling et al., 1982). However, Sileghem et al. (199 1) did not observe differences in 
trypanosome phagocysis by monocytes and macrophages obtained from T. congoleme- 
infected N'Dama and Boran cattle. 
1.4 Genetics of resistance to African trypanosomes 
Infections with African trypanosomes result in a spectrum of diseases in cattle and 
inbred mouse strains. Extensive studies in mice of different breeds found a wide array of 
susceptibility/resistance to different species and strains of African trypanosomes 
(Morrison et al., 1978; l978a; 1979; Jennings et al., 1978; DeGee et al., 1982; Levine and 
Mansfield 198 1; Pinder, 1984; Greenblatt et al., 1984; Ogunrerni and Tabel, 1995). 
Some inbred strains are more resistant (as measured by lower parasitemia and longer 
survival period) than other strains. Studies on strains congenic for the major 
histocornpatability complex indicate that resistance or susceptibility is not linked to these 
genes (Morrison et al., 1978; Pinder et al., 1985; Levine and Mansfield 1981). Studies on 
the inheritance pattern of resistance and susceptibility between F1 crosses of resistant and 
susceptible inbred parents were equivocal. Whereas Pinder (1 984) and DeGee et al. 
(1988) found susceptibility to be a dominant trait, Greenblatt et al. (1984) and Morrison 
and Murray (1979) found resistance to be dominant. In contrast, Ogunrerni and Tabel 
(1995) reported a wide range of susceptibility to T. congoleme infection among the F1 
offsprings of the resistant C57BV6 and susceptible BALB/c mice. Studies with F2 and 
F 1 backcrosses demonstrated that resistance/susceptibility is under a polygenic control 
(Greenblatt et al., 1984; Blackwell 1 988; Ogunremi and Tabel, 1995). 
The mechanisms underlying the differences in resistance/suscepti bility of inbred 
mouse strains to African trypanosomes are poorly understood. However, it has been 
shown that, at least in T. congoleme infection, the relative resistance of C57BL/6 mice 
requires an intact immune system. Their relative resistance is ablated by subclinical 
irradiation (Momson and Murray, 1985). Moreover, T cell-deficient C57BLl6 mice 
infected with T. congolenre have higher parasitemias and shorter survival periods than 
their similarly infected T cell-sufficient littermates (Pinder et al., 1986). An association 
has been made between the degree of resistance and the kinetics of appearance and level 
of VSG-specific antibody to the infecting variant (Mansfield, 1990). Infected resistant 
mice mount early and higher anti-VSG antibody responses that are associated with 
clearance of the infecting variant while susceptible mice fail to make detectable VSG- 
specific antibody responses or control parasitemia (Morrison and Munay, 1979; Levine 
and Mansfield 1984; Mansfield, 1990). Significant differences in the quality of antibody 
responses reported among the resistant and susceptible breeds (Seed et al., 1977; Morrison 
et al., 1978; Mitchell and Pearson, 1983; 1986) could play a significant role in host 
susceptibility to trypanosomes. 
Another factor reported to contribute to differential resistance to trypanosome 
infections in mice is the degree of immunosuppression. Morrison et al. (1978a) showed 
that the kinetics and degree of immunosuppression correlated with the degree of 
susceptibility to infection. Other investigators (Roelants and Pinder, 1984; Pinder et al., 
1986) have reached similar conclusions. Recently it was shown that the nitric oxide 
(Sternberg and McGuigan 1992; Schleifer and Mansfield, 1993; Mabott et al., 1995), and 
IFN-y (Darji et al., 1993; 1996) produced in trypanosome-infected mice are 
immunosuppressive. IFN-y is produced in higher amounts in susceptible than in resistant 
mice. Thus, differential induction and kinetics of secretion of this cytokine could 
influence the outcome of infection in different strains of mice- 
In cattle, it has been observed that certain indigenous west Afiican breeds can 
survive in areas of high tsetse fly infestation where trypanosomiasis is endemic (Murray et 
al., 1982). In contrast, exotic cattle breeds do not s w i v e  in these regions in the absence 
of regular strategic chemotherapy. The trypanotolerant breeds (e.g. N' Darna) possess 
superior ability to withstand disease as assessed by less weight loss, less anemia and 
longer survival (Murray et al., 1982). The ability to suppress the development of anemia 
is one of the major criteria for measuring trypanotolerance in cattle (Murray et al., 1982; 
Murray et al., 1991). Trypanotolerant breeds of cattle are less anemic than the 
trypanosensitive breeds when infected with different strains and species of African 
trypanosomes (Murray et al., 199 1 ; Murray and Morrison, 1979; Authie and Pobel, 1990). 
The genetic or immunological h i s  for the control of anemia by the trypanotolerant 
breeds is not understood. However, higher levels of parasitemia and IgM found in 
susceptible cattle has been suggested to contribute to higher rates of erythrocyte 
destruction (Jenkins and Facer, 1985). 
An immunological basis for trypanotolerance has been proposed by many 
investigators. Most of these studies have focused on the kinetics of induction and quality 
of antibody responses to the infecting organisms. In general, trypanotolerant cattle 
produce an earlier and higher variant-specific antibody response than the 
trypanosusceptible cattle (Chandler, 1958, Dwinger et d., 1992; Akol et al., 1986). 
Trypanotolerant cattle also produced higher IgG responses to the buried epitopes of the 
VSG relative to the susceptible cattle (Williams et al., 1996; Taylor et al., 1996). It has 
been demonstrated that the tolerant cattle produce more IgGl antibodies against the 
invariant antigens of T. congoZenre whereas the susceptible cattle made predominantly an 
IgM antibody response (Authie et al., 1992; 1993). These IgGl antibodies to invariant 
antigens have been associated with resistance (Authie, 1994). Since clearance of parasites 
from the blood is mediated by variant-specific antibodies (Mansfield, 1990), it is 
conceivable that an earlier and higher antibody response by tolerant cattle confers some 
advantage in resistance. 
The role of other immune factors in trypanotolerance has not been extensively 
investigated in cattle. Antigen-specific proliferation of PBMC of trypanosome-infected 
N'Dama cattle were higher than those of Boran cattle (Flynn et al., 1992), an observation 
that could be explained by more severe immunosuppression in trypanosusceptible cattle. 
Furthermore, lymph node cells of infected Boran cattle produce more IFN-y than those of 
infected N' Dama cattle following mitogen stimulation (Sileghern and Flynn, 1 W b ;  Lutje 
et al., 1996). Elevated levels of IL-10 mRNA transcripts have been reported in the 
PBMC, lymph nodes and spleens of trypanosome-infected Boran (Taylor et al., 1996) and 
it was suggested that the suppression of macrophage monokines observed in infected 
Boran cattle may be related to this high level of IL-10. Because IFN-y @Mi et al., 1993; 
1996), has been shown to contribute to immunosuppression and enhanced trypanosome 
susceptibility in mice, it is conceivable that the higher levels of these cytokines observed 
in the susceptible cattle might be involved in their enhanced susceptibility to trypanosome 
infections. 
1.5 T cells and T cell-derived cytokines 
1.5.1 Murine helper T cell subsets 
T helper lymphocytes can be divided into two distinct subsets of effector cells 
based on their functional characteristics and the profile of cytokines they produce 
(reviewed by Mosmann and Sad, 1997). THI subsets of CD4' T cells secrete IL-2, IM-y 
and TNF-P, and TH2 cells produce IL-4, IL-5, IL-6, IL-10 and IL-13 (Mosmann et al., 
1986; Cherwinski et al., 1987; Mosmann et al., 1990; Mosmann and Sad, 1997). A third 
CD4' T cell subset, caIIed T H O  cells, have been defined on the basis of secretion of mixed 
cytokines - IL-2, IL-4, IL-5 and IFN-y (Gajewski and Fitch, 1988; Firestein et al., 1989; 
Street et al., 1990). Although THO cells have been described in a variety of conditions. it 
has been suggested, based on results from in situ mRNA hybridization (Carding et al.. 
1989) and intracellular protein staining (Openshaw et al., 1995), that the overlapping 
cytokine profiles associated with this subset are due to the presence of mixed populations 
of CD4* T cell subsets. Recently, T helper cells producing high amounts of TGF-P have 
been termed TH3 (Chen et al., 1994) and additional phenotypes have been described 
among long-term clones (Mosmann and Sad, 1997). The heterogenicity and quantitative 
differences in cytokine expression may represent distinct phenotypes, developmental 
stages, or transient responses to different stimulatory conditions. 
1.5.2 Helper T cell subsets in humans 
Initial work with human CD4* T cells failed to show distinct TH subsets similar to 
those observed with the murine CD4' T cells (Paliard et al., 1988). However, T cell 
clones derived from individuals with certain pathological or physiological states produced 
distinct cytokines suggestive of polarized T helper subsets. The majority of allergen- 
specific T cell clones derived from atopic individuals were shown to produce IL-4 and IL- 
5 with little or no IFN-y (Wierenga et al.. 1990). In contrast, T cell clones specific for the 
purified protein derivative (PPD) of Mycobacterium iuberculosis derived from the same 
donors sensitized to this antigen, produced mainly IL-2 and IFN-y but no IL-4 (Del Prete 
et al., 1991; Parronchi et al., 1991). Thus, similar to the murine CD4 TH cells, human 
THl subsets secrete IFN-y and TNF-P while TH2 subsets secrete IL4, IL-5, IL-10 and 
IL- 13 (reviewed by Romagnani, 1997). 
1.5.3 TC1 and TC2 CDS' T cells 
Most activated CD8' T cells exhibit a TH1-like cytokine pattern. These cells have 
been termed TC 1 cells (Mosmann and Sad, 1996; Romagnani, 1997). There is increasing 
evidence for the existence of TH2-like CD8' T cells in humans and mice (Salgarne et al., 
1991; Croft et al., 1994). The TC2 cells are thought to arise under some pathological 
conditions (Rornagnani, 1997). Although CD8' TC2 cells secrete IL-4 and IL-5, they still 
retain their cytotoxic abilities (Croft et al., 1994; Sad et al., 1995) and do not appear to 
help B cells in a cognate helper assay (Sad et al., 1995). However, it is possible that non- 
cognate, or bystander B cell help by CD8' TC2 cells may occur in vivo, perhaps due to 
their expression of CWOL (Cronin et al., 1995) or secretion of type 2 cytokines, which 
aid B cells previously activated by a CD4' T helper cell. 
1.5.4 Polarization of THl and TH2 responses 
The factors responsible for the polarization of immune responses with a 
predominant THl or TH2 profile have been extensively studied in mice and humans 
(Mosmann and Sad, 1996; Constant and Bottomly, 1 997; Rornagnani, 1997). Studies in 
transgenic mice have shown that THI and TH2 cells can develop from the same CD4& T 
cell precursor under the influence of environmental and genetic facton acting at the level 
of antigen presentation (Constant and Bottomly, 1997; Romagnani, 1997). Such 
environmental factors include the route of antigen entry, the physical form of antigens. the 
type of adjuvant and the dose of antigen (Constant and Bottomly, 1997). 
The environmental and genetic factors exert their influence mainly by affecting the 
preponderance of a given cytokine in the microenvironment of the responding T helper 
cell(s). IFN-y and IL-12 are thought to be the major cytokines that promote THl 
differentiation (Seder and Paul, 1994; Constant and Bottomly, 1997). The early presence 
of IL-4 is the most potent stimulus for TH2 differentiation (Swain et al, 1990; LeGross et 
al., 1990). IL-12 is produced by many cells, but mostly by macrophages in response to 
certain microbial products (Scott, 1993) and natural killer (NK) cells synthesize IFN-y in 
response to IL-12 (Scott, 1993). These cells are believed to be the primary sources of 
IFN-y and IL- 12 that drive a naive CD4+ T cells to differentiate into a TH 1 subset during a 
primary immune response. The mechanisms responsible for the early IL-4 production 
involved in the differentiation of naive CD4' T cells to TH2 cells are not fully understood. 
In mice, early IL-4 production may be contributed by a subpopulation of CD3' CD4' 
NKl .I- T cells that are restricted by CD 1 molecules (Bendelac et al., 1997). These cells 
have a restricted TCR repertoire and produce large amounts of IL-4 within few hours of 
polyclonal stimulation (Zlotnik et al., 1992; Arase et al., 1993; Bendelac et al., 1997). 
1.5.5 Cross regulation of THl and TH2 cells by cytokines 
TH1 and TH2 responses observed in certain physiological states and following 
immunization with strong immunogens tend to be exclusive of one another in most cases. 
The cytokines produced by each of the two major CD4' subset have a regulatory effect on 
the proliferation or functional activity of the opposing subset. IFN-y produced by THI 
cells inhibits the growth and proliferation of TH2 cells (Gajewski et al., 1989; Gajewski 
and Fitch, 1988). IL-12, which is a potent enhancer of IFN-y production (Seder and Paul, 
1994), indirectly diminishes priming for IL-4 production and hence inhibits the expansion 
of TH2 cells. Similarly, IL-4 preferentially stimulates the generation of TH2 cells and 
prevents priming for IFN-y production (Seder and Paul, 1994). IL-4 has also been shown 
to inhibit IFN-y release by NK cells (Peteman et ai., 1989) and to inhibit TNF 
transcription by activated macrophages (Lehn et al., 1989). IL-10, formerly known as 
cytokine synthesis inhibitory factor (Mosmann, 1990), inhibits cytokine (IL-2 and IFN-y) 
synthesis by TH1 cells (Mosmann, 1990). This inhibitory effect is mediated by acting via 
the antigen presenting cells (Fiorentino et al., 1989; Sher et al., 1991). 
This cross-regulation of THI and TH2 cells by cytokines partially explains the 
strong and polarization of immune responses during many parasitic infections in mice and 
humans. In several cases, alteration of these patterns by cytokines or anti-cytokine 
reagents reverses host resistance or susceptibility to infection. 
1.5.6 TH1 and TH2 CD4' T cells perform distinct functions 
The production of distinct cytokines by TH1 and TH2 CD4' T cells correlates with 
distinct functions in vivo. THI cells are responsible for classical delayed-type 
hypersensitivity (DTH) responses and activation of macrophages for cell mediated 
immunity. Several THl cytokines activate cytotoxic and inflammatory functions 
(Mosmann and Coffman, 1989) and IFN-y is commonly expressed at sites of DTH 
reactions (Yamamura et al., 1991; Tsicopoulos et al., 1992). IFN-y also enhances the 
microbiocidal activity of macrophages (Murray et al., 1988; Stout and Bottomly, 1989). 
As a result, IFN-y associated responses have been shown to be protective against several 
intracellular pathogens including Leishmania major (Sadick et al., 1987; Nathan et al., 
1983; Murray et al., l983), Listeria monocytogenes (Buchmeier and Schneiba, 1985). 
Toxoplasma gondii (Gazzinelli et al., 199 I), Trypanosoma c m i  (Nickell et al., 1993) and 
Cryptmporidium (Unger et al., 199 1). Some B cell help can be provided by THl cells 
and IFN-y has been shown to mediate class switching in B cells from IgM to IgG2a 
isotype (Snapper and Paul, 1987, Boehm et al., 1997). However, at higher TH1 cell 
numbers, B cell responses may be suppressed (Coffman et al., 1988; Del Prete et al., 
199 1). 
TEE cells encourage antibody production by providing cognate help to B cells. In 
addition, TH2 cytokines stimulate B cell growth and differentiation into antibody- 
producing cells. IL-4 mediates class switching to IgGl and IgE (Paul and Ohara, 1987; 
Banchereau et al., 1991) and mice with disruption of IL-4 genes do not have detectable 
levels of serum igE despite having normal numbers of B and T cells (Kuhn et al., 1991). 
When these mice were infected with Nippos~ungylus braziliensis, a parasite known to 
induce strong IgE responses, they were unable to make an IgE response indicating a 
strong dependence of IgE responses on IL-4 (Kuhn et al., 1991). 
IL-5 plays an important role in the development of stimulated B cells into 
antibody-secreting cells (Hamaoka and Ono, 1986). It also mediates class switching to 
IgA (Stevens et al., 1988). Both IL-6 (Kishimoto, 1989) and IL-10 (Roussel et al., 1992) 
promote Ig secretion by activated B cells. 
Because of the profound effects of TH2 cytokines on B cell growth, differentiation 
and antibody secretion, they are commonly found in association with strong antibody and 
allergic responses. 
1.6 Regulation of immunity to parasites by T cell-derived cytokines 
Most parasitic infections tend to be chronic in nature and the resultant persistent 
antigenic stimulation often leads to polarization of T cell subsets (Sher and Coffinan. 
1992). In addition, the biological diversity of parasites and differences in their in vivo 
residence within the host results in distinct forms of antigen presentation and T cell 
activation. Furthermore, there appears to be genetic differences in the immune responses 
and control of many parasitic infections by the host (Sher and Coffinan, 1992). As a 
result of these variables, different effector mechanisms are recruited in response to 
different parasites and both CD4+ and CD8' T cells have been shown to play regulatory 
functions in both helminth and protozoal infections (Sher and Coffinan, 1992). 
1.6.1 Immunity to gastrointestinal nematodes 
Studies with gastrointestinal nematodes have shown that immunity, characterized 
by worm expulsion and reduction in egg output, is dependent upon IL-4 secreted by CD4+ 
T cells (Finkelman et al., 1997). Immunity to experimental Trichuruc muris and 
Heligmonsornoides polygyrus is highly dependent on IL-4 and anti-IL-4 or anti IL-4R 
monoclonal antibodies block host immunity to these infections (Urban et al., 1991 ; Else et 
al., 1994). Administration of recombinant IL-4 alone or in complexes that prolong its half 
life have been shown to cure mice of established primary T. muris and H polygyms 
infections (Finkelman et al., 1993; Else et al., 1994; Urban et al., 1995). IL-4 has also 
been implicated in protective mechanisms against Nippostrongylus brasilienses and 
Trichinella spiralis (Urban et al., 1995, Madden et al., 1991). The protective role of IL-4 
against T. spiralis is believed to be mediated by its enhancing effect on IgE antibody 
production which causes worm expulsion (Ahrnad et al., 1991; Dessein et al., 198 1). 
Most gastrointestinal nematode infections stimulate eosinophils and increase IL-5 
production (Finkelman et al., 1997). Eosinophils kill some parasite larvae in vitro (David 
et al., 1980) and ablation of eosinophils in vivo by anti-IL-5 antibody treatment has been 
shown to enhance the survival of certain nematode parasites (Sasaki et al., 1992; Korenga 
et al., 1994). However, administration of anti-Il-5 antibodies has no effect on the control 
of T. muris, H poly&yrus or N. brariliensis (Urban et al., 199 1; Hemdon and Kayes, 1992; 
Coffinan et al., 1989). 
In contrast, mouse strains that produce a strong THl (IM-y) response to primary 
T. murk infection develop chronic infections and neutralization of this cytokine results in 
protection (Else et al., 1994). Furthermore, treatment of mice infected with N. brasiliensis 
with recombinant IL-12 or IFN-y enhances egg output and prolongs the course of 
infection (Finkelman et al., 1 994). 
Thus it appears that effective immunity against nematodes is associated with TH2 
CD4 T cell responses and TH2-associated cytokines (IL-4 and IL-5) 
1.6.2 Immunity to Schistosoma mansoni 
There is strong evidence that established murine schistosomiasis is associated with 
strong TH2 responses and protection induced by vaccination with irradiated cercariae 
correlates with a more responsive TH1 cytokine production (Grzych et al., 199 1 ; Pearce et 
al., 199 1). This protection can be ablated partially by treatment of vaccinated animals with 
antibodies against IFN-y (Sher et al., 1990). Depletion of IgGZa antibodies fiom serum of 
infected rats showing a strong resistance to reinfection, results in a marked diminution of 
the capacity of such serum to transfer resistance to the schistosomulum (Butterworth, 
1990). Similarly, immunity can be transferred with an IgG2a monoclonal antibody 
against a schistosomulum membrane antigen (Butterworth, 1990). IFN-y, a TH 1 
cytokine, favors the switching of B cells fiom IgM to IgGZa antibody isotype (Snapper 
and Paul, 1987; Boehm et al., 1997). However, THI cytokines (IL-2 and IFN-y) have 
been implicated in fibrosis and granuloma formation in schistosomiasis (Mather et al., 
1 990). 
1.6.3 Immunity to protozoan parasites 
1.6.3.1 Leishmania major 
L. major is an intracellular parasite of macrophages. Cutaneous infections of 
inbred strains of mice with L. major results either in a localized lesion that resolves 
spontaneously or in a progressive disseminated visceral disease that is usually fatal 
(Locksley and Reiner, 1995). It is now known that resistance (healing) and susceptibility 
(non-healing) are conditional traits that represent the development of strong THl and TH2 
responses, respectively. Analysis of cytokines produced by T cells £iom infected mice 
following in vitro restimulation with leishmania antigen show extreme polarization and 
dichotomy in IFN-y and IL-4 production. Healer mice typified by C57BL/6 and CBA 
mice produce substantially higher amounts of IFN- y and are able to mount a strong DTH 
response, but a poor antibody response (Liew et al., 1989; Sadick et al., 1986, Boom et al., 
1990). In contrast, susceptible mice produce very high amounts of IL-4 and IL-5 and 
make strong antibody responses with very high IgE levels (Heinzel et al., 1989; Boom et 
al., 1990; Heinzel et al., 1991). A single injection of monoclonal anti-IFN-y antibody 
converts resistant into susceptible mice (Belosevic et al., 1989) while anti-IL-4 antibodies 
can convert susceptible mice into resistant ones (Sadick et al., 1990). Administration of 
recombinant IL-12 promotes resistance by stimulating IM-y  production and inhibiting 
IL-4 production (Locksley and Reimer, 1995). 
The correlation of THl responses with resistance and TH2 responses with 
susceptibility results from the differential effects of the cytokines produced by these CD4- 
subsets on macrophages. IFN-y activated macrophages acquire microbiocidal abilities 
against L. major via the release of NO (Liew et d., 1990). In contrast, IL-4 inhibits this 
activation (Nacy and Meltzer, 1 99 1 ). 
1.63.2 Trypanosoma cruu' 
Resistance to T. cruzi infections in mice has been associated with TH1-like 
cytokine responses. In particular, IFN-y produced by both CD4+ T cells (Aranjo, 1989; 
Rottenberg et al., 1993) and CD8' T cells (Tarleton, 1990; Tarleton et al., 1992) have 
been shown to mediate resistance to T. crwi infections in mice. in vivo. IFN-y has been 
shown to be essential for clearance of this intracellular parasite in naturally resistant 
mouse strains (Minoprio et al., 1993) and treatment with anti-IFN-y antibodies increases 
parasitemia levels and mortality in infected mice (Torrico et al., 1991 ; Petray et al., 1993). 
Administration of recombinant IFN-y to susceptible mice diminishes parasitemia and 
prevents death during experimental infections (Reed, 1988). In contrast, TH2 cytokines 
(IL4, IL-10) are associated with enhanced susceptibility to the infection (Silva et al., 
1992; Reed et al., 1994). Spleen cells from mice rendered resistant by immunization with 
T. cruzi antigens secrete large amounts of IFN-y and no detectable or very low amounts of 
IL-4, IL-5 and IL- 10 (Hansen et ai., 1996; Taibi et al., 1996). 
1 -63.3 ToxopIasma gondii 
T. gondii is also an intracellular parasite. Similar to T. crwi infections, both CD4' 
and CD8'-derived IFN-y mediate resistance to Toxoplasma gondii infections in mice 
(Gauinelli et al., 1991). In vivo neutralization of IFN-y ablates active immunity 
(Gazzinelli et al., 1991; Suzuki et d., 1988) and the resistance can be adoptively 
transferred by purified CD8+ populations (Suzuki and Remington, 1990). TH2 cytokines 
do not contribute to resistance against T. gondii infections in mice (Sher and Coffinan, 
1992) and IL-10 has been shown to mediate immunosuppression in infected mice (Khan 
et al., 1995). 
1 -63.4 Plasmodium spp 
Protective immunity in rodents vaccinated with the circumsporozoite protein of 
the malaria parasite is T cell-dependent and is mediated by both antibody and cellular 
responses (Sher and Coffman. 1992). Antibody coating of the sporozoite can cause lysis 
and thus prevent infection of the liver cells by these stages. However, very low 
concentrations of IgM anti-circumsporozoite antibody can enhance infection of liver cells 
in vitro. Cellular mechanisms are directed against infected liver cells and involves 
inhibition of intracellular parasite development by IFN-y (Ferreira et al., 1 988) or direct 
lysis of the target cells by CD8+ cytotoxic T-cells (Weiss et al., 1988; Romero et al., 
1989). Also, CD4' TH 1 -like cells have been shown to confer protection against murine 
malaria (Tsujin et al., 1990). Thus, similar to T. gondii, both CD8+ and CD4' T cells 
secreting IFN-y appear to be important in resistance against the hepatic (cellular) stages of 
malaria parasite. 
1.7 Cytokines in African trypanosomiasis 
The roles of cytokines in the pathogenesis of African trypanosomiasis have not 
been extensively studied. One of the paradoxes of trypanosomiasis is that despite the 
apparent impairment of proliferative responses, lymphoid cells retain their ability to 
secrete large amounts of cytokines especially IFN-y (Bakhiet et al., 1990; 1993; Darji et 
al., 1993; 1996; Olsson et al.. 1993; Schleifer et al., 1993). The first direct evidence of 
stimulation of VSG-specific TH cells during trypanosome infection was obtained by 
Schleifer et al. (1993). CD4' TH cells specific for VSG were found predominantly in the 
peritoneum of infected resistant mice and were exclusively of the THI phenotype 
secreting IL-2 and IFN-y but not IL-4 (Schleifer et al., 1993). In contrast, when mice 
were immunized with purified VSG, both TH1 and TH2 VSG-specific cells were induced 
in both the peritoneum and lymphoid organs. These VSG-specific TH cells were shown 
to be Thyl', CD4+, CD8-, CD3+, ap TCR', y6 TCR-, and were restricted by MHC class I1 
(Schleifer et al., 1993). Unfortunately, TH cell responses in infected susceptible mice 
were not studied. 
In other studies, the production of IL-4 and IFN-y were reported to be induced by 
polyclonal activation of CD8- T cells by a T lymphocyte triggering factor released by T. 
brucei (Bakhiet et al., 1993; 1996). In another study, the production of IF'N-y was similar 
in athymic mice compared to euthymic littennates indicating that cells other than thymus- 
derived lymphocytes cells are involved in the secretion of this cytokine during T. brucei 
infections (Bakhiet et al., 1996a). Darji et al. (1996) showed that a macrophage 
hybridoma cell line pulsed with opsonized trypanosomes acquired the ability to induce 
CD8' cell stimulated with Con A cells to secrete large amounts of IFN-y. 
Thus, the cytokine-secreting cells have been identified as CDC TH cells in T. 
brucei rhodesieme (Schliefer et al., 1993) and CD8' in T. brucei brucei infections 
(Bakhiet et al., 1993; Darji et al., 1996). There are no reports on the phenotype of 
cytokine-secreting cells in T. congoleme infection in mice. 
There appears to be complex (both direct and indirect) effects of host cytokines on 
trypanosome survival and pathogenesis. IFN-y has been reported to act as a growth factor 
for T. brucei (Oisson et al., 199 1). However, Kaushik et al. (1 997) failed to demonstrate 
growth stimulatory effects of IFN-y on T. congolense. Mice with disrupted IFN-y genes 
have decreased parasitemia and increased survival time (Bakhiet et al., 1996) and this 
effect was attributed to reduction of parasite multiplication as a result of lack of an IFN-y- 
induced stimulatory effect. However, because IFN-y is known to mediate suppression of 
T cell responses in T. brucei brucei infections (Darji et al., 1993; 1996) it is likely that the 
enhanced resistance observed in IFN-y gene knockout mice may be due to reversal of 
immunosuppression. This would result in a more effective immune response against the 
parasites. I M - y  has also been shown to synergize with a crude soluble extract from T. 
brucei brucei to stimulate nitric oxide production from peritoneal macrophages in vitro, 
leading to suppression of T cell responses (Mabbott et al., 1995). 
Soluble extracts of blood stream forms of various salivarian trypanosomes induce 
TNF-a production by macrophage cell lines in vitro (Magez et al., 1993). Experimental 
infections of mice with T. brucei were found to sensitize macrophages to increased 
production of monokines including TNF-a (Sileghem, 1988). The role of RIF-a in 
trypanosomiasis is equivocal. It has been associated variously with immunosuppression 
(Lucas et al., 1993; Daji et al., 1996) and enhanced resistance (Lucas et al., 1993; Magez 
et aI., 1993; 1997). Membrane-bound TNF-a on a macrophage hybridoma cell line 
pulsed with trypanosomes was reported to act as a co-stirnulatory molecule for induction 
of IFN-y secretion by CD8' T cells, thereby possibly leading to immunosuppression (Daji 
et al., 1996). TNF-a has also been shown to be a negative regulator in trypanosome 
growth control. Treatment of T. brucei-infected mice with anti TNF-a antibodies caused 
a significant increase in parasitemia (Magez et al., 1 993; 1997). Also, injection of soluble 
trypanosome components into mice before infection with T. brucei completely abolished 
parasite development and this effect was blocked by treatment with anti-TNF-a 
antibodies (Magez et al., 1993). Lucas et al. (1994) demonstrated that TNF-a is both 
trypanolytic and trypanostatic for T. brucei brucei and T. brucei rhodesiense in vitro. The 
trypanolytic effect of TNF-a occurs via a novel lectin-like affinity receptor on 7'. brucei 
that is hctionally and spatially distinct from the mammalian TNF-a binding site (Lucas, 
1994). There are no reports of TNF-a in resistance to T. congolense infections in mice. 
Very few studies have focused on the role of RIF-a in trypanosome-associated 
pathological reactions. Rower and Cerarni (1 980) showed that excessive fat metabolism 
and the emaciation observed in T. brucei brucei-infected rabbits were mediated by 
cachectin, a molecule later identified to be TNF-a (BeutIer and Cerami, 1986). Sileghem 
et al. (1994b) demonstrated an association between M F a  production and the severity of 
erythrophagocytosis and thus suggested a role for this cytokine in anemia Infection with 
T. v iva ,  which causes a more severe anemia, was shown to induce higher TNF-a 
production by monocytes fiom both trypanotolerant and trypanosusceptible cattle 
(Sileghem et d., 1994b). The monocytes from less anemic trypanotolerant cattle 
produced significantly lower amounts of TNF-a than those fiom the anemia prone, 
trypanosusceptible breed. Hunter et al. (1 991) showed that mice chronically infected with 
T. brucei brucei and treated with subcurative doses of trypanocidal drugs develop 
inflammatory lesions in the central nervous system. Higher TNF-a mRNA transcripts 
were detected in the brains of such mice but not in either uninfected treated or untreated 
infected animals (Hunter, 1991). They concluded that the TNF-a mRNA was locally 
induced by membranes of degenerating trypanosomes. Recently, treatment of T. evansi- 
infected rabbits and mice with trypanocidal drugs was shown to result in a massive 
increase in serum TNF-a levels and a concomitant decrease in parasite numbers (Lucas et 
al., 1993). Transfer of blood fiom such animals to naike recipients resulted in pronounced 
lethality, inhibitable by pre-treating the recipients with neutralizing anti-TNF-a 
antibodies, indicating that TNF-a is involved in the observed lethality (Lucas et al., 
1993). 
In general, TNF-a appears to have a profound effect on the pathogenesis of 
African trypanosomiasis. The role of this cytokine may depend on a lot of factors, 
including its interaction with other cytokines, the trypanosome species as well as the 
genetic status of the trypanosome-bearing host. 
Relatively little is known about the role of other cytokines in ~ f n c a n  
trypanosomiasis. Higher levels of TGF-P and lower levels of TNF-P mRNA have been 
detected in the spleens of resistant and susceptible mice respectively following infections 
with T. brucei (Bakhiet et al., 1996). The significance of these observations is not known. 
In cattle infected with T. congoleme, higher levels of IL-10 rnRNA transcripts were 
detected in the spleens, lymph nodes and PBMC of susceptible than in the resistant breeds 
(Taylor et al., 1996). It was suggested that higher levels of IL-10 might be associated 
with the higher levels of immunosuppression observed in susceptible breeds (Taylor, 
1998). In T. brucei brucei infections, IL-10 and IL-I2 mRNA were undetectable in the 
spleens of both resistant and susceptible mice (Bakhiet et al., 1996). There is no report on 
the production and role of these cytokines during T. congolense infection in mice. 
2.0 HYPOTHESIS AND OBJECTIVES 
2.1 Introduction 
Infection of different breeds of cattle and mice with various species of Afi-ican 
trypanosomes results in a spectrum of disease. The indigenous West African N'Dama 
cattle are more resistant than Zebu cattle to both natural and experimental infections with 
T. congoZense (Murray et al., 1982; 199 1). Similarly, in a mouse model system, BALBlc 
mice are highly susceptible to experimental E congoleme infections whereas C57BL/6 
mice are relatively resistant, as measured by the level of parasiternia, immunosuppression 
and survival period (Pinder et d., 1986; Otesile et al., 199 1 ; Ogunremi and Tabel, 1995). 
Genetic analyses show that differences in resistance among different breeds of mice are 
not due to differences in the MHC genes (Morrison et al., 1978; Pinder et al., 1985; 
Levine and Mansfield. 198 1). A recent report by Ogunremi and Tabel (1 995) showed that 
the efficiency of clearance of the first wave of parasitemia among the F2 offspring of 
crosses between BALBk and C57BLf6 mice infected with T congoZenre correlated with 
long-term survival. This suggests that the pattern of early responses by infected animals 
could determine the overall outcome of the infection. 
The mechanisms underlying the differences in susceptibility among inbred mouse 
strains to infections by African trypanosomes are still poorly understood. However, 
differences in the kinetics, quantity and quality of antibody responses to the infecting 
variant (Momson and Murray, 1979; Levine and Mansfield 1984; Mitchell and Pearson, 
1986; Mansfield 1990) as well as differences in the degree of immunosuppression 
(Morrison et al., 1978; Roelants et d., 1 979; Pinder et al., 1986) appear to be contributing 
factors. Clearance of trypanosomes from the blood is the result of antibody-mediated 
uptake predominantly by Kupffer cells in the liver, but also by macrophages in the spleen 
(MacAskill et al., 1980; Dempsey and Mansfield, 1983). Studies indicate that mice that 
are highly susceptible to trypanosomiasis produce little or no detectable antibody against 
the VSG during infection (Black et al., 1983; Momson and Murray, 1985; Newson et al., 
1990). However, De Gee and Mansfield (1984) reported a lack of correlation between 
IgM anti-VSG antibody response and overall host resistance. In cattle, an association has 
been made between resistance and the ability to produce IgG antibodies to invariant 
antigens of trypanosomes (Authie et al., 1992; Authie, 1994). Studies on the kinetics as 
well as quality of antibody responses not only to VSG but also to the whole antigens of T. 
congolense in mice are needed to shed more light on the mechanisms of differential 
resistance and the role of antibodies in this phenomenon. 
Trypanosome-induced immunosuppression is considered one of the major 
mechanisms of the parasite to escape the host's immune defense mechanisms (Sileghem 
et al., 1994; Darji et al., 1996). The degree of immunosuppression of lymphoid cells 
correlates with the degree of susceptibility in mice during infections (Morrison et al., 
1 978a; Roelants and Pinder 1984; Pinder et al., 1986). Reduced responsiveness of the 
lymphoid cells of infected animals to parasite-related and unrelated antigens has been 
attributed variously to suppressor macrophages (Akonas, 1 985; Flynn et al., 1 99 1 ; 
Schleifer and Mansfield, 1993), suppressor T cells (Jayanvadena and Waksman 1977; 
Jayanvadena et al.. 1978) or a combination of these cell types (Corsini et al., 1977; 
Pearson et al., 1978a; 1979; Roelants and Pinder 1984). Recently, IFN-y (Darji et al., 
1993; 1996) and NO (Schleifer and Mansfield 1993; Stemberg et al., 1996) have been 
shown to mediate suppression and enhanced susceptibility to T. bmcei infections. NO- 
mediated suppression of lymph node cells does not occur in cattle infected with T. 
congolense (Taylor et al., 1996). This is not surprising in view of the differences between 
T. brucei and T. congofenre. Trypanosorno congofenre. unlike T. brucei, does not invade 
the interstitial tissues. The role of cytokines in T. congolenre-induced immunosuppression 
is not yet known. 
The patterns of cytokine response during many parasite infections detennine or are 
at least strongly related to the relative susceptibility of the host (Sher and C o f i a n  1992; 
Finkelman et al., 1997). Parasitic infections often result in extreme polarization of T cell 
subsets with distinct and non-overlapping cytokine patterns, and consequently distinct 
effector functions. Studies with different parasites have shown that TH2 cytokine 
responses (because of their stirnulatory effect on B cell growth and differentiation) are 
associated with the control of extracellular parasites (Sher and C o h a n ,  1992; Finkelman 
et al., 1997). However, because of the pleiotropic, redundant, synergistic and 
irnmunomodulatory properties of cytokines, it is often very difficult to precisely establish 
a role for a particular cytokine in any disease process. Furthermore, the findings that cells 
other than the conventional CD4' helper T cells do secrete large amounts of cytokines 
hitherto attributed to CD4+ T helper cells. suggests that the role of a particular cytokine 
would depend on its source and the cellular interactions among the producing and non 
producing cells. 
Studies in rodents have shown that certain cytokines influence the outcome of 
infection with T. brucei. IFN-y reportedly produced by polyclonal activation of CD8+ T 
cells has been reported to act as  a growth factor for T. brucei and IFN-y knockout mice 
exhibited enhanced resistance to T. brucei infections (Olson, 199 1 ; Bakhiet et al., 1993 ; 
1996). In another system, IFN-y was reported to cause immunosuppression in lymph 
node cells of T. bmcei infected mice (Daji et al., 1993, 1996). There is as yet no 
extensive study on the patterns of secretion and role of cytokines in T. congolense 
infections in rodents or cattle. However, our preliminary evidence indicates that IL-4, IL- 
10 and TNF-a are present in the plasma of T. congofenre infected mice (Tabel et al., 
1994) and that these cytokines do not have a direct growth stirnulatory effect on the 
parasite (Kaushik et al., 1997). In view of the fact that the speed of control of the first 
wave of parasitemia during T. congolense infections in mice is correlated with long-term 
survival (Ogunremi and Tabel, 1993, it is desirable to investigate the pattern and role of 
early cytokine responses to T congolense infections in mice. 
2.2 Hypothesis 
The early cytokine response to T. congolense infections in mice plays a major role 
in resistance. 
2.3 Objectives 
1. To determine the kinetics of mRNA expression and patterns of secretion of IL-4, IL- 10, 
TNF-a and 1FN-y by splenocytes from T. congolense-infected highly susceptible 
BALBk and relatively resistant C57BU6 mice. 
2. To characterize the phenotype of cells secreting IL-4, IL- 10 and IFN-y in the spleens of 
T. congolense-infected BALB/c mice. 
3. To determine the role of I L 4 ,  IL-10 and IFN-y in the pathogenesis of T. congoZenre 
infection in mice. 
4. To determine whether differences occur in the kinetics, quantity and quality of antibody 
responses to the purified VSG, cryptic epitopes of the VSG and whole antigens of T. 
congolense among infected BALB/c and C57BL/6 mice. 
3.0 IMMUNORlEGULATION IN EXPERIMENTAL MURINE TRWANOSOMA 
CONGOLENSE INFECTION: ANTI-IL-10 ANTIBODIES REVERSE 
TRYPANOSOME-MEDIATED SUPPRESSION OF LYMPHOCYTE 
PROLIFERATION IN WTRO AND MODERATELY BUT SIGNiFICANTLY 
PROLONG THE LIFESPAN OF GENETICALLY SUSCEPTIBLE BALBIC 
MICE. 
3.1 Abstract 
We infected highly susceptible BALB/c and relatively resistant C57BL/6 mice 
with cloned Trypanosoma congolense and followed the effects of these infections on the 
circulating parasite numbers, mouse mortality and cytokine expression. C57BL/6 mice 
controlled their parasitemia and survived for up to 163 5 12 days, while BALBk mice 
could not control their parasitemia and succumbed to the infection within 8.4 + 0.5 days. 
Susceptible BALBlc mice had dramatically higher plasma levels of IL-10 than the 
resistant C57BL/6 mice from day 7 forward. This was preceded by an earlier and higher 
level induction of splenic IL-I0 messenger RNA (rnRNA) expression in the infected 
BALB/c mice. There was a strong negative correlation (r = -0.75; p < 0.03) between the 
splenocyte proliferative responses to concanavalin A (Con A) and their production of IL- 
10 in infected BALB/c mice. Co-treatment of the Con A-stimulated spleen cell cultures 
with monoclonal anti-IL- 10 antibodies, but not isotype-matched control antibodies, could 
completely reverse this suppression of the splenocyte proliferative response. Finally, in 3 
experiments, anti-IL-10 antibody treatment in vivo reduced the peak circulating 
parasitemia of infected BALB/c mice by 43% and increased their median survival periods 
by 38% relative to isotype-matched control antibody-treated mice. These results 
demonstrate that IL-10 has a significant inhibitory effect on the immune system of 
trypanosome-infected BALB/c mice as measured by lymphocyte proliferation in vitro, 
and control of parasitemia and mortality in vivo, but they also show that neutralization of 
this cytokine does not, by itself, reverse the ultimate outcome of the disease. 
3.2 Introduction 
Infections with African trypanosomes are associated with profound 
immunosuppression in both man and animals (reviewed in Darji et al., 1992, Sileghem et 
al.. 1994). A remarkable characteristic of this suppression is a down-regulation of both 
cell-mediated and humoral responses, leading to an increased susceptibility to secondary 
infections and poor responsiveness of trypanosome-bearing individuals to unrelated 
vaccinations (Greenwood et al., 1973). Lymphocytes from infected animals show 
suppressed responsiveness to T-cell mitogens, probably as a result of their decreased IL-2 
secretion and IL-2 receptor (IL-2R) expression (Sileghem and Flym, l992a; Sileghem et 
al., 1986; Darji et al., 1993). Suppression of IL-2R expression in mice infected with T. 
brucei is associated with a non-prostaglandin product released by IFN-y-activated 
macrophages, while the IL-2 secretion is apparently downregulated via prostaglandin- 
dependent effects (Askonas, 1985; Darji et al., 1992; 1993; Sileghem et d., 1994a). 
IL-10 is produced relatively late following activation of T-cells or 
monocytes/macrophages (reviewed in Moore et al., 1993). Its effects have been reported 
to include an inhibition of CD4' and CD8' T-cell proliferation and cytokine synthesis 
following stimulation with T-cell mitogens, superantigens or alloantigens (Ding and 
Shevach, 1992; Moore et al., 1993). This effect is mediated in part by an inhibition of 
antigen presenting cell-dependent stimulation of IL-2 production and a marked decrease 
in the expression of the p55 chain of the IL-2R (Ding et al., 1992). The production of high 
amounts of IL- 10 by splenocytes fiom Tmanosoma cmi-infected mice have been shown 
to mediate susceptibility to the disease (Silva et al., 1992, Reed et al., 1994) and in vivo 
neutralization of IL-10 enhanced the resistance of the highly susceptible mice (Reed et al., 
1994). Because of the similarities of the effects of IL- 10 and trypanosome infection on T- 
cell proliferation and IL-2 and IL-2R expression, we sought to determine whether this 
cytokine has a role in the immunosuppression observed in experimental &can 
trypanosomiasis as well as in enhanced susceptibility to the disease. In agreement with 
our previous preliminary report (Tabel et al., 1994), we show here that, following 
infection with T. congolense, the plasma of the highly susceptible BALB/c mice contains 
significantly higher levels of IL-10 than that of relatively resistant C57BL/6 mice. Also, 
the splenocytes of infected BALBk mice constitutively contained increasingly higher 
steady levels of IL-10 mRNA and produced more IL-10 than those of the resistant mice. 
In contrast, the proliferative responses to Con A of the spleen cells fiom the susceptible 
mice were progressively suppressed during T. congolense infections, and exhibited a 
reciprocal relationship with IL- 10 production. Most importantly, neutralizing anti-IL- 1 0 
antibodies restored the in vitro proliferative responses of spleen cells from infected 
BALB/c mice and, in vivo, these antibody treatments significantly reduced the parasitemia 
and increased the survival period of the highly susceptible mice. 
3.3 Materials and Methods 
3.3.1 Mice 
Female BALBIcAnNCrlBR (BALB/c) and outbred CDl mice were obtained from the 
Animal Resource Center of the University of Saskatchewan, and female C57BL/6NCrBR 
(C57BL/6) mice were purchased from Charles River Laboratories (St. Constant, Quebec). 
BALB/c and C57BL/6 mice were between 8 to 10 weeks of age and CDI mice were 5 
weeks old. All mice were maintained according to the recommendations of the Canadian 
Council of Animal Care. 
3.3.2 Parasite 
T. congolense, variant antigenic type (VAT) TC13 (Tabel, 1982) was used in these 
experiments. Parasites were passaged in immunosuppressed CDI mice as described 
previously (Tabel, 1982). The parasites for infection of the BALBIc and C57BL/6 mice 
were isolated from the blood of the CDI mice by DEAE-cellulose chromatography 
(Lanham & Godfiey 1970). 
3.3.3 Experimental design 
Groups of four to five BALB/c and C57BLl6 mice were infected intraperitoneally (i.p.) 
with 103 organisms of T. congolense TC13 and killed with C02 on days 1-10 post- 
infection. In some experiments, infected mice were treated with berenil (14 mgkg of 
diminazene aceturate; Sigma Chemical Co., St. Louis, Missouri) on day 6 and 7 post- 
infection to cure their infections. On each of the indicated days blood was withdrawn 
fiom the vena cava into syringes containing heparin (final concentration -20 IUlml), and 
the plasma collected after centrifugation of the blood at 1,000 x g for 30 min. The plasma 
was then centrifuged at 13,000 x g for 15 rnin and the supernatant was stored at -35°C 
until used. Each experiment and cytolcine determination was performed at least twice. 
3.3.4 Estimation of parasitemia and survival period 
To estimate the circulating parasite numbers, a drop of blood from the tail vein of each 
infected mouse was examined at 400x magnificaton by phase contrast microscopy. 
Parasitemia was most often estimated by counting the number of parasites present in at 
least 10 fields, but unusually heavy parasite loads were quantified according to Herbert 
and Lumsden (1976). The survival period was defined as the number of days post- 
infection that the infected mice remained alive. Moribund mice were euthanized with 
CO,. 
3.3.5 Splenocyte cultures for measurement of IL-10 synthesis 
Single cell suspensions of spleen cells fiom normal and infected mice were adjusted to 
2x 106 celIs/ml complete medium (RPMI 1640 supplemented with 10% heat-inactivated 
fetal bovine serum [FBS], 2 mM L-glutamine, 50 m M  2-mercaptoethanol, and 100 IU/ml 
penicillin/streptomycin) and cultured in 24 well plates (Corning, New York) at 1.5 
mVwell in a humidified 3 P C ,  5% C02 atmosphere. Some cells were stimulated with 5 
pglml concanavdin A (Con A; Calbiochem, Behring Diagnostics, La Jolla, CA). All 
supernatants were collected after 48 hours, centrifuged at 1,500 x g for 10 min and stored 
at -80°C until used. 
3.3.6 Splenocyte proliferation assay 
Splenocyte proliferation was quantified by the MTT assay as described by Mosmann 
(1983). Briefly, cells from infected mice were cultured for 72 h in 200 p1 of complete 
medium at a density of 105 cellslwell in 96-well flat bottom plates (Falcon@; Becton 
Dickinson, Lincoln Park, NJ), using quadruplicate cultures of pooled cells fiom groups of 
4 mice. Cells were either left untreated or were treated with Con A (5 pg/mI); some 
wells were treated with either 10 pg/ml of rat anti-mouse IL-10 (SXC-2), anti-rat IL-4 
(1 1 B 1 1, American Type Culture Collection [ATCC], Rockville, MD) or control rat IgM 
hybridoma (HECA 452, ATCC #HB11485) antibodies. After 72 hours, MTT (3-[4,5- 
dimethylthiazol-2-yl]-2,S-diphenyl tetrazolium bromide; Sigma Chemical Co) was added 
to a final concentration of -0.48 pg/ml for an additional 3 hr, then lysed the cells with 
acidified isopropanol and quantified the mitochondrial formazan precipitates with an 
ELISA plate reader, by measuring the absorbance at 595 nm wavelength. Results are 
presented as percent proliferation relative to Con-A-stimulated splenocytes fiom normal 
non-infected mice. 
3.3.7 Recombinant murine IL-10, anti-IL-10 antibodies and IL-10 ELISA 
Recombinant murine IL- 10 was purchased fiom BACHEM (Feinchemikalien Ag, 
Bubendorf, Switzerland), an ELISA kit for measurement of plasma IL-10 (Endogen Inc., 
Boston, MA), and paired antibodies for sandwich ELISA assays of splenocyte IL-10 
production (PharMingen, San Diego CA). Each was used according to the manufacturer's 
suggested protoco 1. 
3.3.8 Northern blot analysis 
Total celluiar RNA was extracted from the spleens of normal and T. congolense-infected 
BALB/c and C57BL/6 mice from days 1-9 post-infection using the guanidiniurn 
isothiocyanate/cesium chloride method (Chirgwin et al., 1979). For each sample, 20 pg 
of RNA was electrophoresed in a 1.2% denaturing agarose gel, transferred to a nylon 
membrane (ZetabindTM, CUNO Lab., Meridien, CN.) by capillary action and cross-linked 
by u.v. irradiation (StratalinkerTM, S tratagene, La Jolla, C A). The membranes were 
blocked with 0.1 X SSC/O.j% SDS for 1 hr at 65°C and pre-hybridized overnight at 42'C 
in a solution containing 50% de-ionized fomamide, 0.1 M HEPES, 0.5 M NaCI, 5 mM 
EDTA (pH 8.0), 5X Denhardt's solution, 1% SDS, 0.5% sodium pyrophosphate and 12.5 
pglml salmon sperm DNA. 32~-labeled cDNA probes were prepared by the random 
hexamer-labeling technique (Oligolabeling kit, Pharmacia, Uppsala, Sweden) according to 
the manufacturer's suggested protocol. The mouse IL-10 cDNA consisted of a 550 bp 
Xba [/Not I fragment (kindly provided by Dr. John Elliot, University of Alberta) while the 
human y-actin cDNA comprised a 910 bp EcoRI/Hind III fragment (provided by Drs. B. 
Murphy and V. Misra, University of Saskatchewan). The membranes were hybridized 
overnight at 42°C in pre-hybridization buffer containing 1 x 10' cpm/ml of labeled probes 
and then washed two times with 2X SSC/O.l% SDS for 5 min at room temperature and 
another two times for 30 rnin with 0.2X SSC/O.I% SDS at 42°C. Autoradiography was 
performed at -80°C for 1-10 days. Densitometry of the autoradiograph signals was done 
using the Image 1 program fiom Universal Imaging Corporation (Westchester, PA) and 
the results presented graphically as the ratios of the IL-I0 to y-actin signal density for 
each sample (in order to accommodate any lane-to-lane variation in RNA loading). 
3.3.9 Anti-IL-10 antibodies for in vivo experiments 
SXC 2, a rat IgM anti-mouse IL-10 antibody-secreting hybridoma (Mosmann, et al., 
1990) was a kind gift of Dr. Tim Mosmann (University of Alberta) while isotype-matched 
antibodies (HECA 452, ATCC) directed against a human cutaneous antigen were used for 
control treatments. Hybridomas were grown either in serum- and protein-free medium 
(Gibco BRL, Life Technologies, Mississauga, ON) or in complete medium. The 
hybridoma supernatants, as well as control culture medium (i.e., complete medium), were 
precipitated with 33% w/v crystalline ammonium sulfate and dialyzed extensively against 
phosphate-buffered saline (PBS: pH 7.0). Protein levels were quantified using the 
Bradford method (BIORAD Protein Assay; BIO-RAD Laboratories, Richmond, CA). In 
some preparations, IgM antibodies were W e r  purified on Sephacryl G200 (Pharmacia, 
Uppsala, Sweden) gel filtration columns. Fractions containing the first protein peak 
eluted fiom the column were collected, pooled and concentrated with Amicon Centriprep 
100 concentrators (Arnicon, W.R. Grace and Co., Beverly, MA.). The levels of IgM 
antibodies in the concentrates was determined by single radial immunodiffbsion using 
goat anti-rat IgM antibodies (Cappel, Organon Teknika, Inc., Scarborough, Ontario) and 
purified rat IgM (Cappel) standards. 
3.3.10 Injection of mice with monoclonal antibodies or rIL-10 
Groups of six BALBlc mice were injected intraperitoneally (i.p.) on days 0, 2, 5 and 7 
post-infection with 200 pg of purified anti-IL-10 antibodies in 200 pl of PBS. Control 
mice received an equivalent amount of either similarly-treated isotype-matched control 
antibody or PBS alone. In another experiment, groups of six C57BL/6 mice received 600 
ng of recombinant murine IL-10 per mouse i.p. on days 0, 2, 5 and 7 post infection. 
Treated and control mice were monitored daily for parasitemia and mortality. 
3.3.1 1 Statistical analysis 
Data are represented as means 5 standard error (SE). Significance of differences was 
determined either by Student's t-test or Kruskal-Wallis nonparamehic one-way Analysis 
of Variance (ANOVA) using the StatViewTM.SE 1988 Software (Abacus Concepts Inc. 
Berkeley, CA.). 
3.4 Results 
3.4.1 IL-10 is differentially regulated in genetically susceptible BALBIc and 
resistant C57BLf6 mice infected with T. congohse 
In agreement with what has been reported previously (Ogunrerni and Tabel. 1995), 
BALBk mice infected with 103 organisms of T. congolense were unable to control the 
parasitemia and succumbed to it with mean survival times of 8 -4 + 0.5 days (Figure 3.1 A). 
In similarly infected but relatively resistant C57BLl6 mice, the first wave of parasitemia 
reached its peak at day 7, declined at day 8, and was almost undetectable by day 9 post- 
infection (Figure 3.1 A). As noted previously, the median survival time of T. congolense 
(TC 13)-infected C57BLl6 mice was 163.0 5 12 days (Ogunremi and Tabel, 1995). 
IL-10 was detected at high levels in the plasma of the susceptible BALBIc mice, 
but only at very low levels in the resistant C57BL/6 mice. IL-10 first became detectable 
in the susceptible mice on day 6 post-infection, and increased steadily in concentration to 
a peak on day 10 (Figure 3.1B). There was a strong positive correlation (r = 0.87; p 5 
0.003) between the measured parasitemia and plasma IL- 10 level. Overall, the plasma 
levels of IL-10 were significantly higher in BALBIc mice than in the C57BLl6 mice (p 5 
0.05). 
The expression of IL-10 mRNA in the spleens of infected BALBIc and C57BLl6 
mice was assessed by Northern Analysis and the data expressed graphically as the ratio 
for each sample of the IL-10 &A signal density to that of y-actin. As shown in Figure 
3. I C, BALBIc mice had a higher level induction of IL- 10 mRNA than did C57BLl6 mice. 
The induction of IL- 10 mRNA first became apparent on day 3 post-infection, increased 
markedly on day 4 and remained elevated thereafter in BALBlc mice. In contrast, in 
C57BL/6 mice, the expression of IL-10 mRNA remained relatively low throughout the 
infection period. 

3.4.2 Splenocytes from infected BALB/c mice produce high levels of IL-10 
relative to resistant C57BL/6 mice 
Spleen cells eom infected susceptible BALBk and resistant C57BLI6 mice were cultured 
in vitro for 48 hr either alone or in the presence of Con A and the levels of IL-10 in the 
supernatants were determined by sandwich ELSA (Figure 3.2). On each day tested, both 
spontaneous and Con A-induced secretion of IL-10 were significantIy higher in BALB/c 
cultures than in those from their C57BL/6 counterparts. By day 4 post-infection? IL-I0 
production by the splenocytes From BALB/c mice was high under both conditions and 
remained so throughout the remainder of the infection. In contrast, the splenocytes From 
the resistant C57BL/6 mice only produced substantial amounts of IL-10 on days 6 and 7, 
and by day 8 their production of this cytokine had waned. There was a strong correlation 
(r = 0.84, p < 0.02) between the measured blood parasite numbers and the spontaneous 
secretion of IL-10 in cultures by splenocytes of infected BALBk mice. In general, Con 
A-stimulation resulted in 7- to 50-fold increases in the levels of IL-I 0 secretion by spleen 
cells of both susceptible and resistant mice (Figure 3.2). indicating that T-cells are 
involved in the secretion and/or regulation of this cytokine during experimental T. 
congolense infections in mice. 
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Figure 3.2 Spontaneous and Con A - i n d d  secretion of IL-10 by splenoeytes from 
infected BALB/c (open squares) a d  C57BL16 (closed squares) mice. Normal 
(Day 0) and infected (Days 1-9) spkm c d s  were cultured in 200 p1 of medium in 
96-welI tissue culture clusters at 5 x 1 6  ceh per well for 48 hr in the absence or 
presence of 5 pg/ml Con A, and supanatants were collected and assayed for IL- I0 
by ELISA Results are from a nqmsmtative experiment which was repeated 3 
times. * p < 0.05; ** p < 0.001. 
3.43 IL-10 mediates suppression of splenocyte proliferative responses that occurs 
in infected BALBIc mice 
It is well established in the literature that trypanosome infections lead to a very significant 
suppression of lymphoid reactivity to mitogens and antigens (Daji  et al., 1993; 1996; 
Sileghem et al., 1986; 1987; 1989). While we found that within one day of infection the 
splenocytes of the infected mice exhibited an augmented proliferative response to Con A 
(133 2 7 % of the value for the control, uninfected mice), by day 4 post-infection these 
responses had returned to baseline, and by day 8 post-infection the Con A responses of 
these cells were suppressed (i-e., only 60 2 3 % of the uninfected control mouse 
responses; Figure 3.3A). This suppressive effect was reciprocally related to the 
splenocyte IL- 1 0 production kinetics noted above (r = -0.75 ; p c 0.03). 
Since it has been shown that IL-10 is involved in the down-regulation of T-cell 
responses in many parasitic infections (Denis and Ghadirian 1993; Khan et al., 1995), we 
wished to know if the high plasma and splenic IL-10 levels in infected BALBk mice 
could mediate the observed suppression of the T-cell responses to Con A. We cultured 
splenocytes from infected and control BALBk mice, but then added either anti-IL-10 or 
control antibodies to the cultures and assessed the proliferation of the cells (Figure 3.3b). 
Anti-IL-10 antibodies had no significant effect on the responses of cells from uninfected 
mice to Con A stimulation, but l l l y  reversed (i.e. by 98.9 2 2%; p < 0.001) the 
suppression of proliferation of splenocytes from T. congolense -infected BALB/c mice. 
Control IgM antibodies had no such effect in this system (- 1.00/0 reversal; p > 0.05). 
Figure 3 3  Reversal of T. congolense-elicited suppression of proliferation of 
splenocytes from infected mice. (A) Con A-induced proliferation of spleen cells 
of BALB/c mice is progressively suppressed during experimental T. congolense 
infection and is negatively correlated (r = -0.74, p < 0.03) with the spontaneous 
secretion of IL- 10 in the culture supernatants- (B) Addition of neutralizing anti-IL- 
10 antibodies into the cultures of day 7 or 8 infected spleen cells completely 
reversed the suppression of the Con A-induced proliferative responses. Anti-IL-4 
or control rat IgM antibodies had no such effect. Results are representative of 3 
experiments. * p < 0.05 compared to normal splenocytes; * * p < 0.05 compared to 
isotype-matched control antibody-treated splenocytes. 
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Figure 3.3 
These results demonstrate that IL-10 is important in the immunosuppression observed 
among the splenocytes of T. congolense- infected BALB/c mice. 
Because we have found previously that splenocytes from these mice also secrete 
high levels of IL-4 both spontaneously and in response to Con A challenge (see chapter 
4), we also tested the effects on these responses of neutralizing the endogenous IL-4 in 
this system. Unlike the anti-IL-10 antibodies, anti-IL-4 antibodies did not have any 
significant effect on the proliferative response of splenocytes fkom infected mice, but they 
did significantly decrease (by 50 2 4%; p < 0.01) the proliferative response of Con A- 
challenged splenocytes from control mice . 
3.4.4 The effects of Berenil chemotherapy on the circulating IL-10 levels in T. 
congofenre-infected BALB/c mice 
As noted above, day 9 corresponds to the time at which C57BLl6 mice clear their first 
wave of parasitemia and BALB/c mice succumb to the disease. Chemotherapeutic 
treatment of BALB/c mice with Berenil on days 6 and 7 post-infection lead to an apparent 
clearance of parasites from the blood on day 8. Berenil also reduced the plasma levels of 
IL-10 back to normal (i.e. undetectable) levels and significantly decreased the 
spontaneous and Con A-induced secretion of IL- 10 by splenocytes from animals infected 
for 8 or 9 days. On days 8 and 9. the levels of IL-10 in the 48 hr unstimulated splenocyte 
cultures of infected, untreated versus infected berenil-treated mice were 241.0 If: 17.5 vs. 
72.3 5 8.9 pg/ml (day 8; p < 0.01) and 338.0 5 12.4 vs. 51.3 2 11.2 pg/ml (day 9; p < 
0.0 1 ). Similarly, the levels of IL- 10 production in the Con A-stimulated splenocyte 
cultures were 1928 + 10 1 versus 1096 + 32 pg/ml (day 8; p < 0.05) and 2900 5 132 versus 
670 + 96 p g / d  (day 9; p < 0.01). Berenil treatment of infected BALBk mice also was 
associated with downregulation in the IL-10 mRNA levels on days 8 and 9 post-infection 
(data not shown), and a rapid restoration to near normal levels of the proliferative 
responses to Con A challenge of splenocytes from infected BALB/c mice (Appendix, 
Table 1). These results are consistent with the findings of Rhind et al. (1997), who 
showed that treatment of T. brucei rhodesiense-infected patients with melarsoprol was 
associated with a rapid decline in the hitherto high plasma levels of IL-1 0. 
3.4.5 in vivo administration of anti-IL-10 reduces parasitemia and prolongs the 
median survival period of susceptible BALB/c mice 
We next wished to investigate the potential role of IL-10 as a disease-enhancing 
agent in susceptible BALBIc mice infected with T. congolense. The reasons for this were 
three-fold: fust, the plasma levels and splenocyte production of IL-10 in infected BALB/c 
mice were significantly higher than those of the C57BL/6 mice; second, our in vifro 
evidence strongly implicated IL- 10 in T. congolense-mediated immunosuppression in 
BALBIc mice; and third, Berenil-cure of the BALBIc mice was associated with a 
dampening of IL- 10 production and a reversal of splenocyte suppression in these mice. 
We therefore injected purified monoclonal rat anti-mouse IL-10 antibodies or 
isotype-matched irrelevant control IgM antibodies (200 pghjection) into groups of 
BALB/c mice on days 0, 2, 5, 7 post-infection with T. congolense clone TC13. We then 
monitored the circulating parasite levels of the mice daily. Anti-IL-10 administration 
caused a significant decrease in the parasitemia from day 6 post-infection compared to the 
controls (Figure 3.4A). It also caused a significant decrease in the measured peak 
parasitemia of the treated group compared to the controls (43% decrease, p < 0.0 1 ; Figure 
3.4A) and significantly increased the median survival period from 8 to 11 days (38% 
increase, p c 0.0 1 ; Figure 3.4B). 
3.4.6 Treatment of genetically resistant C57BL16 mice with IL-10 does not render 
them susceptible to trypanosome challenge 
The severity of disease and immunosuppression in the highly susceptible BALB/c mice 
infected with T. congolense appeared to be associated with high levels of IL-10 in the 
plasma and spleen. The question arose then whether administration of IL-10 to a resistant 
mouse strain would enhance their susceptibility to the disease. Groups of 6 C57BU6 
mice were injected i.p. with 600 ng of recombinant murine IL-10 on days 0, 2, 4 and 6 
post-infection. Control mice were injected with saline on the same time schedule. There 
were no significant differences in the levels of circulating parasites among the groups of 
mice treated with either recombinant IL-10 or saline, as determined during the middle of 
the first wave of parasitemia. Similarly, both groups appeared equally healthy at this 
time, suggesting that IL-10 treatments had no significant impact on their resistance to this 
disease. 
PBS 
Control Ab 
Days post-infection 
Figure 3.4 Parasitemia and survival period of T. congoIe11se-infected BALB/c mice 
treated with anti-L10 antibody. In vivo administration of anti-IL-10 antibodies 
during T. congoleme infections signiricantly reduces parasitemia (A) and increases 
the median survival period (B) of the highly susceptible BALB/c mice. Groups of 
6 mice were injected i.p. with 200 pg of anti-IL-10, control antibody or PBS on 
days 0, 2, 5 and 7 post-infec5im Mice were monitored daily for parasitemia and 
swival. * p < 0.001 compared to isotype-matched control antibody-treated group. 
3.5 Discussion 
Our data suggest that endogenously-produced IL- 10 has a moderate disease-enhancing 
role in experimental trypanosome infections in geneticdl y-suscep tible B ALBIc mice. In 
the present, IL- 10 was associated with T. congoiense-mediated suppression of splenic T- 
cell proliferative responses in infected mice and in the control of parasitemia and survival 
of this highly susceptible mouse strain. We have shown that the plasma levels and 
splenocyte production of IL- 10 in infected BALBlc mice were significantly higher than in 
resistant C57BLl6 mice. This IL- 10 production correlated with the rise in parasitemia (r = 
0.93) and was negatively correlated with spleen cells proliferation in response to Con A (r 
= -0.75). Furthermore, Berenil treatment of infected BALBlc mice rapidly cleared the 
parasitemia and led concomitantly to a reduction in plasma IL-10 levels and, finally, in 
vivo administration of anti-IL-LO antibodies significantly reduced the parasitemia and 
increased the median survival period of the highly susceptible BALBIc mice. 
The down-regulation of T-cell proliferation during African trypanosomiasis has 
been attributed to at least two mechanisms, with activated macrophages that have 
interacted with trypanosomes or trypanosomal membranes being central to this effect 
(Askonas 1985; Darji et al., 1992; Sacks et al., 1982; Sileghem et al., 1994a). Both 
prostaglandin-dependent and -independent suppressive mechanisms may be operative 
here (Darji et al., 1992; Kierszenbaum et al., 1991; Sileghem et al., 1986; 1994a), but IL- 
10 is an obvious candidate effector molecule in this suppressor function. It is produced by 
activated macrophages (Ding and Shevach 1992; de Wad Malefyt et al., 1991) and, 
indeed, we have evidence that following phagocytosis of opsonized trypanosomes, bone 
marrow-derived macrophage cell lines from BALB/c mice secrete copious amounts of IL- 
10 relative to similar cells from C57BLl6 mice (R. S. Kaushik, et d., 1998; manuscript in 
preparation). IL- 10 is also produced by a sub-population of C D S  B-cells (O'Garra et al., 
1992) which has been shown to expand greatly during experimental T. congoZenre 
infections in cattle (Naessens and Williams. 1992). However, the finding that T-cell 
mitogen (i.e. Con A) stimulation was associated with up to 50-fold increases in IL-10 
secretion by splenocytes From infected mice indicates that T-cells are at least potentially 
involved in the secretion of this cytokine during experimental T. congolense infections in 
mice. It may be noteworthy though that Iipoarabinomannan (LAM), a cell wall 
component of Mycobacterium tuberculosis which induces IL- I0 production by monocytes 
(Barnes et al., 1992), shares some biochemical similarities with the phosphatidylinositol 
moiety of the variant surface glycoprotein of the African trypanosomes (Barnes et al., 
1992, Ferguson and Williams, 1988). 
Treatment of infected BALBIc mice with berenil on days 6 and 7 lead to clearance 
of parasites fiom the blood and a rapid decline in the IL- 10 mRNA expression and IL-10 
secretion by splenocytes From infected mice. This suggests that the presence of 
trypanosomes in the blood is associated with IL-10 production. The finding that the 
differences in IL-10 production by splenocytes fiom infected BALBlc and C57BL/6 mice 
were apparent as early as day 4 post-infection (Figure 3.2A) despite that fact that 
parasitemia was essentially similar in both strains of mice up to day 6 post-infection 
(Figure 3.1 A), indicates that the differences in IL- 10 secretion were not due to higher 
parasite loads in the susceptible BALBIc mice. Rather, it suggests that the production of 
higher amounts of IL-10 by the susceptible BALB/c mice was as a result of intrinsic 
physiological differences in responses of BALBIc mice to T. congolense infection relative 
to the resistant C57BL/6 mice. 
The role of IL-10 in African trypanosomiasis is not as yet clearly defined. 
Elevated levels of IL-10 mRNA transcripts have been reported in the blood, lymph node 
and splenic leucocytes of T. congolense-infected trypanosusceptible Boran cattle (Taylor 
et aI., 1996) and it has been suggested that this cytokine may be responsible for the 
inhibition of monokine secretion by macrophages from infected cattle (Taylor, 1998). 
Similarly, high levels of IL-10 have been detected in the plasma of human patients 
suffering from chronic T. brucei rhodesiense infections. Treatment of infected patients 
with melarsoprol caused a rapid decline in the plasma levels of this cytokine in these 
patients (Rhind et al., 1997). Our results demonstrate the involvement of IL-10 in T. 
congoZenre-elicited suppression of splenocyte proliferative response to Con A and in 
enhanced susceptibility of BALB/c mice to the disease. 
We have observed that trypanosome-infected BALBk mice also have significantly 
higher levels of IFN-y in their plasma (Tabel et al., 1994) and spleen culture supernatants 
(see chapter 4) than the relatively resistant C57BL16 mice. IFN-y is a prototypic 
macrophage-activating factor and could thus indirectly induce the increases in IL-10 
production observed in this report. Darji et al., (1 996) have shown, for example, that 
CD8' T-cells that are exposed to Trypanosoma brucei brucei-pulsed macrophages secrete 
copious amounts of IM-y. This I N - y  in turn indirectly effects a suppression of T-cell 
proliferative responses, reportedly via a soluble product released from IFN-y-activated 
macrophages (Darji et al. 1992, 1996). We are presently studying the role(s) of this IFN-y 
expression and its interplay with IL-I0 in the enhanced susceptibility to disease and 
immunosuppression seen in BALB/c mice. 
Based on our in vitro results in which anti-IL-10 aniibody treatments completely 
reversed the suppression of Con-A-induced splenocyte proliferation, we had anticipated 
longer survival periods for the anti-11- 1 0-treated T. congolense-infected BALBIc mice 
than were observed. It could be and is likely that, although IL-10 may be important to the 
pathogenesis of this disease, other immunomodulatory molecules are also critically 
involved. It has been shown. for example, that in T. brucei brucei-infected rodents, 
endogenous IFN-y enhances susceptibility to the disease, such that I m - y  gene knock-out 
mice survive longer than their IFN-y sufficient counterparts (Bakhiet et 01. 1996). It is 
almost undoubtedly true that the imrnunoregulation of host resistance to such a complex 
pathogen as T. congolense is very complicated, more so perhaps because of the pleiotropic 
and redundant biologic effects of the many cytokines involved in this disease. An 
alternate, though perhaps more trivial explanation for the unexpectedly low impact of the 
anti-IL-10 antibody treatments could potentidly be related to the IgM isotype of the 
antibodies. While IgG antibodies would penetrate relatively easily through the tissues. the 
much larger IgM antibodies may not do so. Furthermore, IgM-IL-I0 complexes may not 
be as efficiently removed from the circulation as IgG-cytokine complexes, and it has been 
shown that complexing of cytokines to antibodies in vivo can actually protect the cytokine 
from catabolic effects (Martens et al., 1993). 
Attempts to enhance the susceptibility (increased parasitemia and shorter survival 
periods) of the relatively resistant C57BL/6 mice by administration of recombinant IL- 10 
were not successfil. This could be due to insufficient dose to attain physiologically- 
relevant levels of circulating cytokine. This would be particularly important given that 
cytakines in general have very short half lives in vivo. In other instances wherein 
enhanced resistance has been obtained in susceptible mice by in vivo administration of 
anti-cytokine antibodies, similar attempts to make resistant strain mice more susceptible 
by the administration of recombinant cytokines have also failed (Sadick et al., 1991). 
Thus, our inability to render the relatively resistaiit C57BU6 mice more susceptible to T. 
congolense infection by treatment with IL-10 does necessarily not contradict or conflict 
with our data on the susceptible mice. 
The importance of cytokines in altering host resistance to protozoal infections is 
well documented. IL-4, IL-10 and TGF-P have all been shown to be associated with 
enhanced susceptibility to T. c m i  and Leishmania major infections in mice and 
administration of antibodies to these cytokines in vivo has been associated with enhanced 
resistance to these diseases (Reeds et al., 1994; Sadick et al., 1991). IFN-y has been 
claimed to support growth of T. brucei brucei and mice treated with antibodies to IFN--f 
showed reduced parasitemia and longer survival period (Olsson et al., 199 1). Our data 
implicate lL-10 as a disease-enhancing cytokine during T. congolense infection in mice. 
At present time we are examining fkrther the roles and interactions of other cytokines 
with IL- 10 in the pathology of this disease. 
4.0 DIFFERENTIAL INDUCTION, SECRETION AND ROLE OF CYTOKINES 
DURING EXPERIMENTAL TRYPANOSOMA CONCOLENSE INFECTIONS: 
ADMINISTRATION OF ANTI-IF'N-y ANTIBODIES ALTERS TRYPANOSOME- 
SUSCEPTIBLE MICE TO A RESISTANT-LIKE PHENOTYPE 
4.1 Abstract 
The immunologic mechanisms regulating resistance or susceptibility to the blood parasite 
Trypanosoma congolense have been enigmatic. Here, we address the roles of several 
cytokines (IL-4, IFN-y and TNF-a) known to regulate either the immune response of the 
host or the pathogenesis of its infections. We assessed the production of these cytokines in 
vivo and in vitro using genetically susceptible (BALBIc) or resistant (C57BLl6) strains of 
mice infected with cloned T. congolense. We found that the plasma of infected BALB/c 
mice contained dramatically higher levels of IL-4 and IFN-y than the plasma of infected 
C57BL/6 mice. Conversely, the plasma TNF-a levels were significantly elevated in the 
resistant mice relative to the susceptible ones. Differential kinetics for IFN-y mRNA 
accumulation were observed in the spleens of susceptible and resistant mice, with the 
former having earlier and more sustained high steady state mRNA levels than the latter. 
Both unstimulated and concanavalin A (Con A)-induced secretions of IL-4 and IFN-y by 
splenocytes fiom infected BALB/c mice were significantly higher than those from their 
C57BL/6 counterparts. Con A-induced proliferation of splenocytes fiom infected BALB/c 
mice was progressively suppressed. Nitric oxide was not involved in this suppression but 
the suppression was positively correlated with the observed IFN-y secretion. Addition of 
neutralizing monoclonal antibodies to IFN-y to cultures of Con A-stimulated spleen cells 
from infected BALB/c mice effectively reversed this suppression. Furthermore, the 
administration of anti-IFN-y antibodies to BALBk mice early during infection 
dramatically shifted the phenotype of these susceptible mice to a more resistant-like 
phenotype, as expressed by a low and undulating pattern of parasitemia and a > 300% 
increase in survival period. These results strongly suggest that the enhanced induction 
and secretion of IFN-y during T. congolense infections in mice contributes to the relative 
susceptibility of these animals to the disease. 
4.2 Introduction 
African trypanosomes are extra-cellular hernoprotozoan parasites that cause disease and 
death in man and animals in the sub-Saharan Africa. A remarkable feature of salivarim 
trypanosomes is their ability to continually change their surface protein coat, and thereby 
effectively evade the host's immune response (Gray and Luckms, 1976). Infections are 
associated with profound aberrations in the host's immune system, including a 
generalized immunosuppression that affects both the humoral and cellular immune 
compartments (Askonas, 1985; Daji  et al., 1992; Sileghem et al., 1994a). This 
suppression encompasses responses to parasite-related and unrelated antigens and 
mitogens and is responsible for the increased susceptibility of infected animals to 
opportunistic infections as well as for the poor responsiveness of parasite-bearing animals 
to vaccinations against unrelated pathogens (Greenwood et al., 1973). 
The indigenous West African N'dama breed of cattIe are more resistant than the 
Zebu breed to both natural and experimental infections with T. congolense (Mansfield, 
1990; Murray et al., 1982). Similarly, in a mouse model system, BALBk mice are highly 
susceptible to experimental T. congolense infections whereas C57BU6 mice are relatively 
resistant, a s  measured by the levels of parasitemia and immunosuppression and survival 
periods (Pinder et al., 1986; Otesile et al., 1991; Ogunrerni and Tabel, 1995). Genetic 
analyses have shown that differences in resistance to related T. brucei infections in mice 
are not due to differences in the MHC genes (Levine and Mansfield, 1984; Mansfield, 
1990) and that the survival period of BALBlc mice infected with T. congolense is 
significantly correlated with the speed of control of the first wave of parasitemia 
(Ogunrerni and Tabel, 1995). The mechanisms underlying the differences in resistance 
among different breeds of cattle or among inbred mouse strains are poorly understood. 
The patterns of cytokine response during some parasite infections determine or are 
at least strongly correlated to the relative susceptibility of the host (Sher and Coffman, 
1992), although the role(s) of individual cytokines in resistance to trypanosomal 
infections remains equivocal. IFN-y is expressed just preceding the peak of parasitemia in 
mice infected with T. brucei (Bancroft et al., 1981). It has been associated with 
irnrnunosuppression, mediated in part by stimulation of nitric oxide (NO) production by 
macrophages (Sternberg and McGuigan, 1992; Schleifer and Mansfield, 1993), although 
Darji et al., (1996) did not observe any NO-mediated immunosuppression caused by IFN- 
y. IFN-y has also been associated with enhanced host susceptibility to T. brucei infections 
and this effect is related to its direct stirnulatory effect on the growth of T. brucei (Olsson 
et al., 1991). On the other hand, IFN-y also has been reported to mediate parasite control 
and host protection (DeGee et al., 1985). TNF-a appears to play a protective role during 
the initial phase of experimental infection with T. brucei bmcei in mice (Magez et al., 
1993). It has been shown to have a direct lytic effect on T. brucei (L,ucas et al., 1994; 
Magez et., 1997). More recently, the expression of IL-4 mRNA was shown to be higher in 
the relatively resistance C57BL/6 than in susceptible C3H mice infected with T. brucei 
brucei and it was suggested that the differential expression of this cytokine might be 
responsible for the observed differences in resistance between these inbred mouse strains 
(Bakhiet et al., 1996). To M e r  document these inter-strain differences, we examined 
the expression of IL-4, IFN-y and TNF-a in mice infected with T. congolense and the 
roles of the former two cytokines in susceptibility to this parasite. We show here that 
following infection with T. congolense, BALBlc and C57BL/6 mice differentially express 
each of these cytokines, such that the plasma of the highly susceptible BALBlc mice 
contained significantly more IL-4 and IFN-y and less TNF-a than that of the relatively 
resistant C57BW6 mice. The splenocytes from infected BALB/c mice contained more 
IFN-y mRNA and produced much more IL-4 and IFN-y protein than those of the resistant 
C57BL/6 mice. The proliferative responses to Con A of splenocytes from infected 
BALBlc mice were progressively suppressed during infection and thereby showed an 
inverse relationship with IFN-y production. The addition of neutralizing anti-IFN-y 
antibodies into such cultures restored the proliferative responses. Furthermore in vivo, 
anti-IFN-y antibody treatments, but not anti-IL-4 treatments, of infected BALBlc mice 
significantly reduced the parasitemia of these highly susceptible mice and increased their 
life-span relative to untreated or control antibody-treated mice by more than 300%. 
4.3 Materials and Methods 
4.3.1 Mice 
Female BALB/cAnNCrlBR (BALB/c) and outbred CDl mice were obtained from the 
Animal Resource Center of the University of Saskatchewan. Female C57BL/6NCrlBR 
(C57BL/6) mice were purchased from Charles River Laboratories, St. Constant, Quebec. 
The BALB/c and CS7BL/6 mice were 8-10 weeks of age and the CDl mice were 5-6 
weeks old. All mice were maintained according to the recommendations of the Guide for 
the Care and Use of Experimental Animals of the Canadian Council of Animal Care. 
4.3.2 Parasites 
The origin of the T. congolense, variant antigenic type (VAT) TC13 used in the present 
study has been previously described (Tabel, 1982). Cloned trypanosome populations 
were stored as frozen stabilates in liquid nitrogen. Parasites were passaged in CDl mice 
as previously described (Tabel, 1982). The parasites for infection of BALB/c and 
C57BL/6 mice were isolated from the blood of CDl mice three days after passage by 
DEAE anion exchange chromatography (Lanham and Godfiey, 1970). 
4.3.3 Experimental design 
Groups of four to six BALB/c or C57BL/6 mice were infected intraperitonedly (i-p.) with 
1 O3 organisms of T. congolense VAT TC13 and killed with CO, on days 1-1 0 post 
infection. In some experiments, infected mice were treated with berenil (14 mgkg of 
diminazene aceturate; Sigma Chemical Co., St. Louis, Missouri) on day 6 and 7 post- 
infection to cure their infections. On each day indicated, blood was withdrawn from the 
caudal vena cava into syringes containing heparin (final concentration -20 IU/ml), and the 
plasma was collected after centrifuging the blood at 1,000 x g for 30 min. The plasma 
was centrifuged at 13,000 x g for 15 min and the supernatant plasma was stored at -3S°C 
until used. Each experiment (and cytokine determination) was performed at least twice. 
4.3.4 Estimation of parasitemia and survival period 
To estimate the circulating parasite numbers, a drop of blood from the tail vein of each 
infected mouse was examined at 400x magnification by phase contrast microscopy. 
Parasitemia was most often estimated by counting the number of parasites present in at 
least 10 fields, but unusually heavy parasite loads were quantified according to Herbert 
and Lumsden (16). The survival period was defined as the number of days post-infection 
that the infected mice remained alive. Moribund mice were euthanized with CO,. 
BALB/c mice infected with 10' organisms of T. congolense had a mean survival time of 8 
+ 0.5 days and invariably succumbed to the first wave of parasitemia (see Figure 3.1A). 
-
In contrast, infected C57BL/6 mice controlled their first (Figure 3.1A) and many 
subsequent waves of parasitemia. Their survival period was not determined in this study 
but previously has been found to be 163 2 12 days (Ogunremi and Tabel, 1995). 
4.3.5 Splenocyte cultures for measurement of cytokine synthesis 
Single cell suspensions of spleen cells from normal and infected mice were adjusted to 5 x 
lo6 cells/rnl of complete medium (RPMI 1640 supplemented with 10% heat-inactivated 
fetal bovine serum [FBS], 2 rnM L-glutamine, 50 mM 2-mercaptoethanol, and 100 IU/ml 
penicillin/streptomycin) and cultured in 96-well plates (Falcon, VWR Edmonton, AB) at 
0.2 mYwell in a humidified 37"C, 5% CO, atmosphere. Some wells were stimulated with 
5 pg/ml concanavalin A (Con A; Calbiochem, Behring Diagnostics, La Jolla, CA). All 
culture fluids were collected after 48 hours, centrifuged at 1,500 x g for 10 min and the 
supernatant fluids stored at -35°C until used. 
4.3.6 Splenocyte proliferation assay 
Splenocyte proliferation was quantified by the MTT assay as described by Mosrnann 
(1983). Briefly, cells fiom infected mice were cultured for 72 h in 200 pl of complete 
medium at a density of 10' cells/well in 96-well flat bottom plates (~alcon@; Becton 
Dickinson, Lincoln Park, Nn. using quadruplicate cultures of pooled cells fiom groups of 
4 mice. Cells were cultured either without or with Con A (5 pg/ml). Some wells were 
treated with either 5 pg/ml of purified monoclonal rat anti-mouse IM-y antibodies (XMG 
1.2, American Type Tissue Collection [ATCC], Rockville, MD), isotype-matched rat 
IgGl antibody (Cappel, Organon Teknika Inc. Scarborough, ON) or 500 pM (find 
concentration) of nitric oxide synthase (NOS) inhibitor, ~~-monometh~ l -~ -ar~ in ine  
(N'MMA, Sigma).. After 72 hours, we added MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyl tetrazoliurn bromide; Sigma) to a final concentration of 0.48 pg/ml for an 
additional 3 hr. Then the cells were lysed with acidified isopropanol and the dissolved 
mitochondria1 forrnazan precipitates were quantified with an ELISA plate reader by 
measuring the absorbance at 595 nm wavelength. Data are presented as percent 
proliferation relative to splenocytes from uninfected mice stimulated with Con A only. 
4.3.7 Recombinant cytokines and cytokine assays 
Recombinant murine IL-4 and ELISA kits for the determination of plasma IL-4 were 
purchased from ENDOGEN Inc., (Boston, MA). ELISA kits used for determination of 
plasma levels of IFN-y and TNF-a were purchased fiom Genzyme Diagnostics 
(Cambridge, MA). Recombinant murine IL-4, IL-10, IFN-y and TNF-a and the paired 
antibodies used in our sandwich ELISAs for the determination of IL-4, IL-10, IM-y and 
TNF-a in spleen culture supernatants were produced by PharMingen Inc. (San Diego, 
CA). ELISA assays were done according to the manufacturer's suggested protocols. The 
hctional activity of IFN-y in the spleen culture supernatants was quantified by the viral 
cytopathic effect (CPE) reduction assay, using L929 cells and endomyocarditis (EMC) 
virus as described by Familletti et al., (1981). A functional assay was used to detect the 
plasma TNF-a bioactivities as previously described (Green et al., 1984). 
4.3.8 Quantification of nitrite 
Nitric oxide rapidly reacts with oxygen to form nitrate and nitrite, which are relatively 
stable in vitro and are therefore useful for NO quantification (Moncada et al., 1991). The 
concentration of nitrite in supernatant fluids fiom splenocyte cultures was determined by a 
standard Griess reaction (Green et al., 1982). The detection limit of the test was 1 pM 
nitrite. 
4.3.9 Northern blot analysis 
Total cellular RNA was extracted from the spleens of normal and T. congolense-infected 
BALB/c and C57BL/6 mice from days 1-9 post-infection using the guanidinium 
isothiocyanate/cesium chloride method (Chirgwin et al., 1979). For each sample, 20 pg 
of RNA was electrophoresed in a 1.2% denaturing agarose gel, transferred to a nylon 
membrane (ZetabindM, CUNO Lab., Meridien, CN.) by capillary action and cross-linked 
by U.V. irradiation (StratalinkerTM, Stratagene, La Jolla, CA). The membranes were 
blocked with 0.1X SSC/O.5% SDS for 1 hr at 65°C and pre-hybridized overnight at 42°C 
in a solution containing 50% de-ionized formarnide, 0.1 M HEPES, 0.5 M NaCl, 5 mM 
EDTA (pH 8.01, 5X Denhardt's solution, I% SDS, 0.5% sodium pyrophosphate and 12.5 
pg/ml salmon sperm DNA. 3*P-labeled cDNA probes were prepared by the random 
hexarner-labeling technique (Oligolabeling kit, Phmacia,  Uppsala, Sweden) according to 
the manufacturer's suggested protocol. The mouse IFN-y and TNF-a cDNAs consisted of 
550 bp Pst I fragment and 990 bp EcoRI fragments respectively (kindly provided by Dr. 
John Elliot, University of Alberta and Dr. Rik Derynck, Genentech Inc. CA, respectively) 
while the human y-actin cDNA comprised a 91 0 bp EcoRIMind I11 fragment (provided by 
Drs. B. Murphy and V. Misra. University of Saskatchewan). The membranes were 
hybridized overnight at 42°C in pre-hybridization buffer containing 1.5 x 10' cprn/ml of 
labeled probes and then washed two times with 2X SSC/O.I% SDS for 5 min at room 
temperature and another two times for 30 min each with O.2X SSC/O.l% SDS at 42°C. 
Autoradiography was performed at -80°C for 1 - 10 days. Densitornetric analysis of the 
autoradiograph signals was carried out using the Image 1 program fiom Universal 
Imaging Corporation (Westchester, PA). 
4.3.10 Anti-IFN-y and anti-IL-4 antibodies for in vivo experiments 
Anti-IFN-y (XMG 1.2, IgGl isotype, ATCC) and rat anti-mouse IL-4, (1 1 B 1 1, IgG 1 
isotype, ATCC) hybridomas were grown either in serum- and protein-6ee medium 
(GIBCO BRL, Life Technologies, Mississauga, ON) or complete medium. The 
hybridoma supernatants, as well as control culture medium (i.e., complete medium), were 
precipitated with 45% vlv saturated ammonium sulfate solution and dialyzed extensively 
against phosphate-buffered saline (PBS; pH 7.0). Antibodies were fhrther concentrated 
with Arnicon Centriprep 100 concentrators (Amicon, W.R. Grace and Co., Beverly, MA.), 
filtered through 0.2 m syringe filters (Amicon), and protein levels were quantified using 
the Bradford method (BIORAD Protein Assay; BIORAD Laboratories, Richmond, CA). 
The levels of IgGl antibodies in the concentrates were determined by single radial 
irnmunodiffision using goat a~ti-rat IgG antibodies (Cappel) and purified rat IgGl 
(Cap pel) standards. 
4.3.1 1 Treatment of mice with monoclonal antibodies 
For estimation of parasitemia and survival periods, groups of six BALBlc mice were 
injected i.p. on days 0 , 2 , 4  and 6 post-infection with 200 pg of purified anti-IL-4 or anti- 
IFN-y antibodies in 200-400 p1 of PBS. Control mice received PBS alone. Treated and 
control mice were monitored daily for parasitemia and rnoaality. To determine the effect 
of in vivo injections of anti-IFN-y antibodies on cytokine and nitric oxide production, 
groups of four BALBlc mice were injected i-p. with either PBS alone or 200 pg of 
purified anti-IFN-y antibodies in PBS on days 0, 2 and 4 post-infection. Treated and 
control mice were killed on day 7 post-infection. Collection of plasma and spleens for 
splenocyte cultures were carried out as previously described. The levels of IL-10 in the 
plasma and IL- 10 and IF'N-y in culhue supernatants were determined by sandwich ELISA. 
The levels of nitrite in the culture supernatant fluids were determined by a standard Griess 
reaction ( I  3). 
4.3.12 Statistical analysis 
Data are represented as means 2 standard error (SE). Significance of differences was 
determined either by Student's t-test or Kruskal-Wallis nonparametric one-way Analysis 
of Variance (ANOVA) using the StatViewKSE 1988 Software (Abacus Concepts Inc., 
Berkeley, CA.). 
4.4 Results 
4.4.1 The levels of  IL-4, IFN-y and TNFa in the plasma of T. congoIense-infected 
BALB/c and C57BL/6 mice differ significantly 
The levels of IL-4, IFN-y and TNF-a in the plasma of BALBIc and C57BLl6 mice 
infected with T. congolense were measured by sandwich ELISA. IL-4 was detected in the 
plasma of BALB/c mice starting at day 5 post-infection and the levels rapidly increased to 
a peak at day 6 (138 pg/ml), and then gradually declined to insignificant levels by day 9 
post-infection (Figure 4.1A). In contrast, the IL-4 levels in the plasma of C57BLl6 mice 
remained very low or were undetectable throughout the infection period. IN-y  was first 
detected on day 5, also peaked on day 6, but then remained high until death in BALBlc 
mice (Figure 4.1B). The levels of IFN-y in the BALBlc mice were consistently 
significantly higher (p < 0.05) than in those of the C57BLl6 mice. Treatment of infected 
BALB/c mice with Berenil on days 6 and 7 post-infection was associated with a dramatic 
decline in the plasma IFN-y levels on days 8 and 9 post-infection (504 + 31 pg/ml for 
untreated mice vs. 72 + 9 pg/ml for treated animals on day 8, p < 0.01; and similarly 741 
+ 10 pglml vs. 17 2 9 pg/ml, p < 0.001 on day 9 respectively). TNF-a levels in plasma 
d
samples of normal BALB/c mice (as determined by a commercial ELISA kit), were 
surprisingly high (80 pg/ml, Figure 4. LC), although T N F a  was not detectable in these 
samples using a fhctional assay sensitive to 10 p g / d  of TNF-a (data not shown). 
0 2 4 6 8 1 0  
Days post-infection Days post-infection Days post Infection 
Figure 4.1 Plasma levels of IL-4, IFN-y and TNF-a in BALBh (closed squares) and C57BLl6 (open squares) mice infected 
with T. congolense. Plasma samples were collected from four mice on each day post-infection. IL-4 (A), IFN-y (8) and 
TNF-a (C) levels were determined by sandwich ELISA. Data are presented as mean i: SE. The results presented are fiom 
one of two similar experiments. 
Neither the ELISA nor functional assays could detect TNFa  in the plasma of normal 
C57BL/6 mice (Figure 4.1C). The levels of TNF-a in the infected animals of both strains 
of mice increased with the progression of the disease, although they were significantly 
higher @ < 0.05) in C57BL/6 mice than in BALB/c mice on days 6 to 9 post-infection 
(Figure 4. IC). By day 9 post-infection, C57BLl6 mice had about 2.5 times more TNF-a 
in their plasma than the BALBk mice. This period corresponds to the time of control of 
first the wave of parasitemia in C57BLl6 and the time of death in BALB/c mice. The 
TNF-a proteins detected in the plasma of infected C57BL/6 mice by ELISA were tested 
by hctional assay and found to be biologically active. 
4.4.2 Splenic IFN-y and TNFa and hepatic TNF-a mRNA expressions are 
differentially regulated in susceptible BALB/c and resistant C57BL16 mice 
infected with T. congolense 
The steady state levels of IFN-y and TNF-a mRNA in the spleens and TNF-a mRNA in 
the livers of infected BALB/c and C57BL/6 mice was assessed by northern analysis. A 
significant difference was observed in the kinetics of expression of IFN-y mRNA by the 
splenocytes from infected BALB/c and C57BL/6 mice. IFN-y mRNA accumulated to 
high levels in the spleens of infected BALBIc mice by day 3 post-infection and remained 
high thereafter. In the C57BL/6 mice, EN-y mRNA was not detected at very high levels 
until day 6 but then was quickly down-regulated thereafter so that by day 8 the steady 
state levels were about 25% of those at day 6 (Figure 4.2A). Treatment of infected 

BALB/c mice with Berenil on days 6 and 7 post-infection markedly reduced the 
subsequent expression of IFN-y mRNA in the spleen, such that on days 8 and 9 IFN-y 
mRNA was undetectable by northern analysis (data not shown). The kinetics and patterns 
of expression of TNF-a mRNA in the spleens of infected mice were similar in the two 
strains (Figure 4.2B). However, TNF-a rnRNA expression in the livers of BALB/c mice 
gradually rose to a peak on day 7 and markedly declined on day 8 post-infection. This 
drop in T N F a  mRNA levels corresponded with the peak of parasitemia and the onset of 
morbidity in these animals. In contrast, in infected C57BL/6 mice and akin to the plasma 
levels (Figure 4.1 C), TNF-a mRNA levels steadily increased with the progression of the 
infection and were highest on day 9 post-infection by which time the first wave of 
parasitemia was almost controlled (Figure 4.2C). 
4.4.3 Splenocytes from infected BALB/c mice produce higher levels of IL-4 and 
IFN-y than spleen cells from infected C57BLl6 mice 
Splenocytes from infected, highly susceptible BALB/c and relatively resistant C57BL/6 
mice were cultured in vitro for 48 hr either alone or in the presence of Con A and the 
levels of IL-4 and IFN-y in the supernatants determined using a sandwich ELISA. On 
each day tested, both unstirnulated (Figure 4.3) and Con A-induced secretion of these 
cytokines (Appendix figures 1 & 2) were significantly higher in cultures of BALBlc cells 
than in those From C57BLl6 mice. The production of IL-4 by unstimulated BALB/c 
splenocytes first became apparent on day 4, peaked on day 6 and decreased by day 8 post- 
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Figure 4.3 Secretion of IL-4 (A) and 1FN-7 (B) as meaaured by ELTSA or  functional assay (IFN-y only; frame C )  in cultures 
of unstimulated splenocytes from BALBlc and C57BLI6 mice infected with T. congolense. Splenocytes from mice 
infected for varying periods of time were cultured for 48 hr and the supernatant fluids were assayed for IL-4 and IFNq as 
I 
described in materials and methods. Data are presented as mean 2 SE. The results presented are from one of three similar 
experiments. 
infection (Figure 4.3A), but unstimulated C57BLl6 splenocytes produced no detectable 
IL-4 throughout the infection period tested. There was a gradual decline in Con A-induced 
production of IL-4 following infection in BALB/c mice, but by day 7 post-infection, the 
trend was reversed and Con A-driven IL-4 production increased markedly and remained 
high until the death of the mice (Appendix figure 1). In contrast, Con A-driven 
production of IL-4 by splenoc ytes from C5 7B L/6 mice remained either undetectable or 
were significantly lower @ < 0.001) than those from BALB/c mice (Appendix figure 1). 
The production of IFN-y was significantly higher in BALB/c cultures than in the C57BL/6 
cultures. By day 4 post-infection, IFN-y production by unstirnulated splenocytes from 
BALBlc mice was high and remained so throughout the remainder of the infection (Figure 
4.3B). In contrast, the splenocytes from resistant C57BL/6 mice only produced significant 
amounts of IFN-y on days 5 and 6 and by days 7 and 8 post-infection, their production of 
this cytokine had largely waned (Figure 4.3B). There was a strong correlation between 
the rise in parasitemia and the spontaneous secretion of IM-y in culture by splenocytes cf 
infected BALB/c mice (r = 0.89, p < 0.01). Because of the potentially contradictory co- 
production of high levels of I M - y  as well as IL-4 and IL-10 (see chapter 3) in the 
BALB/c mice, we wished to confirm the IFN-y ELISA results using a fhctional assay for 
this cytokine. We observed similar patterns of splenocyte IFN-y production using this 
assay and thereby also confirmed that the immunologically detectable IFN-y in both 
BALB/c and C57BL/6 mice was functionally active (Figure 4.3C). There was no 
detectable TNF-a production by ELISA or bioassay in culture fluids of either the 
unstimulated or Con A-stimulated splenocytes fiom infected BALBlc or C57BLl6 mice 
after 48 hr in culture. 
4.4.4 IFN-y mediates the suppression of mitogen-driven splenocyte proliferation 
in T. congolense-infected BALB/c mice 
A prominent feature of African trypanosomiasis is suppression of lymphocyte reactivity 
to mitogens and antigens (Askonas, 1985; Darji et al., 1992; Sileghern et al., 1994b) and 
the degree of immunosuppression correlates negatively with the resistance exhibited by 
different strains of mice (Pinder et al., 1986). Because it has been shown that IFN-y is 
involved in the down-regulation of T-cell responses in T. brucei brucei (Darji et al., 1993; 
1996) and other parasitic infections (Leite de Moraes et al., 1994; Candolfi et al., 1995) in 
mice, we wished to determine whether the increased production of IFN-y in T. 
congolense-infected BALB/c mice was involved in the suppression of their T-cell 
responses to Con A (see below). 
Spleen cells fiom infected BALB/c mice showed a progressive suppression of 
their proliferative responses to Con A stimulation, most markedly on days 7 to 9 post- 
infection (82 + 10% suppression relative to uninfected controls on day 8). To assess 
the involvement of IFN-y in this suppression, we set up splenocyte cultures from day 
8-infected and control BALBIc mice, adding either anti-IFN-y or equivalent levels of 
isotype-matched control antibodies to the cultures and again assessed the proliferative 
response of the cells to Con A challenge. As shown in figure 4.4, anti-IM-y antibody 
had no significant effect on the Con A response of splenocytes fiom normal mice. but 
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Fi p r e 4.4 Reversal of T. congoleme-elicited suppression of s plenocyt es from 
BALB/c mice infected with T. congoieme by neutralizing mti-m-y 
antibodies. Splenocytes from d e c t e d  or day 7 infected mice were stimulated 
with Con A alone (hatched bars), Con A plus isotype-matched control antibody 
(dotted bars) or Con A plus anti-IFN-y antibodies (solid bars). The proliferation 
of the unstimulated splenocytes from unidected or infected mice in medium 
alone were less than 8%. Data are presented as mean 2 % coefficient of 
variation. The results are from one of three similar experiments. 
abrogated the suppressive effects of T. congolense infection on the proliferation of 
splenocytes from infected mice. In contrast, isotype-matched control antibody had no 
detectable effects on the Con A response of splenocytes from uninfected or infected 
mice. 
Suppression of splenocyte proliferative responses to mitogens in mice infected 
with either T. brucei brucei (Sternberg and McGuigan, 1992) or T. bmcei rhodesiense 
(Schleifer and Mansfield, 1993) have been reported to be partially mediated by NO 
produced by IFN-y-activated rnacrophages. However, Taylor et al. (1996) reported 
that NO-mediated immunosuppression does not operate in cattle infected with T. 
congoleme. In order to test whether NO in some way affects the suppression of 
splenocyte proliferative response observed in T. congolense-infected mice, we 
repeated our proliferation assays, but included a specific NOS inhibitor (N%) in 
the spleen cultures to block the production of NO. As shown in table 4.1, anti-IFN-y 
antibodies again effectively reversed the suppression of Con A-driven proliferation of 
splenocytes from T. congolense-infected mice, but the addition of 500 p M  N%MA 
to the cultures, which inhibited NO production by 93 9.5%, had no significant effect 
on the proliferative responses of these splenocytes. 
These results clearly show that IFN-y is involved in the suppression of 
splenocyte proliferative response associated with T. congolense infections and suggest 
that this cytokine could be important in the disease-promoting immunosuppression 
observed in infected, genetically susceptible mice. They also demonstrate that, as in 
cattle (Taylor et al., 1996), NO does not mediate the suppression of splenocyte 
proliferative responses observed in T. congolense-infected mice. 
Table 4.1. Nitric oxide-independent suppression of Con A-induced proliferation of 
splenocytes from T. congolense-infected BALB/c mice. 
Culture conditiona Percent proliferation + SE 
0 Splenocytes + Con A 100+6 
(I) Splenocytes + Con A 25 2 9b 
(I) Splenocytes + Con A + control antibody 24 5 8' 
(I) Splenocytes + Con A + anti-IFN-y 93 2 7.5 
(I) Splenocytes + Con A + N%MA 28 + 11' 
"Splenocytes from uninfected (U) or T. congolense-infected (I) BALB/c mice were 
cultured at 10' cells/well in a 96-well tissue culture plates in the presence or absence of 5 
pg/ml anti-IFN-y, rat IgGl (isotype-matched control antibody) or 500 pM of NOS 
inhibitor, (N%MA). The cultures were stimulated with 5 pg/ml Con A for 72 hr and 
proliferation of splenocytes was measured by the MTT dye incorporation assay. 
b p < 0.01 vs. splenocytes from uninfected mice. 
'p < 0.0 1 vs. anti- I M - y  antibody-treated cultures. 
4.4.5 In vivo anti-IFN-y administration early during infection reduces 
parasitemia and dramatically prolongs the survival period of genetically 
susceptible BALB/c mice 
We next wished to determine whether neutralization of endogenous IFN-y in genetically 
susceptible BALB/c mice infected with T. congoleme would influence the outcome of the 
disease. The reasons for this arose fiom: i) our earlier observation that the plasma and 
splenocyte culture supernatants fiom infected BALBIc mice consistently contained 
significantly more IFN-y than those fkom their C57BLl6 counterpart mice; ii) the strong 
correlation of IFN-y expression with the rise in parasitemia in susceptible mice; iii) the 
anti-IFN-y-mediated reversal of suppression of the proliferative responses of splenocytes 
from infected BALB/c mice to Con A challenge; and iv) the observation that treatment of 
infected mice with the trypanocidal drug Berenil effectively abolished IFN-y expression in 
infected BALBIc mice. 
Groups of BALBIc mice were injected intraperitoneally with either purified 
monoclonal anti-IFN-y antibodies, anti-IL-4 antibodies (200 pg in 200-400 p1 of PBS per 
injection) or PBS on days 0, 2, 4 and 6 post-infection with T. congolense. The circulating 
parasitemia and survival of the mice were monitored daily. All of the PBS and anti-IL-4- 
treated mice succumbed to their infections within 7-9 days, with each becoming moribund 
at about the time their circulating parasite loads peaked (Figure 4.5 A &B). However, 
anti-IFN-y-treated BALBIc mice effectively adopted a trypanosome-resistant phenotype. 
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Figure 4.5 Parasitemia (A) and survival period (B) of T. congolense-infected BALB/c mice treated with anti-IFN-y 
antibodies. Groups of six BALBlc mice were injected i.p. with either PBS (open squares), anti-IL-4 antibodies (closed 
squares) or anti-IFN-y antibodies (open circles) as described in materials and methods. Parasitemia was monitored daily by 
direct assessment of peripheral blood. The results are from one of two similar experiments. 
Although anti-IFN-y-treatments were stopped on day 6 post-infection, more than half of 
the animals successllly controlled their disease through 3-4 successive waves of 
parasitemia over the next 25 days, almost eliminating trypanosomes fiom their blood 
twice (days 13 and 32; Figure 4.5A). Overall, the anti-IFN-y-treated animals had 
substantially fewer circulating parasites (30% decrease; p c 0.01), and a dramatically 
prolonged mean survival period (> 325% prolonged, p c 0.003; Figure 4.5B) relative to 
the PBS or anti-11-4-treated groups. 
4.4.6 in vivo neutralization of IFN-y dramatically reduces plasma IL-10 and 
spontaneous and Con A-induced secretion of IL-10 by splenocytes from T. 
congolense-in fec ted B ALB/c mice 
We studied the effects of our in vivo anti-IFN-y irnmunotherapy on IL-10 and IFN-y 
production in T. congofense-infected BALB/c mice for two reasons. First, we have 
previously shown that anti-IL- 1 0 antibodies completely reverse trypanosomiasis- 
associated suppression of splenocyte proliferative responses to Con A and also reduce the 
circulating parasitemia and increase the survival periods of infected BALB/c mice (see 
chapter 3). Second, although the biology of T. brucei infections in mice is substantially 
different thm that of 7'. congolense, and anti-IFN-y antibody treatments in T. brucei- 
infected mice were not as effective as those observed herein, it was shown in the T. brucei 
system that anti-IFN-y antibodies inhibited the release of an unidentified soluble factor 
that is associated with suppression of lymph node cell proliferation fiom parasite-pulsed 
macrophages (Darji et al., 1996). We recently have obtained evidence that bone marrow- 
derived macrophages from genetically susceptible but not resistant mice, when pulsed 
simultaneously with IM-y and T. congolense lysates, increase their secretion of IL- I0 by 
2-4 fold (Kaushik et al., manuscript in preparation). 
Groups of mice were injected i.p. with either PBS or 200 pg of anti-IFN-y 
antibodies on days 0, 2 and 4 post-infection. On day 7 the mice were killed and we 
determined the amounts of I M - y  and IL-10 produced by the splenocytes in vitro. We also 
measured the levels of IL-I0 in the plasma of the infected mice. As shown in Figure 6, 
anti-IFN-y antibody treatments reduced the secretion of IFN-y (Figure 4.6A) and IL- 10 
(Figure 4.6B) by unstirnulated splenocytes and the Con A-induced secretion of IL-I0 
(Figure 4.6C) by splenocytes From infected mice, as well as the plasma levels of IL-I 0 
(Figure 4.6D). 
Because it has been reported that the production of NO by splenic macrophages in 
T. brucei rhodesiense-infected mice was mediated by IFN-y (Schleifer and Mansfield, 
1993) and inhibition of NO synthesis abolished immunosuppression and enhanced the 
resistance of T. brucei brucei-infected mice (Mabbott et al., 1995), we determined 
whether the beneficial effects of anti-IFN-y antibodies observed in this study was 
mediated, in part, by inhibition of NO synthesis. Anti-IRJ-y antibody-treatment of 5: 
congoleme-infected BALBk mice surprisingly enhanced the production of NO by 
splenocytes from these mice on day 7 after treatment relative to untreated controls (41.3 2 
1.3 p M  vs. 27.4 2 0.8 pM, p < 0.002; for anti-IFN-y- and PBS-treated mice respectively). 
Figure 4.6 Effects of in vivo administration of anti-IFN-g antibodies on plasma 
IL-10 and secretion of IL-10 by splenocytes from T. congolense-infected 
BALBfc mice. Groups of 4 infected BALB/c mice were injected with either 
PBS alone or 200 pg of anti-IFN-y antibodies as described in materials and 
methods. On day 7 post-infection, the mice were killed to obtain plasma 
samples and to establish splenocyte cultures. The results depict unstimulated 
secretion of IFN-y (A) and IL-10 (B) and Con A-induced IL-I0 secretion (C) by 
splenocytes, as well as plasma levels of IL-10 (D) in anti-IFN-y-treated mice. 
Data are presented as mean + SE. 
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These results unequivocally link IFN-y activity in infected BALBk mice with the 
expression of IL-10. The results, at least in part, imply that the protective effect of anti- 
I M - y  antibodies could be associated with the reduction of IL-10 secretion. This 
observation is consistent with our previous report wherein we demonstrated that IL- I0 is a 
disease-enhancing cytokine in the context of experimental T. congolense infections in 
BALBlc mice (see chapter 3). 
4.5 Discussion 
The present study clearly shows that endogenously produced IFN-y plays a 
disease-enhancing role in experimental T. congolense infections in highly susceptible 
BALBlc mice. The numbers of parasites in the blood were reduced and the survival 
periods were increased by more than 300% following in vivo injections of neudizing 
anti-IFN-y antibodies into such animals, and anti-IFN-y antibodies reversed the splenocyte 
suppression observed within the infected mice in vitro. Furthermore, Berenil cure of these 
animals rapidly cleared the parasitemia and led to a dramatic reduction in the plasma 
levels and secretion of IFN-y by splenocytes from infected mice. 
Suppression of antigen- and mitogen-driven T cell proliferation in the spleen 
and lymph nodes is a prominent feature of African trypanosomiasis (Askonas, 1985; 
Daji et al., 1992; Sileghem et al., 1994%). This has been suggested as one of the 
mechanisms responsible for the observed increase in the susceptibility of 
trypanosome-bearing hosts to opportunistic infections (Greenwood et al., 1973). In 
mice experimentally infected with T. brucei brucei, albeit a significantly different 
parasite than T. congolense, the suppression of lymph node T cell proliferative 
responses is associated with endogenously secreted IFN-y which mediated the 
observed decrease of IL-2 receptor (IL-2R) expression on CD4' T cells. In that 
system, anti-IFN-y antibodies abolish this in v i ~ o  lymphoid suppression via the 
restoration of IL-2R expression (Darji et al., 1993; 1996). However, IFN-y by itself 
was not enough to mediate this suppression. An unknown soluble factor(s) released by 
T. brucei-challenged macrophages also was required to fully implement this 
suppressive effect (Darji et al., 1996). Nitric oxide released by IFN-y-activated 
macrophages has been shown to mediate immunosuppression in mice infected with 7'. 
brucei brucei (Sterberg and McGuigan, 1992; Mabbott et al., 1995) and T. brucei 
rhodesiense (Schleifer and Mansfield, 1993). However, Taylor et al. (1 996) showed 
that NO does not contribute to immunosuppression in T. congolense infections in 
cattle and suggested that the expression of high levels of IL-I0 mRNA transcripts in 
the spleens and lymph nodes in these animals may contribute to the observed 
immunosuppression in infected cattle. We have previously shown that endogenously 
produced IL-10 is associated with the suppression of splenocyte proliferative 
responses to Con A challenge in T. congolense-infected mice, with the highly 
suppressed splenocytes of susceptible BALB/c mice secreting significantly higher 
levels of this cytokine than the spleen cells of the resistant C57BL/6 mice (chapter 3). 
Also, anti-IL-10 antibodies completely reversed this in vitro suppression of 
proliferation the BALB/c splenocytes (chapter 3). We have evidence that IFN-y 
treatment of bone marrow-derived macrophages from highly susceptible BALBlc (but 
not relatively resistant C57BL/6 mice) combined with exposure to T. congolense 
lysates. causes 2-4-fold increases in their production of IL-I0 in response to in vitro 
challenge with T. congolense (Kaushik et al., manuscript in preparation). In line with 
this. we observed herein that in vivo injections of anti-IFN-y antibodies significantly 
reduced the plasma levels of IL- 10 and the secretion of IL-1 0 by splenocytes from T. 
congolense-infected BALBIc mice. IL- LO down-regulates the expression on antigen- 
presenting cells, of the costimulatory molecule B7, which is necessary for T cell 
activation (Moore et al., 1993; Willems et al., 1994). Thus, it is quite likely that the 
immunosuppressive effect of IFN-y observed in mice infected with T. congolense, 
could be mediated, at least in part, via IL-10 secreted by macrophages following their 
interactions with trypanosomes (or their products). 
Some aspects of immunosuppression in mice infected with T. brucei brucei 
(Sternberg and McGuigan, 1992) and T. brucei rhodesiense (Schleifer and Mansfield, 
1993) have been reported to be mediated by NO produced by IFN-y-activated 
macrophages. However, Taylor et a1 (1996) did not observe any NO-mediated 
immunosuppression in cattle infected with T. congolense. Our data clearly indicate 
that, as in cattle (Taylor et al., 1996), NO does not mediate immunosuppression in 
BALB/c mice infected with T. congolense. This is consistent with our observation that 
splenoc ytes from T. congolense-infected B ALB/c and C57BL/6 mice produce almost 
similar amounts of NO despite the apparently higher production of IFN-y and greater 
immunosuppression in BALBk than in C57BLl6 splenocytes (Appendix figure 3). 
Moreover, treatment of infected BALBk mice with anti-IM-y antibodies actually 
increased the production of NO by splenocytes fiom these mice relative to untreated 
control mice. While on the surface it may be surprising that such marked differences 
exist between T. congolense and T. brucei, especially in view of their close structural 
and molecular similarities, we suspect that, among other things, the inherently 
invasive nature of T. brucei as well as differences in some enzymes and in the strains 
of mice used could be important distinguishing factors between the two murine 
models of trypanosomiasis. 
In experimental T. brucei infections in mice, IFN-y has been claimed to have a 
direct growth stimulatory effect on the parasites (Olsson et al., 1991) and as such, the 
reductions in parasitemia and increases in survival periods following anti-IFN-y antibody 
administration were attributed to an inhibition of this stimulatory effect by the antibodies 
(Bakhiet et al., 1990). We have been unable to demonstrate such a growth-stirnulatory 
effect of IFN-y on T. congolense (Kaushik et al., 1997). The reduction in parasitemia and 
the enhanced survival of anti-IFN-y antibody-treated mice reported here would seem more 
likely to be due to an indirect effect, at least in part, resulting fiom the reversal of 
immunosuppression, with a subsequent induction of effective immune response against 
the parasites. In agreement with this hypothesis, we have recently characterized a 
population of Thy 1.2'CD4-8- cells in the spleens of 7'. congolense-infected BALB/c mice 
that produce very high amounts of IL- 10 and IFN-y. These antigen-specific cells co-purify 
with plastic-, nylon wool- and Sephadex G- 10-adherent cells and nonspecifically suppress 
T and B cell responses to mitogens and sheep red blood cess respectively (see chapter 5). 
We detected much more TNFa  in the plasma of the relatively resistant C57BL/6 
mice than in the highly susceptible BALBlc mice and this difference increased markedly 
as the infections progressed. '%e role of TNF-a in the pathogenesis of African 
trypanosomiasis is not yet clearly known. TNF-a has been associated with a suppression 
of lymph node cell proliferative responses (Darji et al., 1992), but it has also been shown 
to be both trypanostatic and trypanolytic for T. brucei brucei and T. brucei rhodesiense in 
vivo and in vitro (Lucas et al., 1994; Magez et al., 1997). The trypanolytic effect of TNF- 
a on T. brucei occurs via a novel lectin-like affinity receptor on the trypanosomes that is 
functionally and spatially distinct from the previously characterized mammalian TNF-a 
receptor binding sites (Lucas et al., 1994). It is undetermined whether T. congolense has 
such binding sites for TNF-a, but the finding that the biologically active form of this 
cytokine was present at much higher levels in the plasma of the more resistant mice at the 
time of control of the circulating parasiternia is consistent with its being associated with 
more effective parasite control and enhanced resistance. 
TNF-a mRNA accumulated to higher steady state levels in the livers than in the 
splenic tissues of all mice and, in addition, the hepatic TNF-a mRNA levels were higher 
on day 9 post-infection in the resistant C57BL/6 than in the susceptible BALB/c mice. 
This suggests that much of the TNF-a detected in the circulation could have been of 
hepatic origin, most probably Kupffer cell-derived. Elimination of trypanosomes fiom 
the blood of infected mice is reportedly mediated primarily by Kupffer cells, the primary 
macrophage population of the liver (MacAskill et al., 1980). Macrophages are a major 
source of TNF-a (Beutler and Cerarni, 1989) and soluble extracts fiom T. brucei have 
been reported to induce production of this cytokine by macrophages in vitro (Magez et al., 
1993), as have the glycophosphatidylinositol (GPI) moieties derived fiom the variant 
surface glycoprotein of T. bmcei (Tachado and Schofield, 1994). IFN-y-primed peritoneal 
and bone marrow-derived macrophages from C57BL6 mice, upon interaction with T. 
congolense lysate, secrete significantly higher amounts of TNF-a than similarly treated 
BALBk mice macrophages (Kaushik et al., manuscript in preparation). 
The simultaneous presence of high levels of IL-4, IL-10 and IFN-y in the plasma 
(Tabel et al., 1994) and splenocyte culture supernatants (see chapter 3) from infected 
BALBk mice is intriguing, considering the ostensibly dichotomous cross-regulatory 
effects of these cytokines on THl and TH2 cells. The significantly higher levels of IL-4 
detected in the plasma and culture supernatants of splenocytes From infected BALBk 
mice contrasts sharply with the lack of or very low levels of IL-4 detected in the C57BL/6 
mice. According to the contemporary immunologic theory, IL-4 is a major factor in 
driving the differentiation of uncommitted T-helper cells to the TH2 phenotype (Seder 
and Paul, 1994), the phenotype presently considered to favor more effective immunologic 
control of extracellular parasites (Sher and Coffinan, 1992). This hypothesis might not 
necessarily apply to the control of African trypanosomes. We did find that treatment of 
resistant and susceptible mice with monoclonal antibodies to IL-4 during T. congolense 
infections did not alter their disease. However, it would be prudent to note that alternate 
explanations for this result could also be feasible, including, for example, inadequate 
neutralization of the cytokine by the antibodies. 
It has been suggested that a balance between IFN-y and TNF-a secretion in mice 
infected with T. brucei determines the course of parasiternia and the outcome of the 
disease (Darji, et al., 1992). If so, it is feasible that such a balance could also affect the 
disease outcome during T. congolense infections in mice. Although we presently have no 
direct evidence for the beneficial effects of TNF-a in T. congolenre-infected mice, the 
finding that only this cytokine was elevated in the plasma of the resistant mice suggests an 
association between high levels of this cytokine and resistance. As mentioned, we have 
recently found that bone marrow-derived macrophages from resistant mice produce higher 
amounts of TNF-a upon interaction with T. congoleme lysate than those fiom susceptible 
mice. High levels of I M - y  could stimulate BALB/c mcrophages, following interaction 
with trypanosomes or their products, to release copious amounts of IL- 10. IL- 10, in turn, 
would contribute to a down-regulation of immune responses (see chapter 3) and R I F a  
secretion by macrophages (Moore et al., 1993) leading to increased susceptibility. 
Conversely, high levels of T N F a  could restrict the parasite growth by its static and lytic 
effects on the trypanosomes (Lucas et al., 1993; Magez et d., 1993; 1997) thereby 
limiting the parasite load and allowing the host to mount an effective immune response 
against the multiplying parasites. 
5.0 EXPERIMENTAL MURINE: TRYPANOSOM2 CONGOLENSE INFECTIONS: 
ROLE OF SPLENIC ADHERENT THYI'CD4S CELLS IN THE PRODUCTION 
OF IL-4, IL-10 AND IFN-y AND M TRYPANOSOME-INDUCED 
IMMUNOSUPPRESSION. 
5.1 Abstract 
Trypanosome-induced suppression of T and B cell responses to parasite-related 
and -unrelated antigens is considered a major mechanism of evasion of the host's immune 
defenses by the parasite. Reduced T and B cell responses have been attributed to 
suppressor T cells, suppressor macrophages, or both. We have previously shown that 
endogenously produced IL-10 and IFN-y mediate the suppression of T cell responses in 
Trypanosoma congolense-infected mice. Here, we show for the first time that, 
Thy 1 -2TD4-8' cells that co-purify with plastic-, nylon wool- or Sephadex G- 10-adherent 
cell populations, in synergy with adherent Thyl.2- cells, are the major producers of IL-4, 
IL-10 and IFN-y in T. congoZense-infected mice. We fuaher demonstrate the involvement 
of these cells in the suppression of T cell proliferative responses to mitogen and in B cell 
responses to an unrelated antigen. 
5.2 Introduction 
African trypanosomes are protozoan parasites that cause disease and death in 
humans and animals. Trypanosoma congolease infections result in severe acute or chronic 
debilitating disease in cattle and other domestic animals. Tvpanosoma congolense is an 
extracellular parasite living in the blood stream of the host and as such, to survive, it must 
have developed very sophisticated mechanisms to evade the host's immune defenses. 
Trypanosome-induced immunosuppression is considered one of the major mechanisms of 
evasion From the host's immune defenses by the parasite (reviewed by Roelants and 
Pinder, 1984: Askonas, 1985; Darji et al., 1992; Sileghem et d., 1994). 
lrnmunosuppression has been described in both natural and experimental infections of 
domestic mammals as well as laboratory rodents and is suggested to be responsible for 
poor responsiveness of trypanosome-bearing hosts to vaccinations (Greenwood et al., 
1973). Lymphocytes from infected hosts give a lower response to T cell mitogens or 
allogeneic cells in vitro (Sileghem et al., 1994). Both in vivo (Murray et al., 1977) and in 
vitro (Eardley and Jayawardena, 1977; Jayawardena and Waksman, 1977) T cell- 
dependent and T cell-independent B cell responses are suppressed. Similarly, suppression 
of antigen-specific T cell proliferative responses to unrelated antigens has been reported in 
infected animals ( D q j  et al., 1996). There is as yet no consensus about the mechanisms 
underlying trypanosome-induced suppression of lymphoid cells. Reduced T and B cell 
responsiveness has been attributed to suppressor T-cells (Eardley and Jayawardena, 1977; 
Jayawardena et d., 1978), suppressor macrophages (Wellhausen and Mansfield, 1979; 
1980; Askonas, 1985; Sileghem et al., 1986; Flynn et d., 1991, Schliefer and Mansfield, 
1993), or a combination of these cell types (Corsini et d., 1977; Roelants and Pinder, 
1984). 
In response to trypanosomal antigens generated during infection, the host's 
immune system produces an array of molecules including cytokines. In T. brucei 
infections, endogenous I M - y  produced by CD8' T cells has been associated with the 
downregulation of lymph node cell proliferative responses to mitogens (Darji et al., 1996) 
and enhanced susceptibility to the disease (Bakhiet et al., 1990; Olsson et al., 1991). 
Depletion of CD8' cells has been shown to suppress both the growth of T. brucei and 
IFN-y secretion in infected rodents (Bakhiet et al., 1990). In this system, it was reported 
that T. brucei releases a molecule that binds to the CD8 molecule on T cells and 
polyclonally activates the CD8* T cells to secrete copious amounts of IFN-y, which, in 
turn, has been reported to stimulate parasite growth (Olsson et al., 199 1). 
BALBk mice are highly susceptible to experimental T. congolense infections 
while C57BL/6 mice are relatively resistant, as measured by the degree and pattern of 
parasitemia and survival period (Otesile and Tabel, 1987; Ogunremi and Tabel, 1995). 
Genetic analysis indicates that the efficiency of control of the first wave of parasitemia in 
mice infected with T. congolense correlates with the survival period (Ogunrerni and 
Tabel, 1995). The patterns of cytokine responses during some parasite infections 
determine or are at least strongly correlated to susceptibility of the host (Sher and 
Coffinan, 1992). We have recently shown that during experimental T. congolense 
infections, the plasma of the highly susceptible BALBIc mice as well as the supernatant 
fluids of their spleen cell cultures contain significantly higher levels of IL-4, IL-10 and 
IM-y than those fiom resistant C57BL/6 mice (see chapters 3 and 4). In addition, we 
found that IL-I0 and IFN-y contributed to the suppression of splenocyte proliferative 
responses to concanavalin A (Con A) in these mice (see chapters 3 and 4). Furthermore, 
in vivo neutralization of these cytokines significantly enhanced the resistance of the highly 
susceptible BALB/c mice to T. congolense infections, as measured by reductions in 
parasitemia and increased mean survival periods. However, in contrast to the report on T. 
brucei (Olsson et al; 1991), we have been unable to demonstrate any growth stirnulatory 
effect of either IFN-y or IL-10 on T. congolense (Kaushik et al., 1997), indicating that the 
beneficial effects of in vivo neutralization of these cytokines were indirect, at least in part 
due to a reversal of immunosuppression. Here, we show that in contrast to 7'. brucei 
infections. most of the IL-4. IL-10 and IM-y  production in T. congolense-infected 
BALBIc mice is mediated by small numbers of Thy1.2+CD4+8- and Thy1.2TD4-8' cells 
that co-purify with plastic-, nylon wool- or Sephadex G-10-adherent cells. We also show 
that the secretion of these cytokines requires cooperation between Thyl.2' and Thyl.2' 
cells in the spleens of infected mice rather than by polyclonal activation involving the 
direct binding of T. congolense-derived molecules to T cells as was reported for T. brucei 
(Olsson et al., 1991). We fiuther demonstrate that these cells are involved in the in vitro 
suppression of B cell responses to a T cell-dependent antigen as well as in the suppression 
of T cell proliferative responses to Con A. 
5.3 Material and Methods 
5.3.1 Mice 
Female BALB/cAnNCrlBR (BALB/c) and outbred CD1 mice were obtained fiom the 
Animal Resource Centre of the University of Saskatchewan. BALWc mice were between 
8 to 10 weeks and CD 1 mice were 5-6 weeks old. All mice were maintained according to 
the recommendations of the Guide to the Care and Use of Experimental Animals of the 
Canadian Council for Animal Care. 
5.3.2 Parasites 
The origin of the T. congolense, variant antigenic type (VAT) TC13 used in the present 
study has been previously described (Otesile and Tabel, 1 987). Cloned trypanosome 
populations were stored as frozen stabilates in liquid nitrogen. Parasites were passaged in 
CDI mice as previously described (Tabel, 1982). The parasites for infection of BALB/c 
mice were isolated fiom the blood of CDI mice three days after passage by DEAE anion 
exchange chromatography (Lanham and Godfrey. 1970). 
5.3.3 Experimental design 
BALB/c mice were infected intrapexitoneally (i.p.) with 10' organisms of T. congolense 
VAT TC 13 in 0.1 ml of Tris-saline-glucose supplemented with 10% heat inactivated fetal 
bovine serum (FBS). Infected mice had a prepatent period of 4 days and developed a 
fulminating and uncontrollable parasitemia that peaked on day 7-9 post-infection. Their 
mean survival period was 8 5 0.5 days. On day 7 post-infection, groups of 6-8 infected 
and control uninfected mice were killed with CO, and their spleens were made into single 
cell suspensions by teasing in complete medium. This medium consisted of RPM1-1640 
(Sigma, Oakville, ON) supplemented with 10% FBS, 2 rnM L-glutmine, 50 mM 2- 
mercarptoethanol and 100 LU. each of penicillin and streptomycin (Gibco, Life 
Technologies, Grand Island, NY). 
5.3.4 Depletion of splenocyte subsets 
One ml aliquots of a splenocyte suspension containing lo7 cells/ml in complete medium 
were added to polypropylene tubes containing 50 p1 of purified monoclonal rat antibody 
to mouse CD4 (GK 1.5, American Type Tissue Collection, [ATCC], Rockville, MD), 
CD8 (TIB 2 1 1. ATCC) or Thy1.2 (TIB 99, ATCC) and incubated on ice for 45 min. 
After 2 washings in RPMI-1640 medium supplemented with 5% FBS (RPMI-5), the cells 
were resuspended in 1 ml RPMI-5 containing 100 pl of LOW-TOX-M rabbit complement 
(Cedarlane, Homby, ON) and incubated at 37OC for 45 rnin. The cells were washed 2 
times, resuspended in complete medium, counted and aliquots were stained either with 
FITC-anti-mouse CD4, PE-anti-mouse CD8 or PE-anti-mouse Thyl.2 (PharMingen, San 
Diego, CA) antibodies for FACS analysis. In all cases, CD4', CD8' and Thyl.2- cells 
depletions were 2 99%. The percentages of non-target cells (CD8' in case of CD4- 
depletions and vice versa) were not significantly affected by these treatments. Whereas 
depletion of Thyl.2' cells resulted in the complete loss of detectable CD8' cells, between 
1.2-1 -8% of CD4' cells were stained with anti-CD4 antibodies. 
5.3.5 Separation of cells by adherence or non-adherence to plastic dishes 
Splenocytes from infected mice were separated into plastic-adherent and non-adherent 
populations as described by Khan et al., (1995), with minor modifications. Briefly, 15 ml 
of cells (1 07/ml) in complete medium were seeded into 20 x 100 mrn tissue culture-treated 
plastic petri dishes (Falcon #3001, VWR, Edmonton, AB) and incubated at 37°C in a 
humidified atmosphere containing 5% CO,. After 3 hr, the non-adherent populations were 
collected and the petri dishes were washed 3 times with medium. The adherent cells were 
dislodged with ice-cold versene (0.02% EDTA in phosphate buffered saline [PBS], pH 
7.2) and gentle scraping. Once separated, the cells were washed 2 times with complete 
medium and the purity was determined by staining a cytospin preparation for non-specific 
esterase (Ennist and Jones, 1983) and Giemsa stain. The adherent cells were greater than 
85% macrophages as assessed by their microscopic morphology. The percentage of 
contaminating T cells as assessed by FACS analysis was less than 8% on all occasions. 
5.3.6 Enrichment of T cells by non-adherence to nylon and Sephadex G-10 
Nylon wool and Sephadex G-10 columns were prepared according to the methods 
described by Hathcock (1994qb). Briefly, 8 rnl of packed sterile nylon wool in 10 ml 
syringes and 30 ml of packed sterile Sephadex G-10 (Pharmacia, Uppsala, Sweden) in 35 
ml syringes were equilibrated by running 50 ml complete medium through each column 
followed by incubation for 45 min at 37°C. Two milliliters and 5 ml of a pre-warmed 
(37°C) single-spleen cell suspension in complete medium (5 x lo' cells/ml) were applied 
to nylon wool or Sephadex G-10 columns, respectively and the columns were incubated 
for 30 min at 37°C. Non-adherent (i.e. effluent) cells were obtained by washing the 
columns with 15 ml (nylon wool) or 35 ml (Sephadex G-10) of complete medium. The 
non-adherent cells were 2 80 and 65% (nylon wool and Sephadex G-10 respectively) 
Thyl.2- as assessed by FACS. To obtain the adherent cells, the nylon wool or the 
Sephadex G-10 slurry was dislodged From each column, flooded with warm medium, 
stirred for 2 min with a pipette and then incubated for 10 min at room temperature. The 
dislodged cells were washed 2 times; their viability, as assessed by trypan blue dye 
exclusion, was greater than 95%. The adherent cells fiom all columns contained less than 
8% Thy1 -2' cells as assessed by FACS. 
5.3.7 Positive enrichment of CDC and Thyl.2' cells 
Enrichment of CD4' and Thyl.2' cells was done by positive selection using rat anti- 
mouse CD4 or rat anti-mouse Thyl.2 antibodies coupled to paramagnetic beads 
respectively (Miltenyi Biotec, Auburn, AL) according to the manufacturer's suggested 
protocols. Briefly, 1 ml aliquots of a single spleen cell suspension (4 x lo7/ml and 3.0 x 
10'1ml for CD4' and Thy 1.2' enrichments respectively) were washed 2 times with buffer 
(PBS supplemented with 5% FBS and 2 rnM EDTA, pH 7.2) and resuspended in 0.5 ml of 
buffer. Then, 80 p1 rat anti-rnouse Thyl.2 antibodies attached to paramagnetic beads 
(Miltenyi) were added to each tube, which was incubated for 20 min at 4°C. AAer 
washing, the cells were resuspended in 0.5 ml of buffer and applied onto a MiniMACS 
Type MS+ column (Miltenyi) attached to a magnet. Non-adherent (i.e. negative) cells 
were collected by washing the column while still in contact with the magnet with 2.5 rnl 
of buffer. To obtain the eluate (i.e. marker-positive) cells, the column was separated fiom 
the magnet and bound cells were eluted by flushing 2 rnl of buffer through the column 
with a plunger. Both effluent and eluate cells were washed ? times with complete 
medium; their viability, as assessed by trypan blue dye exclusion, was always greater than 
99%. Positively enriched cells were greater than 97% positive for their respective 
markers, as assessed by FACS analyses. The negative (effluent) populations contain 
between 5-8% Thy 1.2' cells. 
5.3.8 FACS analysis 
One hundred microliter aliquots of lo7 cells/mI in complete medium were incubated for 
15 min on ice with 10 p1 of rat anti-mouse CD 16/CD32 (Fcy IIAII Receptor, Fc   lock^^, 
PharMingen) monoclonal antibody. Then 10 p1 of appropriate antibodies diluted 1 :5 in 
FACS wash solution (2% BSA in PBS, pH 7.2) was added and incubated for 30 min at 
4°C. The cells were washed 3 times with FACS wash, resuspended in 100 p1 of FACS 
wash and fixed by adding 100 p1 of 2% paraformaldehyde. Fixed cells were analyzed 
using a flow cytometer (FACScan, Becton Dickinson, Mountain View, CA). 
5.3.9 Assay for cooperation of cells and antigen specificity of cytokine secretion 
Splenocytes from both normal and T. congolense-infected BALB/c mice were separated 
into Thyl.2' (eluate) and Thy1 -2' (effluent) populations by positive selection using anti- 
Thy 1 antibody-coated paramagnetic beads (above). The effluent cells, containing between 
5-8% of Thyl.2' cells, were further depleted of the residual contaminating Thyl.2' cells 
by treatment with anti-Thyl.2 antibodies and complement. This treatment removed all 
detectable Thy1.2' cells fiom the effluent populations as assessed by FACS analysis. 
Positively-enriched Thyl.2' cells were cultured either alone or in combination with 
varying concentrations (2.5-20%) of Thy 1.2- cells. 
In another series of experiments, cultures of enriched Thyl.2+ cells from infected 
or uninfected mice were supplemented with whole spleen cells fiom uninfected mice 
completely depleted of Thyl.2' cells by treatment with anti-Thyl.2 antibodies and 
complement (APC). The cultures were subsequently pulsed with 1 O6 trypanosome- 
equivalent of lysates obtained by subjecting parasites isolated by DEAE-cellulose 
chromatography (Lanham and Godfrey, 1977) from the blood of immunosuppressed CD 1 
mice through 3 cycles of Freezing and thawing at -80°C. 
5.3.10 Splenocyte cultures 
Splenocytes were cultured at a concentration of 2.5 x 106 celldm1 in 200 p1 volumes in 
96-well tissue culture plates in a humidified incubator at 37OC, 5% CO, atmosphere. All 
cultures were harvested after 48 hr, centrifuged at 1,500 x g for 15 min and the 
supernatant fluids were stored at -35°C until used. 
5.3.11 Cytokine assays 
The levels of IL-4, IL-10, and IFN-y in the splenocyte culture supernatants were 
determined by routine sandwich ELISA, according to the manufacturer's suggested 
protocols. Recombinant murine IL-4, IL-10 and IFN-y used to generate standard curves 
and paired antibodies against murine IL-4, IL-10, and IFN-y for sandwich ELISA assays 
were produced by PharMingen Inc. (San Diego, CA) and purchased From Cedarlane Inc. 
(Homby, ON). The limits of detection of the ELISAs were 15 p g / d  for IL-4 and 31 
p g h l  for IL- 1 0 and IFN-y . A1 1 experiments were repeated at least two times. 
5.3.12 Splenocyte proliferation assay 
Splenocyte proliferation was quantified by the [)H]T~R uptake assay. Briefly, cells fiom 
uninfected and 7-day infected mice were cultured in 200 p1 complete medium at a density 
of 3 x 10' cells/well in 96-well flat bottom plates (~alcon@, VWR, Edmonton. AB). 
Quadruplicate cultures of pooled cells from groups of 4 mice were performed. To assess 
the suppressive effects of Sephadex G-10-adherent cells, co-cultures of 2 x 10"pleen 
cells fiom uninfected mice and 10' undepleted or Thyl.2- depleted adherent cells fiom 
infected mice were performed. Cells were cultured either with or without Con A (5 
pg/ml). After 48 hr, the cultures were pulsed overnight with 0.5 pCi 13H]TdR (1 mCi/rnl; 
Amersham, Chicago, IL) and cells were harvested with an automated cell harvester (PHD 
cell harvester; Cambridge Technology Inc., Watertown, MA). Incorporation of ['HIT~R 
was determined with a scintillation counter. 
5.3.13 Assay for hemolytic plaque forming cells (PFC) 
B cell responses to sheep red blood cells (SRBC) were assayed by PFC using the slide 
modification of Jeme technique (Dresser, 1978). Groups of mice (4 mice per group) were 
primed intravenously with 0.1% SRBC in PBS and boosted two days later with 10% 
SRBC. Seven days after primary immunization, the mice were killed, the spleens 
collected and suspensions of single-spleen cells prepared. The cells (10~/weU) were 
cultured in 200 p1 volumes in 96-well tissue culture plates in the presence or absence of 
SRBC (2.5 x 10'/well). Some cultures received additional 2.5 x 10' undepleted or 
Thy 1.2'-depleted Sephadex G- l 0-adherent cells fiom uninfected or infected BALBIc 
mice. After four days of in vitro culture, the cells were harvested, washed and used for 
PFC assay against SRBC. 
5.3.14 Statistical analysis 
Data are presented as mean 2 standard error (SE). Significance of differences was 
determined by Student's t-test using the StatViewTM SE Software (Abacus Concepts Inc, 
Berkeley, CA). 
5.4 Results 
5.4.1 Depletion of Thyl.2' or CD4', but not CD8+, cells abolishes spontaneous 
secretion of IL-4, IL-10 and IFN-y by splenocytes from T. congolense-infected 
BAL,B/c mice 
In agreement with our previous results (chapters 3 and 4), unstimulated splenocytes from 
BALBIc mice infected with T. congolense for 7 days, but not spleen cells fiom uninfected 
BALB/c mice, when cultured for 48 hr, secreted considerable amounts of IL-4, IL-10 and 
IFN-y (Figure 5.lA-C). To determine which cell types were associated with the secretion 
of these cytokines by the splenocytes of infected mice, we carried out complement- 
mediated lysis of CD4', CD8' or Thy1 -2' cells using monoclonal antibodies directed 
against these cell surface molecules. In each case. the treatment resulted in greater than 
99% depletion of the appropriate cell type as assessed by FACS. Depletion of CD4- cells 
completely abolished the spontaneous secretion of IL-4 and IFN-y and reduced (by 2 
80%) the secretion of IL-10 by splenocytes fiom infected mice (Figure 5.1A-C). 
Depletion of CD8' cells had no significant effect on IL-10 and IFN-y production but 
caused a minimal and significant increase (1 25%; p < 0.05) in IL-4 production. Depletion 
of CD4' and CD8' cells together or depletion of Thyl.2' cells also effectively abolished 
the production of these cytokines (Figure 5. I A-C). These results clearly indicate that 

Thy 1.2+CD4+8- cells are involved in the regulation andor secretion of IL-4, IL- I0 and 
IFN-y by splenocytes from T. congolense-infected BALB/c mice. These results are in 
contrast with previous reports that showed CD8' T-cells to be the main producers of IFN- 
y in experimental T. brucei infections in mice (Olsson et al., 199 1; Darji et al, 1996). 
5.4.2 Nylon wool- or Sephadex G-10-enriched T cells from the spleens of 7'. 
congdense-infected BALB/c mice do not secrete IL-4, IL-10 and IFN-y 
The above results suggested the possibility that conventional T-cells of the helper 
phenotype were the main sources of IL-4, IL-10 and IFN-y during T. congolense 
infections in BALB/c mice. If this were the case, T cell-enriched splenocyte populations 
would be expected to produce much more of these cytokines than non-T cell-enriched 
splenocytes. We carried out T-cell enrichment by passing splenocytes fiom infected mice 
either through nylon wool or Sephadex G-10 columns (Hathcock, 1994ab). FACS 
analyses of the effluent (non-adherent) cells showed the expected increases in the 
percentages of Thy1.2', CD4' and CD8+ cells with fewer than 20% contaminating non-T 
cells. These cells also proliferated strongly (3-5-fold more than unfractionated controls) 
and secreted large amounts of IL- 10 and IFN-y in culture in response to stimulation with 
concanavalin A (Con A; data not shown). The enriched T cells were cultured for 48 hr and 
the culture supernatants assayed for IL-4, IL-10 and IFN-y. Surprisingly, the T cell- 
enriched spleen cell populations from infected mice almost entirely lacked the ability to 
secrete these cytokines when cultured without mitogen (Figure 5.2A-C), suggesting that 
the responsible cytokine-secreting cells were effectively removed by passage through 
these columns. 
5.4.3 IL-4, IL-10- and IFN-y-producing cells co-purify with ceil populations 
adherent to plastic, nylon wool or Sephadex G-10 
Because the nylon wool- or Sephadex G-10-enriched T cells from infected mice failed to 
secrete IL-4, IL-10 or IFN-y when cultured without mitogen stimulation, we hypothesized 
that the cytokine-producing cells have co-purified with the column-adherent cell 
populations. To test this, we allowed splenocytes from BALB/c mice infected for 7 days 
to adhere either to plastic petri dishes, nylon wool or Sephadex G-10, and then cultured 
both the non-adherent and adherent cells for 48 hr and assayed their supernatants for IL-4, 
IL-10 and IFN-y. As noted above, the production of IL-4. IL-10 and IFN-y by cells non- 
adherent to nylon wool, Sephadex G-10 or plastic was again dramatically reduced 
compared with that by untreated whole splenocyte suspensions from infected mice (Figure 
53A-C). In contrast, each of these cytokines was produced at high levels by the adherent 
cells (Figure 5.3). Indeed, the plastic-adherent spleen cells produced 3-4 fold more IL-4 
and 1.5 fold more IL-10 and IFN-y than did the unfractionated spleen cells (Figure 5.3A- 
C); and nylon wool- or Sephadex G-1 0-adherent cells produced more IL-10 and as much 
IFN-y as did the dact ionated cells (Figure 3). Neither plastic-, nylon wool- nor 
Sephadex G- 1 0-adherent cells from normal uninfected mice produced detectable levels of 
Sephad non-adhr i 
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Figure 5.2 Nylon woo!- or Sephadex G-10-enriched T cells from the spleens of  T. congotense-infected mice do not produce 
iL-4 (A), 1L-I0 (B) or  1FN-y (C) spontaneously in vifro. Single-cell suspension of spleens from BALB/c mice infected with 
T. congolense for 7 days were passed through nylon wool or Sephadex G-10 columns and the effluent (non-adherent) cells 
were collected. Whole spleen cell suspensions (splenocytes) of infected mice or column-fractionated spleen cell suspensions, 
i.e. nylon wool effluent (nylon non-adhr) and Sephadex 0-10 effluent (sephad non-adhr) were cultured at 5 x 10~/well in a 96- 
well tissue culture plates without mi togens. After 48 hr, the supernatant fluids were collected and assayed for IL-4,iL- 10 and 
IFN-y by ELISA. The set of results presented is one of three similar experiments. 

IL-4 (< 15 pg/ml), IL-10 or IFN-y (< 3 1 pg/ml) in culture, indicating that the secretion of 
these cytokines was dependent on the T. congolense infection. 
5.4.4 Thy 1 .Z'CD4'8- and Thy1.2'CD4-CD8 adherent cells produce andlor 
regulate the production of IL-4, IL-10 and IFN-y by splenocytes of T. congolense- 
infected BALB/c mice 
Since depletion of CD4' and Thyl.2' cells fiom whole splenocytes of T. congoleme- 
infected mice resulted in abolition or marked reduction in IL-4, IL-10 and IFN-y 
production, it was surprising that cells that co-purified with plastic- or matrix-adherent 
cell populations were the major producers of these cytokines. Adherent cells of normal 
mice reportedly comprise mostly macrophages and few other accessory cells (Hatchcock 
1994b), none of which secrete IL-4 or IM-y. We then analyzed the adherent cells fiom 
infected mice by FACS to assess their expression of each T cell marker, and found that 
they contained 5-8% Thyl.Z+ cells. We therefore repeated the plastic-adherent cell 
purification, but subsequently depleted the purified adherent cells of residual CD4+, CD8' 
or Thyl.2- cells by complement-mediated lysis and then assessed the abilities of the 
remaining adherent cells to produce IL-4, IL-10 and IFN-y (Figure 5.4A-C). The depletion 
procedures were 2 99% effective in removing the target cell populations, as determined 
by FACS analyses. Depletion of CD4' cells substantially but incompletely reduced IL-4, 
IL- 10 and IR\I-y production by the adherent splenocytes. Depletion of CD8' cells had no 
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Figure 5.4 Adherent ~ h y l . 2 ~ ~ ~ 4 ' 8 -  and ~ h y l . 2 ' ~ ~ 4 ~  secrete 1L-4 (A), lLlO (B) and IFNy (C). Splenocytes from BALBlc 
mice infected for 7 days were separated into plastic-adherent (Adhr) and non-adherent (Non-adhr) populations as described in 
materials and methods. The adherent populations were depleted of CD~', C D ~ '  or Thy1.2' cells by treatment with anti-CD4, 
anti-CD8 or anti-Thyl.2 antibodies and complement respectively. This treatment resulted in 2 99% depletion of target cells. 
The resulting cell populations as well as whole spleen-cell suspensions (splenocytes) from infected mice were then cultured 
without mitogens at a density of 5 x 10'1well. After 48 hr, their supernatant fluids were collected and assayed for IL-4,lL-10 
and IFN-y by ELlSA. Depletion of CD~'  cells caused a reduction in the level of secretion of these cytokines while depletion of 
C D ~ '  cells had either no or minimal effect. Depletion of Thy1.2' cells lead to a total abolition in secretion of these cytokines. . 
Similar results were obtained with either nylon wool- or Sephadex G-logadherent cells. The set of results presented is one of 
two similar experiments. 
effect on IL-10 production, but increased significantly the level of IL-4 secretion @ < 
0.0 1 ) and minimally decreased the IFN-y secretion @ < 0.05) by the plastic-adherent cells. 
In contrast, depletion of Thy1.2' cells completely abolished the secretion of each of these 
cytokines by the adherent cells. 
To find out whether the cytokine-secreting Thyl.2' cells that co-purified with the 
adherent cell populations could be replaced by conventionally purified T cells (which 
were > 80% Thyl.2+ as assessed by FACS), we depleted our plastic-adherent cells from 
infected mice of Thyl.2' cells but then added back 10% of T cells (i.e. nylon non- 
adherent cells) and again assessed the abilities of the T cell-reconstituted Thy 1.2-depleted 
plastic-adherent spleen cells to secrete IL-4, IL-10 and IM-y. This T cell reconstitution 
restored only about 3% of the IFN-y synthesis (320 5 25 p g h l  versus 10,500 + 490 
pg/ml, p < 0.001; for Thyl.2-depleted T cell reconstituted adherent and undepleted 
adherent cells respectively) and had no restorative effects on IL-4 and IL-10. Thus, the 
Thy 1.2- cytokine-secreting cells among the adherent cell populations of the infected mice 
appear to be of a unique phenotype. 
Since Thy1 -2' cell depletion completely ablated cytokine production, but CD4- 
depletion only moderately affected IL-4, IL-10 and IFN-y secretion, the data suggest that 
there exists among the adherent cells a small but important sub-population of Thy1.2*, 
CD4, CD8- cytokine-secreting cells. Our results with the CD8' cell depletion experiments 
also suggest that CD8+ cells among the adherent populations might negatively affect IL-4 
production by these cells. 
5.4.5 IL-4, IL-10 and IFN-y production requires synergy of Thyl.2' and Thyl.2- 
cells 
An apparent paradox associated with African trypanosomiasis is the observation that 
despite the impairment of their proliferative capacity, splenocytes and lymph node cells 
from infected animals secrete large amounts of cytokines, particularly IFN-y (Sileghem et 
al., 1989; Olsson et al., 1991 ; Schleifer et al., 1993; Daji et al., 1996; chapters 3 and 4). 
This has led to the suggestion that the cytokine-producing cells are induced or activated in 
an antigen non-specific manner, perhaps by a mechanism such as polyclonal T cell 
activation mediated by a direct interaction of trypanosome-derived molecules with the T 
cells (Olsson et al., 1993). To address this issue, we carried out positive selection of CD4' 
and Thyl.2- cells from splenocytes of T. congolense-infected BALB/c mice by using 
columns of magnetic beads coated with specific antibodies (MACS technology; see 
below). Positively enriched cells were > 97% pure for the CD4- or Thy1 2' markers 
respectively as assessed by FACS analyses. As shown in Figure 5.5, neither the MACS 
Thyl.2-positive nor -negative populations secreted substantial amounts of IL-4, IL-10 or 
IFN-y relative to the unfiactionated spleen cells suggesting that the production of these 
cytokines by the Thy 1.2' cells might require cooperation with Thy 1.2- cells. 
Thy 1.2- P 
Figure 5.5. Enriched ~hyl .2 '  and C D ~ '  splenocytes of T. congoletnse-infected mice lacked the ability to secrete IL-4 (A), IL- 
10 (B) and 1FN-y (C). Single-cell suspensions were prepared from the spleens of BALBlc mice infected with T. congolense 
for 7 days. Positive selection of Thyl.2 and CD4 cells was carried out with paramagnetic beads coated with antibodies to 
Thyl.2 and CD4 respectively. The enriched cells were 2 97% pure for their respective target cells as assessed by FACS 
analyses. Positive (Thy 1.2') and negative (Thy 1.2') cells as well as whole spleen cell suspensions (splenocytes) from infected 
mice were cultured without mitogens at a density of 5 x 10~/well in a 96-well tissue culture plate. After 48 hr, the supernatant 
fluids were collected and assayed for IL-4, IL-10 and IFN-y by ELISA. The set of results presented is one of three similar 
experiments. 
In another set of experiments, Thyl.2' cells were cultured either alone or in the 
presence of varying concentrations of Thyl.2-negative cells which had been completely 
depleted of all residual Thyl.2' cells by treatment with anti-Thyl.2 antibodies and 
complement. Supplementation of positively-selected Thyl.2' cells from infected mice 
with Thyl -2' cells derived fiom the spleens of infected (Figure 5.6), but not uninfected 
(data not shown), mice resulted in a dose-dependent restoration of cytokine production by 
the T cells. Thyl.2- cells fiom the infected mice did not induce positively-selected 
Thyl.2' spleen cells from uninfected mice to secrete detectable levels of IFN-y and 
induced only low/background production of IL- 10 (Table 5.1 ). These results demonstrate 
that the secretion of IL-10 and IFN-y by splenocytes fiom T. congolense-infected mice 
operates via the cooperation of Thyl.2' and Thyl.2' cells derived fiom the spleens of T. 
congolense-infected mice. 
To test whether the production of IL-10 and I M - y  by enriched Thyl -2' cells fiom 
the spleens of infected mice might occur by an antigen-specific mechanism, we 
supplemented cultures of Thyl.2' cells with whole spleen cells from uninfected mice 
which had been completely depleted of Thyl.2' cells by treatment with anti-Thyl.2 
antibodies and complement (APC). These cultures were then pulsed with 106 parasite- 
equivalent of T. congolerzse lysate. As shown in table 5.2, supplementation with APC 
restores the abilities of Thy 1.2' cells from infected, but not uninfected, mice to secrete IL- 
10 and IFN-y in response to T. congoZense lysates. Direct pulsing of Thy1.2' cells horn 
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Thyl.2t t 2.5% ThytS 
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Figure 5.6 Secretion of IL-10 and IFN-y by enriched ~ h y l . 2 '  cells from the spleens of infected mice i3 drastically reduced. 
Thyl.2- cells restored 1L-10 and IFN-y secretion in a dose-dependent manner. ~ h y l . 2 ~  enrichment was carried out with 
paramagnetic beads coated with anti-Thyl.2 antibodies (materials and methods). The effluent cell populations (Thy 1.2') were 
treated with anti-Thy 1.2 antibodies and complement to completely deplete them of any residual Thy 1.2' cells. Enriched 
Thyl.2' cells were cultured at a density of 5 x i0'1well without rnitogens either alone or with varying concentrations of 
Thyl.2' cells. Cultures were also set up with 5 x 10' cells/well of whole spleen cell suspensions (splenocytes) from infected 
BALB/c mice as well as effluent cells (Thy 1.23 cells alone. After 48 hr, the supernatant fluids were collected and assayed for 
IL-I 0 and IFN-y by ELISA. The set of results presented is one of two similar experiments. 
TABLE 5.1. Optimal secretion of IL- 1 0 and IFN-y requires cooperation of positively enriched 
Thy 1' cells and Thy 1.2- cells derived fiom the spleens of T. congolense-infected, but 
not uninfected, micea. 
Culture condition Concentration of cpokine in 
culture fluid @g/d)  
IL- 10 IFN-y 
infectedb, splenocytesc 1805 2 42 5134+64 
Infected, Thy 1.2' cells 412 + 6' 500 2 24' 
Infected, Thy 1 2- cells 39 50 + 10 
Infected, Thy l.2+ cells + Infected, Thy 1.2- cells 2342 25 4708 +4 46 
Infected, Thy l.2+ cells + Normal, Thy 1.2- cells 130 18 432  12 
~orrnal*, splenocytes 65 + 12 ND 
Normal, Thy 1 -2' cells 3 8 5 3  ND 
Normal, Thy 1.2' cells + Infected, Thy 1.2- cells 103 2 56' ND 
" Single-cell suspension of spleens from uninfected or infected mice were separated into 
Thy 1.2- and Thy 1.2- populations using anti-Thy 1.2 antibody-coated paramagnetic beads. The 
Thy 1.2- populations were funher treated with anti-Thy 1.2 antibody and complement to 
completely deplete them of any residual Thy 1.2' cells. The enriched Thyl.2' cells were 
cultured at 5 x 10' cells/well either alone or with 5 x lo4 Thy 1.2- cells in 96-well tissue culture 
plates. After 48 hr, the supernatant fluids were collected and assayed for IL-10 and I M - y  by 
ELISA. Values presented represent the mean S.E of four wells. The results shown are 
representative of two similar experiments. 
b cells derived from infected mice 
'whole spleen cell cultures 
dcells derived fiom uninfected mice 
' p < 0.00 1 versus whole spleen cells fiom infected mice 
' p < 0.001 versus Infected, Thy1.2' + 5 x 10' Infected, Thy1 -2- cells 
ND = Not detected (i.e. below the sensitivity of the ELISA) 
TABLE 5.2. Secretion of IL-I0 and IFN-y by Thyl' cells in the spleens of T. congolense- 
infected BALB/c mice is trypanosome-specific and requires splenic Thyl.2' cells as 
antigen-presenting cells. 
Culture conditiona Concentration of cytokine in 
culture fluid @g/ml) 
IL- 10 IFN-y 
infectedb, splenocytesc 726 2 12 2256 2 14 
Infected, Thy 1 -2' cells ND 80 2 15 
Infected, Thy 1.2' cells + Trypsd ND ND 
Infected, Thy1.2' cells + APCe + Tryps 1020 2 41 1744 36 
~ormal', splenocytes ND ND 
Normal, Thy 1.2' cells ND ND 
Normal, Thy 1.2' cells + APC + Tryps ND ND 
APC + Tryps ND ND 
a Single-cell suspensions of spleens fiom uninfected or infected mice were enriched for Thy 1.2- 
cells by anti-Thy 1.2 antibody-coated paramagnetic beads. Enriched Thy 1 2' cells (5 x 1 o5 
cells/well) were supplemented with 10' uninfected spleen cells (APC) completely depleted of 
Thyl.2' cells by treatment with anti-Thy 1.2 antibodies and complement and cultured in a 96- 
well tissue culture plates in the presence or absence of T. congolense lysate. After 48 hr, the 
supernatant fluids were collected and assayed for IL-10 and IFN-y by ELISA. Values presented 
represent the mean f S.E of four wells. 
Cells derived fiom infected mice 
' Whole spleen cell cultures 
Trypanosoma congolense lysate 
' Whole spleen cells fiom uninfected mice treated with anti-Thy 1.2 antibodies + complement 
' cells derived from uninfected mice 
ND = Not detected (values below the sensitivity of the ELISA) 
either uninfected or T. congolense-infected mice with T. congolense lysates did not induce 
either IL-I 0 or IFN-y secretion. These results suggest that the production of IL-10 and 
IFN-y by splenocytes fiom T. congolense-infected BALBk mice might occur by an 
antigen-specific mechanism rather than by direct binding of T. congolense-derived 
molecules to T cells as was reported for T. brucei (Olsson et al., 1993). 
5.4.6 Adherent Thyl.2' spleen cells from T. congolense-infected mice suppress T 
and B cell responses to mitogen and parasite-unrelated antigen 
One of the prominent features of trypanosomiasis is a suppression of T and B cell 
responses to parasite-related and -unrelated antigens (Roelants and Pinder, 1984; 
Askonas, 1985; Sileghem et al., 1994). Suppressor T cells (Eardley and Jayawardena, 
1977; Jayawardena et al., 1978), or macrophages (Askonas, 1985; Sileghem et al., 1986; 
Schliefer and Mansfield, 1993), or a combination of these cell types (Corsini et al., 1977; 
Roelants and Pinder. 1984) have variously been implicated in this effect. Because IL-10 
(chapter 3) and IFN-y (Darji et al., 1996; see chapter 4) have been shown to be involved in 
suppression of T cell responses in trypanosome-infected animals. we wished to know if 
the matrix-adherent Thy 1 -2- cells which secrete large amounts of IL- 10 and IFN-y (above) 
might effect a suppression of the T and B cell responses. To test the potential effects on T 
cell responses, we co-cultured spleen cells &om uninfected mice with Sephadex-G-10- 
adherent cells purified fiom the spleens of either uninfected or T. congolense-infected 
BALB/c mice and challenged the cells with Con A. In some co-cultures, the Sephadex G- 
1 O-adherent cells were further Thy 1 -2-depleted as above before being used in the cultures. 
Co-culture of spleen cells from uninfected mice with Sephadex-adherent cells fiom 
infected, but not uninfected, mice resulted in a significant (48 2 5%) suppression of the 
proliferative response to Con A. Depletion of Thyl.2- cells from the adherent cells 
reversed this suppression (Figure 5.7A). 
In another set of experiments, spleen cells fiom BALB/c mice immunized 7 days 
previously with sheep red blood cells (SRBC) were stimulated in vitro with SRBC in the 
absence or presence of Sephadex G-Wadherent cells from either uninfected or T. 
congolense-infected mice. Four days later, the B cell responses to SRBC were measured 
using a hemolytic plaque-forming cell (PFC) assay. As shown in Figure 5.7B, adherent 
cells fiom the spleens of infected, but not those from uninfected, mice significantly 
suppressed (80 + 3%) the B cell response to SRBC. Again. depletion of Thyl.2' cells 
from the adherent cells of infected mice effectively reversed this suppression. 
Taken together, these results suggest that adherent Thyl.2' cells fiom the spleens 
of T. congolense-infected mice are involved in the suppression of T and B cell responses 
observed in these animals. They demonstrate also that this suppression is not effected in 
an antigen-specific fashion. 
Figure 5.7 Adherent Thy12+ c e h  suppress T and B cell responses. Sephadm-G-10- 
adhcrmt cell populations were obtained h m  dngle-cell suspensions of spleens 
fiom uninfected (no=) or B m / c  mice infected for 7 days with T. congoZenre 
(infect). Depletion of residual ~ h y  l2+ cek was carried out by treatment with 
antibody and complemmt of adhmnt cells derived fiom uninfected (Thy12 
norm.) or infected (Thy 1 2 -  infect.) mice. (A) Whole splecn-ceU suspensions from 
uninfected or infected mice were cultured either alone (3 x 10' c e ~ w e l l )  orwith 
undepIeted or Thy 12depieted ScphRdex-G- l &adherent cells (1 05/weu) h m  
uninfected or infected mice in the presence of 5 pgl ml Con A. After 48 k, the 
cultures were pulsed with 0.5 pCi ['II]T~R overnight and the uptake of ['HJT~R 
was determined. (B) BALB/c mice were primed with 0. 1% SBRC and boosted 
with 10% SBRC 3 days later. Seven days a h  primary immtmi7atioq the mice 
were eutbanized and single-cell suspensions were made from their spleens. 
Splenocytcs (1 06/weIl) were c u i t u d  in viho in the presence of 2.5 x 10' SRBC 
and 2.5 x 1 oS/wefl undepleted or Thy1 2-depleted Sephadex-G- 1 0-adherent cells 
from normal or infected mice. After 4 days of culture, the number of anti-SRBC 
plaque-forming cells (PFC) was determined. 
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5.5 Discussion 
This work identified a unique set of T cells that is involved in the regulation and/or 
secretion of IL-4, IL-10 and IFN-y in the spleens of BALBIc mice infected with T. 
congolense. According to the data presented here, both Thy 1.2TD4-8- and Thy 1.2TD4' 
8- cells are involved in this process. In T. brucei-infected rodents, CD8' but not CD4- 
cells have been shown to be the major producers of IFN-y (Bakhiet et al., 1990; 1993). In 
that system, direct binding of a trypanosoma1 component to the CD8 molecule on CD8' T 
cells was reported to trigger the production of large amounts of IFN-y (Olsson et al.. 199 1 ; 
Bakhiet et al., 1990). IFN-y was funher reported to have a direct growth-stirnulatory effect 
on the parasite (Bakhiet et al., 1990; 1996), such that depletion of these cells in vivo 
during infection was associated with a reduction in parasitemia and enhanced resistance to 
the disease (Bakhiet et at., 1991). In addition, CD8-, but not CDCknockout mice 
exhibited an enhanced resistance to T. brucei infections (Rottenberg et al., 1993) and this 
effect was reportedly mediated via a suppression of IFN-y secretion. In T. congolense- 
infected mice, we found higher levels of IL-10 and IFN-y rnRNA induction and cytokine 
expression by spleen cells of infected highly susceptible BALB/c than by those of 
relatively resistant C57BL/6 mice (see chapters 3 and 4). However, we were unable to 
show any growth stirnulatory effect of IFN-y on T. congolense (Kaushik et d., 1997). Our 
data rather indicate that the production of higher levels of IL-10 and IFN-y by the 
susceptible mice contributes to their enhanced susceptibility to the disease, in part through 
the immunosuppressive effects of these cytokines (see chapters 3 and 4). Our current data 
also differ from that obtained in the T. brucei-infected mice, in that they show that 
Thyl.TCD4'8- and Thy 1.2TD4-8- cells are the major producers andlor regulators of IL-4, 
IL-10 and IFN-y in BALBlc mice infected with T. congolense. In fact, our evidence 
suggests that CD8' cells could be involved in a down-regulation of these cytokines, since 
depletion of CD8+ cells often led to a relative increase in the secretion of some of these 
cytokines (Figures 5.1 & 5.4). This finding is in agreement with recent observations that 
depletion of CD8- cells in T. congolense-infected susceptible Zebu cattle has no effect in 
the outcome of the disease (Sileghem and Naessens, 1995), despite the fact that spleen 
and lymph node cells from infected animals secrete high levels of 1FN-y in vitro (Flynn et 
al., 1992). While on the surface it may be surprising that such marked differences exist 
between T. brucei and T. congolense, especially in view of their close structural and 
molecular similarities, we suspect that, among other things, the inherently invasive nature 
of T. brucei as well as the differences in the strains of mice used could be important 
distinguishing factors between the two model systems. 
We provided clues that secretion of cytokines (IL-4, IL-10 and IFN-y) by the 
Thy 1.2' cells from the spleens of T. congolense-infected BALBIc mice might occur by an 
antigen-specific manner rather than by mechanisms of polyclonal activation involving 
direct binding of T. congolense-derived molecules to T cells as was reported for T. brucei 
infections (Bakhiet et al., 1990; Olsson et al., 1993). Several lines of evidence support 
this. Firstly, cpokine secretion was restricted to a small percentage of T cells present in 
the plastic-, nylon wool- or Sephadex G-10-adherent cell populations. Furthermore, 
positively selected Thy 1.2' cells could not produce IL-4, IL- 10 or IFN-y unless these 
purified T cells were supplemented with purified Thy1.2- cells kom infected mice. 
Supplementation with only Thyl.2- spleen cells (APC) from uninfected mice did not 
restore cytokine secretion by Thyl.2' cells fiom infected mice. However, in the presence 
of T. congolense lysate, these APC were able to restore cytokine secretion by Thyl.2- 
splenocytes fiom infected, but not u d e c t e d ,  mice. This cytokine secretion response 
could not be restored by pulsing purified Thy 1.2' T cells with optimal concentrations of T. 
congolense antigens alone. The purified Thy1.2- cells From infected mice were unable to 
induce cytokine secretion by positively-enriched Thyl.2' cells fiom uninfected mice. This 
is probably due to the fact that the few antigen-specific Thyl.Z+ cells which would be 
expected to exist in the spleens of uninfected mice would require much more than 48 hr of 
primary in v i m  culture for expansion and cytokine secretion, whereas those fiom mice 
infected for 7 days have been primed and expanded in vivo. 
We established a potential role for such adherent Thyl.2' cells in the pathogenesis 
of African trypanososmiasis by demonstrating their involvement in the suppression of T 
and B cell responses to mitogen and SRBC respectively. Co-culture of the adherent cells 
from infected mice with whole spleen cells from uninfected mice resulted in a suppression 
of the normal proliferative responses to Con A, and this effect was abolished by depletion 
of Thyl.2' cells fiom the adherent cell populations (Figure 5.7A). Furthermore, the 
dramatic suppression of B cell response to SRBC in vitro by the adherent cell populations 
was also ablated by depletion of these Thyl.2' cells (Figure 5.7B). Adoptive transfer 
experiments have shown that both T cells (Eardley and Jayawardena, 1977; Jayawardena 
et al., 1978) and adherent macrophage-like cells (Askonas, 1985; Sileghem et al., 1986; 
Flynn et al., 1991; Schleifer and Mansfield, 1993) are involved in the suppression of 
lymphoid cell responses in trypanosome-infected mice. In a review of the mechanisms of 
trypanosome-induced immunosuppression, Roelants and Pinder ( 1984) suggested that 
both cell types are important. Our present data demonstrate that adherent T cells or T cells 
that co-purify with adherent cell populations are involved in the pathogenesis of 
immunosuppression observed in T. congoleme-infected mice. We have previously shown 
that IL-10 and IFN-y produced during T. congolense infections mediate suppression of 
lymphoid cell proliferative responses (see chapters 3 and 4). Our finding that the secretion 
of IL-10 and IFN-y by spleen cells from infected mice requires cooperation between 
adherent-Thy 1.2- and -Thy 1.2' cells W e r  supports the reports of Corsini et al. (1 978) 
and suggestions of Roelants and Pinder (1984) that both T cells and macrophages are 
important in trypanosome-induced immunosuppression. Suppressor T cells could alter 
(via cell to cell contact or cytokines) macrophage functions and its cytokine patterns 
thereby rendering them suppressive. In line with this, we have obtained recent evidence 
that simultaneous exposure of bone marrow-derived mzcrophages from trypanosome- 
susceptible but not -resistant mice to IFN-y and trypanosomal lysate increases 2-4 fold 
their IL-10 secretion (Kaushik et al., manuscript in preparation). IL-10 is a potent 
immunosuppressive cytokine (Moore et al., 1990) and its increases contribute to 
trypanosome-induced immunosuppression (see chapter 3). 
Several lines of evidence suggest that the cell(s) producing IL-4, IL-10 and IFN-y 
in the spleens of T. congolense-infected BALBIc mice are not conventional helper T-cells. 
First, nylon wool- and Sephadex G-10-non-adherent cells, which are enriched for 
conventional T-cells, did not secrete these cytokines (Figure 5.2) and the production of 
these cytokines by cells non-adherent to plastic was dramatically reduced. Second, plastic- 
adherent cell populations produced 2-5 fold more of each cytokine than did the non- 
adherent cells, despite the fact that they contained only about 5 4 %  of CD4' and/or CD8' 
cells. Furthermore, nylon wool- and Sephadex G-1 0-adherent cells containing fewer than 
5% of CD4' and/or CD8' cells produced as much or even more of each cytokine than did 
unfractionated splenocytes from infected mice. Moreover, depletion of CD4' cells from 
the adherent cell populations did not completely abolish the secretion of these cytokines, 
and CD8' cell depletion had very little negative effect; only the depletion of Thy 1.2' cells 
fiom the adherent cells could completely abolish cytokine secretion. 
It has not yet been tested whether IL-4, IL-10- and IFN-y-secreting cells were 
NK 1 ' T-cells. NK 1 * T cells, which can either be Thy I.2TD4'8- (60%) or Thy l.2'CD4-8- 
(40%), are known to secrete large amounts of IL-4, IL-10 and IFN-y upon appropriate 
stimulation, and comprise about 0.5 - 1% of splenocytes from normal mice (reviewed by 
Bendelac, 1995; Vicari and Zlotnik, 1996; Bendelac et al., 1997). Their activation is 
restricted by the CDl molecule and they recognize both hydrophobic peptides and lipid 
antigens presented in association with CD 1 (Porcelli et al., 1992; Bendelac et al., 1997). 
Because they have a conventional ap TCR (with the associated CD3 molecules), they are 
activated by anti-CD3 or anti-ap TCR antibodies to release large amounts of cytokines, 
including IL-4, IL-10 and 1FN-y (Zlotnik et al., 1992; Arase et al., 1993; Vicari and 
Zlotnik, 1996). This might explain why splenocytes fiom T. congolense-infected B A L M  
mice secrete large amounts of IL-4, IL-10 and IFN-y following Con A stimulation despite 
the fact that proliferative responses are usually suppressed (chapter 3). Double negative 
NKI . I  T cells have been reported to act as suppressor cells in hemopoesis (Yankelevich et 
al., 1989; W y  and Demert, 1992) and during tumor development (Tamada et al., 1997). 
Also, these cells have been shown to have regulatory properties by suppressing the 
induction of autoreactive lymphocytes (Takeda and Demert, 1993; Sumida et al., 1995; 
Meiza et aI., 1996). 
The mechanisms of induction and activation of adherent Thy1.2+CD4'8- and 
Thy1.2TD4-8- cells during African trypanosomiasis is as yet unknown. However, it is 
conceivable that they may be induced following recognition of some trypanosoma1 
antigen, e.g. the lipid portion of the variant surface glycoprotein. Whatever the 
mechanisms are, our results indicate that the stimulation of adherent Thy1.2-CD4'8- and 
Thy 1.2TD4-8- cells to produce IL-4, IL- 10 and IFN-y requires cooperation between these 
cells and Thyl.2- cells derived from the spleens of T congoleme-infected mice and that 
these cells are involved in immunosuppression observed in infected animals. 
6.0 CYTOKINE AND ANTIBODY RESPONSES TO EXPERIMENTAL 
TRYPAIVOSOIMA CONGOLENSE INFECTIONS IN TWO INBRED STRAINS OF 
MICE THAT DIFFER IN RESISTANCE 
6.1 Abstract 
We studied IL-4, IL-I0 and IFN-y secretion by splenocytes and the plasma levels of 
different antibody isotypes against various antigens of Trypanosoma congolense in highly 
susceptible BALBIc and relatively resistant C57BW6 mice during the early course of 
infection with T. congoleme. The pattern and kinetics of cytokine spot-forming cells in 
the spleens were essentially similar in the two mouse strains although higher numbers 
were detected in the spleens of BALBIc than C57BL/6 mice on some days post-infection. 
However, the amount IL-4, IL-10 and IFN-y secreted into the culture fluids was 
dramatically different. From day 4 forward, splenocytes fiom BALBIc mice secreted very 
high levels of these cytokines. In contrast, unstimulated splenocytes fiom infected 
C57BL/6 mice did not secrete detectable levels of IL-4 throughout the period tested. The 
secretion of IL-10 and IFN-y by C57BLl6 splenocytes only became appreciable on day 6 
and was down-regulated by day 8, when the first wave of parasitemia is being controlled. 
Infected BALBlc mice mounted an earlier IgM antibody response to VSG, formalin-fixed 
L congolense and whole T. congolense lysates than did infected C57BL/6 mice. 
However, infected BALBIc mice failed to make any detectable IgG3 and IgG2a antibody 
responses to these antigens whereas infected C57BL16 mice made strong IgG3 and IgG2a 
response. We hypothesize that enhanced resistance against T. congolense infections in 
mice may be mediated by a THl cell response. 
6.2 Introduction 
Trypanosomes are extra-cellular hemoprotozoan parasites that cause disease and 
death in man and animals in the sub8ahara.n Africa. Trypanosoma congolense infections 
result in acute or chronic debilitating disease in cattle and other domestic animals. Cattle 
and inbred strains of mice differ in their susceptibility to infections with different species 
and strains of African trypanosomes. The indigenous west African taurine breed of cattle 
are more resistant than the Zebu breed, as measured by the level of parasitemia, anemia 
and survival period after both natural and experimental infections with various species of 
African hypanosomes (reviewed by Murray et al., 1982). Differences in the ability to 
control parasitemia and the duration of survival has also been observed in inbred strains of 
mice infected with African trypanosornes (Morrison et al., 1978; Levine and Mansfield, 
1984; Greenblatt et sl., 1985; Pinder et al., 1986; Ogunremi and Tabel, 1995). Generally, 
the highly susceptible mice are unable to control the first wave of parasitemia after 
infection whereas the relatively resistant mice are able to control many waves of 
parasitemia before dying. Genetic analyses showed that the differences in ability to 
control parasitemia among various strains of mice is not linked to the MHC genes (Levine 
and Mansfield, 198 1 ; 1984) and may be under a polygenic control (Pinder, 1984; DeGee 
et al., 1988; Ogunremi and Tabel, 1995). Further smdies utilizing radiation chimeras 
indicated that resistance is influenced by both radio-resistant and -sensitive cells residing 
in the bone marrow or the spleen (DeGee and Mansfield, 1984; Greenblatt et al., 1985). 
Comparative serological studies of trypanosome-infected susceptible and resistant 
strains of mice show that the efficiency of clearance of first wave of parasitemia is 
correlated with the serum levels of antibodies specific for the variant specific variant 
surface glycoprotein (VSG). Resistant strains of mice have earlier and higher serum anti- 
VSG antibody response than susceptible strains (Whitelaw et al., 1983; Mitchell and 
Pearson, 1986; Black et al., 1983; 1986; Otesile and Tabel, 1987). Because it has been 
shown that nude nice infected with T. brucei rhodesiense were capable of controlling 
their first wave of parasitemia (Campbell et d., 1978), one could argue that an IgM anti- 
VSG antibody response is sufficient to control variant specific parasitemia (Mansfield, 
1990). However, DeGee and Mansfield (1984) showed that the levels of IgM anti-VSG 
antibody was not correlated with protection in mice infected with T. brucei rhodesiense. 
Similarly, Otesile and Tabel (1987) have shown that anti-VSG antibodies are necessary, 
but not sufficient for the control of T. congolense infections in BALB/c mice. 
The patterns of cytokine responses during some parasite infections determine or 
are at least strongly correlated to the susceptibility of the host (reviewed by Sher and 
Coffinan, 1992). IL-4 produced by TH2 cells has been shown to promote B cell growth 
and differentiation into antibody-secreting cells as well as switch from IgM to IgGl 
antibody isotype (Finkelman and Holmes, 1990). IFN-y produced by THl cells on the 
other hand promotes cell-mediated immunity and production of IgGZa and IgG3 antibody 
isotypes (Finkelman and Holmes, 1990; Boehrn et al., 1997). The relationships between 
the cytokine and antibody responses in the resistant and susceptible mice infected with 
Afican trypanosomes have not been studied in detail. During infections with T. brucei 
rhodesieme, THI cells secreting IL-2 and IFN-y were detected predominantly in the 
peritoneal cavity and rarely in the spleen of infected resistant mice (Schleifer et al., 1993). 
In another study using in situ hybridization, no differences were observed in the levels of 
IFN-y and IL-10, IL-13 and RIF-a mRNA transcripts between the splenocytes of T. 
brucei brucei-infected susceptible (C3H.Q) and resistant (BIO.Q) mice (Bakhiet et al.. 
1996). The expression of IL-4 rnRNA transcripts were, however, higher in the resistant 
mice, but this cytokine did not seem to be positively correlated with resistance to 
infection, as deletion of the IL-4 gene in these mice was associated with enhanced 
resistance to the infection (Bakhiet et al., 1996). 
Trypanosoma congolense organisms are intravascular but extra-cellular parasites. 
Their elimination fiom the blood of infected animals depends largely on the antibody 
responses to various antigens of the parasite. The regulatory mechanisms that influence 
the differences in the quantity and quality of antibody response to the VSG and other 
antigens of African trypanosomes are still not known. but are undoubtedly influenced by 
T cells (Reinitz and Mansfield, 1990; Mansfield, 1990). Various cytokines secreted by T 
cells may, in addition to having a direct effect also indirectly influence B cell responses 
by causing immunosuppression. We have previously shown that endogenously produced 
IL-10 and IFNy mediate the suppression of mitogen-driven proliferative responses of 
splenocytes fiom BALBk mice infected with T. congolense (see chapters 3 and 4). 
Neutralization of these cytokines in vivo enhanced the resistance of the highly susceptible 
BALBk mice to T. congolense infection. Here, we show that differences exist in the 
number of IL-4-, IL-10- and IFN-y-secreting cells in the spleens, as well as in the levels of 
these cytokines secreted in cultures by splenocytes fiom T. congolense-infected BALBIc 
and C57BL/6 mice. We also show marked differences between BALBIc and C57BL16 
mice regarding the Ig antibody responses to various antigens of T. congoleme. 
6.3 Materials and Methods 
6.3.1 Mice 
Female BALB/cAnNCrlBR (BALBk) and outbred CDl mice were obtained fkom the 
Animal Resource Center of the University of Saskatchewan, and female C57BL/6NCrlBR 
(C57BLh) mice were purchased from Charles River Laboratories (St. Constant, Quebec). 
BALBIc and C57BL/6 mice were between 8 to 10 weeks of age and CDl mice were 5 
weeks old. All mice were maintained according to the recommendations of the Canadian 
Council of Animal Care. 
6.3.2 Parasites 
Trypanosoma congolense, variant antigenic type (VAT) TC 1 3 (Otesile and Tabel, 1987) 
was used in these experiments. Parasites were passaged in immunosuppressed CD 1 mice 
as described previously (Tabel, 1982). The parasites for infection of the BALBk and 
C57BLl6 mice were isolated from the blood of the CD1 mice by DEAE-cellulose 
chromatography (Lanham and Godfrey, 1970). 
6-33 Experimental design 
Groups of four to five BALB/c and C57BL/6 mice were infected intraperitoneally (i.p.) 
with 103 organisms of T. congoleme TC13 and killed with C02 on days 1 to 8 post- 
infection. On each day indicated, blood was withdrawn from the caudal vena cava into 
syringes containing heparin (final concentration -20 IU/ml), and the plasma collected 
after centrifuging the blood at 1,000 x g for 30 rnin. Subsequently, the plasma was 
centrifuged at 13,000 x g for 15 rnin and the supernatant plasma was stored at -35°C until 
used. 
6.3.4 Estimation of parasitemia and survival period 
To estimate the circulating parasite numbers, a drop of blood from the tail vein of each 
infected mouse was examined at 400x power by phase contrast microscopy. Parasitemia 
was estimated by counting the number of parasites present in at least 10 fields. The 
survival period was defined as the number of days post-infection that the infected mice 
remained alive. Moribund mice were euthanized with COz. 
6.3.5 Singlespleen cell suspensions 
The spleens from euthanized mice (above) were made into single-cell suspensions by 
teasing in complete medium (RPMI 1640 medium supplemented with 10% heat- 
inactivated fetal bovine serum [FBS], 50 m M  2-mercaptoethanol, 2 mM L-glutamine and 
100 Units each of penicillin/streptomycin). The single-spleen cell suspensions were then 
used for cultures or to detect single cells secreting cytokines (see below). 
63.6 Single-cell assay for cytokine secretion 
The ELISPOT method described by Czerkinsky et ai. (5) was used to detect single 
cytokine (IL-4, IL-10 and IM-y)-producing cells. Briefly, 96-well microtiter plates in 
which the bottom was made of nitrocellulose (Polyfiltronics Inc., Rockland, MA) were 
coated overnight with 50 p.1 of 2 pg/ml monoclonal rat anti-mouse IL-4, IL-10 or IFN-y 
(PharMingen, San Diego, CA). The plates were washed two times with RPMI 1640 
medium (Sigma, Oakville, ON) and blocked for 2-4 hr at room temperature with 200 p1 
complete medium. Single cell suspensions of spleens from infected mice were applied in 
200 p1 aliquots at a density of 5 x 10' cells/well and incubated overnight at 37°C in a 
humidified atmosphere of 5% C 0 2 .  The next morning, the plates were given a brief 
agitation in an ELISA plate shaker and the cells were removed by flicking the plates. 
Following repeated washings in phosphate buffered saline (PBS) containing 0.05% 
Tween 20 (PBSIT), 100 pl of 1 pg/ml biotinylated rat anti-mouse IL-4, IL-10 or IFN-y 
(Pharmingen) diluted in PBS/T was applied to each well and incubated for 2 hr at 37°C. 
After washing, 100 p1 of 1 :700 dilution of alkaline phosphatase streptavidin (Vector Lab. 
Burlingame, CA) was added and the plates were incubated for 30 min at 37°C. The spots 
were developed by adding I00 pi 5-bromo-4-chloro-indolylphosphate p-toluidine and 
nitroblue tetrazolium chloride solution (Gibco). The spots corresponding to single cells 
that had secreted cytokine were counted by the use of a dissecting microscope equipped 
with a grid. 
6.3.7 Splenocyte Cultures 
Splenocytes were cultured at a concentration of 2.5 x lo6 cells/mI in 200 p1 volumes in 
96-well tissue culture plates in a humidified incubator at 37"C, 5% COz atmosphere. All 
cultures were harvested after 48 hr, centrifuged at 1,500 x g for 15 min and the 
supernatant fluids were stored at -35°C until used. 
6.3.8 Cytokine assays 
The levels of IL-4, IL-10, and IFN-y in the splenocyte culture supernatants were 
determined by routine sandwich ELISA. according to the manufacturer's suggested 
protocols. Recombinant murine IL-4, IL-10 and IFN-y used to generate standard curves 
and paired antibodies against murine IL-4, IL-1 0, and IFN-y for sandwich ELISA assays 
were made by PharMingen and purchased from Cedarlane (Homby, ON). The sensitivities 
of the ELISA assays were 15 pg/ml for IL-4 and 3 1 pg/ml for IL- 10 and IFN-y. 
6.3.9 ELISA assays for IgG antibodies 
6.3.9.1 Purified VSG ELISA 
VSG was purified from T. congolense VAT TC 13 by a combination of ion exchange and 
gel filtration chromatography as previously described by Liu et al., (1 993). The purified 
VSG migrated as a single molecular species with an apparent molecular weight of 54 kDa 
under non-reducing conditions. The identity was c ~ ~ r m e d  by Western blot using 
polyclonal rabbit anti-TC13 serum. ELISA plates were coated with 12.5 pg/ml (50 
pVwell) and incubated at 4°C overnight. The plates were washed twice in PBS/T and non- 
specific binding sites were blocked for 2hr at room temperature with 200 p1 PBS 
containing 10% heat-inactivated fetal calf serum (PBS-FBS). Serum samples, diluted 150 
in PBS-FBS were added to each well and incubated for 2 hr at 37°C. After washing (4 
times), 100 p1 of previously determined dilutions of rabbit anti-mouse isotype specific 
antibodies (Cappel, Organon Teknika Corporation, Durham, NC) in PBS-FBS were added 
to each well and incubated for 1 hr at 37°C. The plates were washed 6 times and 100 pl of 
1:10,000 dilution of biotinylated mouse monoclonal anti-rabbit antibodies (Sigma 
Imrnunochemicals, Oakville, ON) was added to each well and incubated for 45 min at 
37°C. After 8 washings, 100 pl of 1 :SO00 dilution of streptavidin-hone radish peroxidase 
(Vector Laboratories Inc., Burlingame, CA) was added to each well followed by another 
incubation for 30 min at 37°C. The plates were washed 10 times and color development 
was achieved by adding 100 p1 of 2,2' azino-di 3-ethyl-benz-thiazoline sulphonate 
(ABTS, Kirkegaard & Perry Lab, Gaithersburg, MD) and incubating for 15-30 min at 
room temperature. Optical densities were read in a microtitre plate reader at a wavelength 
of 405 nrn. 
6.3.9.2 Fixed trypanosome ELISA 
Freshly isolated trypanosornes were diluted in phosphate buffered saline (PBS) to a f ind 
concentration of 2.5 x 106/ml and 50 pl was added to each well of an ELISA plate 
(Imrnunlon 2, Dynatech, VWR Edmonton, AB). The plates were centrifuged at 500 x g 
for 5 min and then 50 p1 of 2% paraformaldehyde in PBS was added to each well and 
incubated overnight at 4°C. The plates were washed two times with PBS/T and blocked 
with 200 p1 of PBS-FBS for 2 hr at room temperature. Thereafter, the ELISA procedure 
described above was then followed. 
6.3.9.3 Whole trypanosome lysate ELISA 
Whole trypanosome lysate was prepared by 3 cycles of fieezing and thawing of freshly 
isolated trypanosomes at -80°C in the presence of 5 mM N-tosyl-L-lysine 
chloromethylketone (TLCK; Sigma) and the total protein content was determined by the 
Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, Richmond, CA). ELISA plates were 
coated overnight at 4°C with 50 pl of the lysate containing 25 pg/ml total protein. The 
plates were washed 2 times with PBS-T and non-specific binding sites were blocked with 
PBS-FBS for 2 hr at room temperature. Thereafter, the ELISA procedure described above 
was followed. 
6.3.10 Quantitative IgM ELISA 
Essentially, the same protocol as that employed for the IgG ELISA was used with minor 
changes. After blocking, the plates were washed 4 times with PBST and 100 pl of 1:300 
dilution of goat anti-mouse IgM antibodies (Cappel) was added to each well and 
incubated for 2 hr at 37°C. The plates were washed 6 times, and then 100 p1 of 1:2,500 
dilution of peroxidase-conjugated rabbit anti-goat IgG (Cappel) to each well. 
Subsequently, the plates were incubated for 1 hr at 37°C. Afier washing, the plates were 
developed by adding 100 p1 of ABTS substrate to each well. 
63.1 1 Statistical analysis 
Data are represented as means + standard enor (SE). Significance of differences was 
determined by Student's t-test using the StatViewTM.SE 1 98 8 Software (Abacus Concepts 
Inc. Berkley, CA). 
6.4 Results 
6.4.1 Survival time and parasitemia 
BALB/c and C57BL/6 mice infected with 103 organisms of T. congolense had a pre- 
patent period of 4 days. There was no significant difference in parasitemia on days 5 and 
6 in between the two mouse strains (see Figure 3.1A). From day 7 on, BALBIc mice 
showed significantly higher parasitemia than C57BL/6 mice and succumb to the infection 
with a mean survival period of 8.4 2 0.5 days. In contrast, in infected C57BL/6 mice, the 
first wave of parasitemia peaked at day 7 and was almost controlled day 9 post infection 
(Figure see 3.1A). Their mean survival time was not tested in these series of experiments 
but has previously been shown to be 163.0 5 12 days (Ogunremi and Tabel, 1995). 
6.4.2 Frequency of IL-4-, IL-10- and IFN-y-secreting cells in the spleens of T. 
congolense-infected BALB/c and C57BLl6 mice 
As a first step, we assessed the number of cytokine-secreting cells in the spleens from the 
highly susceptible BALBIc and relatively resistant C57BL/6 mice infected with T. 
congolense. Both mouse strains showed a similar pattern in the kinetics of splenocytes 
secreting IL-4, IL-10 or IFN-y (Figure 6.1). Cytokine-secreting cells became detectable by 
day 4 in the two mouse stains and gradually increased in numbers as the infection 
progressed. The fiequency of IL-4-secreting cells in the spleens from both strains of mice 
peaked on day 8, with their numbers being significantly @ < 0.05) higher in BALB/c than 
C57BL/6 mice on days 4,5 and 8 (Figure 6.1A). IL- 10 secreting cells became apparent on 
day 5 post-infection, peaked on day 7 and were slightly reduced by day 8 in the two 
mouse strains Generally, the numbers of IL-10-secreting cells were higher in the spleens 
fiom infected BALB/c than in those fiom C57BLJ6 mice (Figure 6.1B). IFN-y-secreting 
cells were detected by day 4 in the spleens of the two stains of mice. The number of these 
cells increased steadily, peaked on day 6 in both mouse strains and remained high up to 
day 8 in BALB/c mice (Figure 6.1 C). In contrast, the frequency of IFN-y-secreting cells in 
the spleen of infected C57BL/6 mice gradually declined after day 6. Overall, the 
Frequency of IFN-y-secreting cells was significantly (p < 0.05) higher in spleens fiom 
infected BALBlc than in those from C57BL/6 mice from day 4 on. 
6.4.3 Levels of cytokine protein in cultures of splenocytes from infected BALB/c 
and C57BLI6 mice 
While the pattern and kinetics of appearance of IL-4, IL-10- and IFN-y-secreting cells 
were essentially similar in infected BALWc and C57BL/6 mice, the actual amount of 
protein secretion in cultures by these cells were paradoxically different. The secretion of 
IL-4, IL-10 and IFN-y in cultures by splenocytes fiom infected BALBJc mice became 

apparent by day 4, peaked on day 6 and remained high by day 8 post-infection (see figures 
3.2A and 4.3A & B). In contrast, secretion of IL-4 by splenocytes from infected C57BL/6 
mice remained undetectable throughout the period of infection (see figure 4.3A) while 
secretion of substantial amounts of IL-10 and IFN-y became only apparent by day 6 and 
were quickly down-regulated by day 8 (see figures 3.2A and 4.3B). In general, the 
secretion of IL-10 and IFN-y in cultures by splenocytes from infected BALB/c mice were 
significantly @ < 0.001) higher than those from C57BL/6 mice. 
Two important observations were made regarding the number of cytokine- 
secreting cells as measured by ELISPOT assay and the level of cytokines secreted into 
culture fluids as measured by ELISA. Whereas the differences between the number of 
cytokine-secreting cells detected in the two mouse strains were marginal (Figure 6 4 ,  
very marked differences were observed in the levels of protein detected in culture fluids 
(Figure 3.2A and 4.3 A & B), with BALB/c splenocytes apparently secreting significantly 
(p < 0.001) higher amounts of cytokines than their C57BL/6 counterparts. Also, although 
the frequency of IL-4-secreting cells were much higher than that of IL-10 or IFN-y 
(approximate ratio 2: 1 for IL-4- vs. IM-y-secreting cells), the IL-10 and IFN-y-secreting 
cells produce much more cytokine on a cell-per-cell basis than did IFN-y-producing cells 
(ratio 1:85 for IL-4 vs. IFN-y on day 6 post-infection). These results clearly show that 
there was no correlation between the frequency of cytokine-secreting cells and the actual 
amount of cytokine secretion by the cells. 
6.4.5 Antibodies to purified VSG 
The levels of IgM, IgG1, IgG2a and 1gG3 antibodies against purified VSG of T. 
congolense clone TC13 in the plasma of infected BALBIc and C57BLl6 mice were 
measured by ELISA. As shown in figure 6.3A, IgM anti-VSG antibodies appeared earlier 
in BALB/c than in C57BLl6 mice. IgM anti-VSG antibodies were measurable by day 4, 
peaked on days 5 and 6 and slightly declined on days 7 and 8 post-infection (Figure 
6.2A). In contrast, IgM antibodies in the plasma of infected C57BLl6 mice remained 
undetectable until day 7 and increased to high levels on day 8. Similarly, infected BALB/c 
mice contained significantly higher levels of IgGl anti-VSG antibodies in their plasma 
than did infected C57BY6 mice (Figure 6.2B). In contrast, the levels of IgG2a and IgG3 
anti-VSG antibodies were significantly higher (p < 0.001) in the plasma of infected 
C57BLl6 than in those of BALB/c mice from days 6 post-infection (Figures 6.2C & D). 
In fact, BALBIc mice did not make any detectable IgG3 antibody response to the purified 
VSG throughout the infection period. These results demonstrate that the highly 
susceptible BALB/c mice could mount an early and higher IgM anti-VSG antibody 
response but were incapable of mounting either IgG2a or IgG3 antibody responses to the 
VSG. 
Figure 6.2 Antibodies to purified VSG of T. congolense. IgM (A), IgGl (B), 
IgG2a (C) and IgG3 @) antibody responses against the purified VSG in 
BALB/c (open squares) and C57BLf6 (closed squares) mice infected with T. 
congo2eme. Groups of 4-5 infected mice were killed on each day indicated with 
COz and blood was collected into heparinized syringes for plasma (materials 
and methods). ELISA plates were coated overnight with 12.5 pg/ml (50 
pg/well) of purified VSG in PBS and plasma samples were used at 150 
dilution. Note the earlier IgM and higher IgGl antibody responses mounted by 
the BALBk than the C57BL/6 mice. Data are presented as mean SE. The set 
of results shown is a representative of two similar experiments. 
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Figure 6.2 
6.4.5 Antibodies to the cryptic VSG epitopes 
Tryponosoma congolense clone TC13 on the ELISA plates was fixed using the cross- 
linking agent, paraformaldehyde. Fixation disrupts the surface coats of trypanosomes 
leading to the exposure of cryptic epitopes on the VSG (Reinitz and Mansfield, 1990). 
Infected BALBlc and C57BL/6 mice mounted essentially equivalent IgM responses to the 
cryptic epitopes of the VSG (Figure 6.3A), although these antibodies were detected by 
day 4 in the BALB/c mice and were significantly elevated (p < 0.05) relative to the 
C57BL/6 mice until day 6. Thereafter, the levels of IgM in the plasma of the two strains 
rose steadily, but with C57BL/6 mice significantly (p < 0.05) producing more than 
BALB/c mice. Infected BALBIc mice did not make any appreciable IgG (IgGl, IgG2a 
and IgG3) antibody response to the cryptic epitopes of the VSG. In contrast, a strong IgG 
response was mounted by infected C57BL/6 mice starting on day 5 (IgG3) or 6 (IgG1 and 
IgG2a) and peaking on day 7 (Figure 6.3B-D). The high IgG antibody levels in the plasma 
of infected C57BL/6 mice persisted up to day 9 (not shown) by which time the first wave 
of parasitemia were apparently controlled by these mice. 
Figure 6 3  Antibodies to formalin-fied T. congolense. Levels of IgM (A), IgGl 
(B), IgG2a (C) and IgG3 (D) antibodies against formalin-fixed trypanosomes in 
the plasma of infected BALB/c and C57BL/6 mice. ELISA plates were coated 
with 2.5 x 10' fixed trypanosomes per well and the plasma samples were used 
at 150 dilution. Data are presented as mean + SE. The set of results shown is a 
representative of two similar experiments. Legends are as for figure 6.4. 
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Figure 6 3  
6.4.6 Antibodies to whole T. congolense lysate 
Although it has been suggested that anti-VSG antibodies are necessary for the control of 
variant specific parasitemia, recent reports indicate that antibodies to the invariant 
antigens of trypanosomes are also associated with resistance to trypanosome infections in 
cattle (Boulange and Authie1993; Authie et al., 1992; 1993a; Authie et al., 1993; Authie, 
1994). To measure the antibody response to the whole T. congoleme TC13 antigens, 
freeze-thawed trypanosomes were used to coat ELISA plates. 
Plasma fkom infected BALB/c and C57BL/6 mice collected at different days after 
infection contained high levels of IgM antibodies to the whole parasite lysate. The 
kinetics and patterns of appearance of IgM antibodies were similar in the two strains of 
mice throughout the infection period (Figure 6.4A). In contrast, the levels of IgG 
antibodies in the plasma of the two mice strains were remarkably different. While IgG 
antibodies against the whole parasite lysate remained at the pre-infection levels in the 
plasma of infected BALB/c mice, a steady rise was observed in those of C57BL/6 mice 
starting from day 6 post-infection (Figure 6.4B-D). A strong IgG2a and IgG3 antibody 
response occurred in C57BL/6 mice starting on day 6 and increasing steadily through 
days 7-8. IgGl antibody response started on day 7 and remained high by day 8 in 
C57BLl6 mice. 
Figure 6.4 Antibodies to whole T. congolense lysate. IgM (A), IgGl (B), IgG2a 
(C) and IgG3 @) antibody responses to the whole T. congolense lysate in 
infected BALB/c and C57BL/6 mice. ELISA plates were coated with 1.25 
pg/well of whole T. congoleme clone TC13 Iysate and plasma samples were 
used at 150 dilution. The set of results presented is a representative of two 
similar experiments. Legends are as for figure 6.4. 
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Figure 6.4 
6.5 Discussion 
The present study shows that differences exist in the secretion of IL-4, IL- 10 and IFN-y in 
mouse strains of varying susceptibility to T. congolense infections. The susceptible 
BALB/c mice had significantly higher numben of cells secreting these cytokines than the 
resistant C57BL/6 mice. Although the kinetics and pattern of appearance of IL4,  IL-10 
IFN-y-secreting cells were essentially similar. the frequency of these cells were 
moderately but significantly (p < 0.05) higher in BALB/c than in C57BL/6 mice on some 
days after infection. However, a striking difference was observed in the amounts of 
cytokine secreted in culture by splenocytes from these mice. For instance, although IL-4- 
secreting cells were detectable by ELISPOT among the splenocytes of infected C57BL/6 
mice, these populations did not secrete detectable amounts (< 15 pg/ml) of I L 4  in culture, 
when assayed by ELISA (compare figures 4.3A and 6.1A). Similarly, although greater 
numbers of IL-4- than IFN-y-secreting splenocytes (approximate ratio, 2: 1) were detected 
on day 6 in the BALB/c mice, the ratio of IL-4 to IFN-y protein secreted in culture was 
dramatically different (IL-4:IFN-y = 1:85). Furthermore, dramatic differences were 
observed in the secretion of IL-10 and IM-y protein in the splenocyte cultures from the 
two mouse strains. The secretion of these cytokines occurred earlier in BALB/c mice and 
remained high throughout the infection. These observations suggest that the use of the 
number of cytokine-secreting cells as measured by ELISPOT to determine the type of 
helper T cell response in an immune response may not be very accurate, as there appears 
to be marked apparent differences between commitment to secretion and the actual 
amount secreted by the committed cell (Figures 4.2 & 6.1). 
The splenocytes fiom the susceptible mice produced greater amounts of IL-4, IL- 
10 and IFN-y in culture than did those from the relatively resistant mice. IL-10 has a 
profound down-regulatory effect on macrophages (Fiorentino et al., 199 1; Moore et al., 
1993), including inhibition of cytokine synthesis by these cells (Fiorentino et al., 1991). 
IL-10 also inhibits antigen-specific proliferation of T-cells (Moore et al., 1993) and this 
effect appears to be, in part, due to inhibitory effects on antigen presenting cells. We have 
shown previously that IL-I0 and IFN-y contribute to suppression of mitogen-induced 
proliferative responses of splenocytes from T. congoZenre-infected BALBlc mice and also 
to an enhanced susceptibility to the disease (see chapters 3 and 4). Recently, we have 
obtained evidence that when pulsed wih T. congolense lysates, IFN-y-primed bone 
marrow-derived macrophages fiom BALBk, but not those fiom C57BLl6 mice, up- 
regulate their IL-10 secretion by 2-4 fold (Kaushik et al., manuscript in preparation). 
Thus, the higher levels of IFN-y secretion by splenocytes fiom infected BALBk mice 
could potentially enhance IL-10, secretion leading to a more pronounced 
immunosuppression and an enhanced susceptibility in these animals. IL- 10 has also been 
shown to inhibit 1FN-y-mediated nitric oxide (NO) and tumor necrosis factor alpha (TNF- 
a) release by macrophages (Fiorentino et al., 199 1; Gazzinelli et al., 1992). TNFa  has 
both static (Lucas et al., 1994) and lytic (Magez et al., 1997) effects on trypanosomes in 
vitro and inhibits trypanosome growth in vivo (Magez et al., 1993), while NO has a static 
effect on T. brucei in vitro (Vincendeau et al., 1992). Thus, high levels of IL- 10 secretion 
by splenocytes from infected BALEVc mice could down-regulate the production of TNF-a 
as well as NO by macrophages, thereby preventing their inhibitory effects on parasite 
multiplication and survival. 
Both mouse strains were capable of mounting an IgM response against the purified 
VSG, cryptic (fixed) VSG, and whole trypanosome lysates. In fact, BALB/c mice 
mounted an earlier IgM antibody response to these antigens than did the C57BLI6 mice. 
Our data suggest that IgM antibody responses against various antigens of T. congolense 
may not be associated with the control of parasitemia, since the BALBk mice made an 
earlier and higher specific IgM antibody response than the C57BL/6 mice. It is worth 
emphasizing that both mouse strains had almost identical parasite loads up to day 6 post- 
infection and during this period, higher levels of parasite-specific IgM antibodies were 
present in the plasma of infected BALBk than in those of resistant C57BL/6 mice. These 
results are consistent with the reports of DeGee and Mansfield, (1984) that showed that 
the plasma levels of IgM antibodies to T. brucei rhodesiense in infected mice did not 
correlate with resistance to the infection. 
The plasma levels of IgG antibodies were dramatically different in the two mouse 
strains. Only IgGl antibodies to purified VSG were higher in the plasma of BALB/c than 
in that of C57BL/6 mice. In contrast, infected BALBk mice were unable to make any 
substantial amounts of IgGZa and IgG3 antibody responses to the purified VSG and also 
failed to make any IgG (IgG1, IgGZa and IgG3) response to the cryptic epitopes of the 
VSG (fixed trypanosomes) or whole trypanosome lysate. The fact that these differences 
were apparent only at the level of IgG antibody isotypes suggests that this was not 
probably due to the antibody being absorbed out by an excess antigen load related to a 
higher parasitemia in the BALB/c mice, as has been suggested by Newson et al. (1990). 
Although results of in vitro and in vivo studies on the relative potentials of IgM 
and IgG anti-trypanosome antibodies to confer protection have been equivocal, most 
evidence suggests that IgG may be more efficient than IgM in controlling T. congoleme 
infections in mice (Morrison et al., 1978) and cattle (Williams et al., 1996). In cattle, 
higher frequencies of cells secreting IgM specific for the linear epitopes of the VSG as 
well as invariant antigens of T. congolense were found in the infected trypanosusceptible 
Boran (Taylor et al., 1996). In contrast, infected trypanotolerant N'Dama cattle have 
higher frequencies of spleen cells secreting VSG-specific IgG antibodies than do Boran 
cattle. Also, serum levels of VSG- (Williams et al., 1996) and T. congolense invariant 
antigen-specific IgG antibodies (Authie et al., 1992; 1993ab) were higher in N'Dama 
than Boran cattle infected with T. congolense. These superior IgG antibody responses to 
the cryptic epitopes of the VSG (Williams et al., 1996) and invariant antigens of T. 
congolense (Authie et al., 1992; 1993a,b) have been suggested to be of importance in 
trypanotolerance (Authie 1994: Agur and Meher. 1997; Taylor, 1 998). 
We found no correlation between cytokine production by splenocytes fiom 
infected mice and the isotype of antibodies against the various antigens of the T. 
congolense. IL-4 produced by TH2 cells has been shown to favor the switch from IgM to 
IgG 1 and IgE antibodies whereas IFN-y produced by TH 1 cells favors IgG2a and IgG3 
isotype switching (Finkelman and Holmes, 1990; Boehrn et al., 1997). The fact that 
BALB/c mice were unable to make IgGZa and IgG3 antibodies despite the secretion of 
high levels of IFN-y by their splenocytes suggests that the measured IFN-y may not be 
produced by conventional T helper cells and this might not have been available within the 
immediate vicinty of cooperating TH-B cells. We have obtained evidence that most of the 
IL-10 and IFN-y detected in T. congolense-infected BALBk mice is produced by small 
numbers of Thy1.2TD4-8- splenocytes that co-purify with plastic-, nylon wool- or 
Sephadex G-10-adherent cell populations (see chapter 5). These unique cells are 
stimulated in an antigen-specific manner, rather by polyclonal activation, and are involved 
in T. congolense-elicited suppression of T and B cell responses (see chapter 5). The lack 
of correlation between the high levels of IFN-y secretion and IgGZa response to the VSG 
has also been reported in mice infected with T. brucei rhodesiense (Mansfield, 1994). The 
secretion of greater amounts of IL-4 by splenocytes fkom infected susceptible BALBk 
than that fiom resistant C57BL/6 mice suggests that this cytokine may be associated with 
enhanced susceptibility to T. congolense infections in mice. This also seems to be the case 
with T. brucei infections since deletion of the IL-4 gene enhanced the survival times of 
mice infected with T. brucei brucei (Bakhiet et al., 1996). 
It is intriguing that the IgG antibody levels against the various antigens of T. 
congolense were higher in the plasma of C57BL/6 mice, despite the lower levels of 
splenocyte IFN-y and IL-4 secretion by these mice relative to the BALB/c mice. It could 
be that most of the IFN-y, which is known to favor IgG2a and IgG3 isotype switching by 
B cells (Finkelman and Holrnes 1990; Boehrn et al., 1997), was secreted by TH1 cells in 
C57BL/6 mice. An alternative explanation for this might be related to differences in 
monokine secretion by macrophages from the two mouse strains following their 
interaction with trypanosornes. In this regard, we have evidence that, when pulsed with T. 
congolense lysates, IFN-y-primed bone marrow-derived macrophages fiom BALB/c mice 
secrete significantly higher amounts of IL-I 0 than those from C57BL16 mice. In contrast, 
C57BL/6 macrophages secrete significantly more IL-12 p40 than do BALB/c 
macrophages (Kaushik et al., manuscript in preparation). We suspect that this differential 
production of IL-I 0 and IL-12 by macrophages from the two strains could have diverse 
effects on the B and T cells of the infected mice, including growth and differentiation 
effects, and isotype switching (B cells) or suppression. IL-10, a potent THI down- 
regulatory cytokine (Moore et al., 1993), suppresses splenocyte proliferative responses to 
Con A and enhances susceptibility to T. congolense infections in BALB/c mice (see 
chapter 3). Thus, the production of high levels of IL-10 by BALBlc mice could potentially 
down-regulate THI cell-dependent B cell responses, and thereby lead to such lower IgG2a 
and IgG3 antibody responses as were observed in this study. In contrast, the high level 
production of IL-12 by macrophages from the resistant C57BL/6 mice would favor THl 
cell development (Trinchieri, 1995) and thus IgGZa and IgG3 isotype switching (Boehm 
et al., 1997), as also was observed in this study. 
In conclusion, we hypothesize that enhanced resistance (effective control of 
parasitemia and increased survival period) to T. congolense infections in mice is mediated 
by a TH 1 cell response. 
7.0 GENERAL DISCUSSION 
7.1 Cytokine patterns during T. congolense infections 
The present study shows that, during T. congoleme infections, susceptible BALB/c mice 
have higher levels of IL-4. IL-10 and IFN-y in their plasma than do resistant C57BL/6 
mice. In contrast, higher levels of TNF-a were detected in the plasma of infected resistant 
mice than in the susceptible mice. Consistent with the levels of IL-10 and IFN-y in the 
plasma, the steady state levels of mRNA for these cytokines in the splenic tissues 
increased earlier following infection and were higher in infected BALB/c mice than in 
C57BL/6 mice. As expected based on the mRNA results, both the spontaneous and Con 
A-induced production of IL-4, IL-10 and IFN-y by splenocytes of infected BALB/c mice 
also were higher than with those of infected C57BV6 mice. Although the patterns and 
kinetics of appearance of IL-4, IL-10 and IM-y-spot-forming cells were similar, greater 
numbers of cytokine-secreting cells were detected in the spleens of BALB/c mice than in 
C57BL/6 mice on some days. 
The marked difference between the numbers of cytokine-secreting cells as 
detected by the ELISPOT assay and the amount of cytokine secreted into the culture 
fluids as measured by ELlSA was unexpected (see Figure 4.3 and 6.1). For instance, the 
numbers of IL-4-secreting cells were higher than IFN-y-secreting cells whereas IFN-y- 
secreting cells were by far the most producers on per cell basis in cultures. Moreover, 
although there were marginal but significant differences in numbers of IL-4-, IL-10- and 
IFN-y-secreting cells in the spleens of infected BALB/c and C57BL/6 mice, dramatic 
differences were observed in the production of these cytokines in cultures with BALB/c 
splenocytes producing significantly higher amounts than C57BL/6 splenocytes. These 
observations indicate that there is a marked difference between commitment to production 
of a cytokine and the quantity of the cytokine secreted in culture fluids by the committed 
cell. Whereas ELISPOT assay could detect cells producing as few as 100 molecules of a 
specific cytokine ( K l i ~ l a n  and Nutman, 1994), the minimun sensitivity of the ELISA 
assay is in the order of picograms. Thus, this difference in the sensitivities of the two 
assays might explain the differences in the results obtained by ELISPOT and ELISA 
assays observed in this study. 
Detailed studies on the differential expression of cytokines in mice exhibiting 
varying degrees of resistance to African trypanosomes are scanty. Schleifer and Mansfield 
(1 993a) demonstrated that CD4' T cell clones derived from the peritoneal cavities of 
resistant mouse strains infected with T. brucei rhodesiense were of the THI phenotype 
(i.e. secreted high levels of IL-2 and IFN-y). Unfortunately, cytokine responses by 
infected susceptible mouse strains were not analyzed in this study. In contrast, Bakhiet et 
al. (1996) reported that IFN-y secretion by splenocytes fiom T. brucei brucei-infected 
mice was similar in the resistant and susceptible strains, while only the resistant mice had 
cells secreting IL-4. These workers concluded that resistance to this parasite was related to 
the ability to produce IL-4. However, the deletion of IL-4 genes in the resistant mice 
actually enhanced their resistance to T. brucei brucei infection suggesting that enhanced 
resistance to this parasite does not depend on the production IL-4. 
The concomitant presence of high levels of IL-4, IL-10 and IFN-y in the plasma 
and splenocyte cultures of infected BALBIc mice stimulated our curiosity, primarily 
because of the known reciprocal cross-regulation by these cytokines of TH1-TH2 
responses. Consequently, questions were asked regarding the cellular source(s) and role(s) 
of these cytokines in the pathogenesis and enhanced susceptibility of BALBIc mice to T. 
congolense infections. 
7.2 IL-10 and IFN-y mediate T. congolense-induced immunosuppression 
The role of cytokines in the pathogenesis and enhanced susceptibility of BALBIc 
mice to T. congolense infections was a primary research aim of this thesis work. 
Generalized immunosuppression affecting both humoral and cellular immune 
compartments is a common feature associated with African trypanosomes infections 
(Askonas, 1985; Darji et al.. 1992; Sileghem et al., 1994a). It has been suggested that this 
is one of the factors responsible for the increased susceptibility of trypanosome-bearing 
individuals to opportunistic infections (Greenwood et al., 1973; Maxie et al., 1979). The 
present study clearly showed an involvement of endogenously produced IL-10 and IM-y 
in the T. congolense-mediated suppression of splenic T cell proliferative responses to a 
mitogen. 
The downregulation of T cell proliferation during T. brucei infections has been 
attributed to at least two unlinked mechanisms, involving decreases in IL-2 secretion on 
one hand and IL-2R expression on the other (Sileghem et al., 1994a). The suppression of 
IL-2 secretion is reportedly mediated by prostaglandins (Sileghem et d., 1986; 1994a) 
while the suppression of IL-2R expression is mediated by IFN-y @aji  et al., 1996), 
although IFN-y expression by itself was not sufficient to mediate this suppression. An 
unknown soluble factor released by T. brucei-pulsed macrophages was required to 
mediate this IL-2-related suppression (Daji et al., 1996). Our studies may well provide 
some insights into the nature of this unknown soluble factor. Exposure to T. congoleme 
lysates, of IFN-y-primed bone marrow-derived macrophages fiom highly susceptible 
BALB/c, but not relatively resistant C57BL16 mice, causes 2-4 fold increases in their IL- 
10 production (Kaushik et al; manuscript in preparation). Thus, it is feasible that the IFN- 
y-mediated suppression of proliferative responses of lymphoid cells observed in the 
present study (Figure 4.4) and other studies (Darji et al., 1993; 1996) may be indirect, at 
least in part, mediated via the up-regulation of IL-10 secretion by macrophages. In line 
with this is the observation that administration of neutralizing anti-IFN-y antibodies to T. 
congolense-infected BALBk mice dramatically reduced their plasma levels of IL-10 as 
well as the spontaneous and Con A-induced secretion of IL-10 by their splenocytes 
(Figure 4.6A,B). 
Some aspects of immunosuppression in T. brucei infections in mice are reported to 
be mediated by NO produced by IFN-y-activated macrophages (Sternberg and McGuigan, 
1992; Schleifer and Mansfield, 1993; Sternberg et al., 1994; Mabott et al., 1996). 
However, Darji et al. (1996) failed to observe any NO-mediated immunosuppression of 
lymph node cells from mice infected with T. brucei, a d  furthermore, in cattle infected 
with T. congoleme and T. v iva ,  NO production is depressed and NO does not mediate the 
T cell suppression observed in these animals (Taylor et al., 1996). In addition, both 
peritoneal and bone marrow-derived macrophages fiom the relatively resistant C57BLl6 
mice, upon interaction with T. congolense lysates in the presence of IM-y, produce more 
NO than similarly treated cells fiom susceptible BALBlc mice (Kaushik et al., manuscript 
in preparation). Moreover, there is no difference in the production of  NO by splenocytes 
fiom T. congoiense-infected BALBIc and C57BL/6 mice (Appendix figure 3), yet the 
proliferative responses of splenocytes fkom BALBk were more suppressed than those 
from C57BL/6 mice. Furthermore, the addition of the inducible nitric oxide synthase 
inhibitor into cultures of Con A-stimulated splenocytes fkom day 7 infected BALB/c mice 
does not reverse the suppression of proliferative responses observed in these splenocytes. 
Also, splenocytes fkom anti-IFN-y-treated BALB/c mice secrete higher amounts of NO 
than their PBS-treated controls (see section 4.4.6). These observations strongly indicate 
that, like in cattle (Taylor et al., 1996), NO-mediated suppression does not operate during 
T. congolense infections in mice. Thus, the restoring effect of anti-IFN-y treatment on 
proliferation of splenocytes fiom T. congolense-infected mice observed in the present 
study was not mediated by reduction in NO synthesis. 
7.3 Cellular sources of IL-4, IL-10 and IFN-y in the spleens of infected BALbfc 
mice 
This study identified a unique set of T cells that is involved in the regulation 
and/or secretion of IL-4, IL-I0 and IM-y in the spleens of 7'. congolense-infected mice. 
These Thy 1.2TD4-8- cells co-purify with plastic-, nylon wool- or Sephadex G- 10- 
adherent cell populations. The production of IL-4, IL-10 and IFN-y by the Thyl.2' cells 
requires cooperation between these cells and Thy1.2- cells present in the spleens of T. 
congolense-infected, but not uninfected, mice and occurs by an antigen-specific 
mechanism. In T. brucei-infected rodents, CD8' T cells have been reported to be the 
major producers of IL-4 and IFN-y (Bakhiet et al., 1990; 1993; 1996). In that system, 
direct binding of a trypanosome-derived lymphocyte triggering factor to the CD8 
molecule on CD8' T cells was reported to trigger these cells to produce large amounts of 
IFN-y (Bakhiet et al., 1990; Olsson et ai.. 199 1). The results reported here differ from 
those of the T. brucei system in that they clearly show that Thy1.2TD4'8' and 
Thy1.2TD4-8' cells are the major producers of IL-4, IL-10 and I M - y  in the spleens of 
BALBlc mice infected with T. congolense. 
During T. congolense infections in mice, progressive increases in the numbers of 
IgThyl- cells in the spleens of infected mice have been reported (Roelants et al., 1978; 
1979; Kar et al., 1979; Roelants and Pinder. 1 984). The characterization of these cells was 
based on microscopic examination of cells treated with fluorescein-labeled anti-Thy1 
antibodies, a method which might not detect low level expression of Thy1 -2 antigen. It is 
conceivable that these IgThy 1- cells (so-called " null cells") were in reality Thy I' and 
equivalent to our Thy1 -2TD4'8' cells. This is likely to be so since this same research 
group reported in another study the existence of immunosuppressive Thy 1 +"& cells in the 
spleens of T. congolense-infected mice (Pearson et al., 1979a). It would be worthwhile to 
investigate whether the Thyl.2TD4-8- cells from our model express lower levels of 
Thy1.2 antigens than do Thy 1.2+CD4' and Thy 1 .2'CDSt cells and whether their numbers 
increase progresively in the spleen of T. congolense-infected mice. 
A potential role these adherent Thy1.2'CD4'8' cells in the pathogenesis of T. 
congolense infection was established by demonstrating their involvement in suppression 
of T and B cell responses to rnitogen and SRBC respectively. Previous reports from 
independent laboratories have shown that both T cells (Eardley and Jayawardena, 1977; 
Jayawardena et d., 1978, Pearson et al., 1979) and adherent macrophage-like cells 
(Askonas, 1985; Sileghem et al., 1986; Flynn et al., 199 1 ; Schleifer and Mansfield, 1993) 
are involved in the suppression of lymphoid responses in trypanosome-infected mice. In a 
thorough review of the mechanisms of trypanosome-induced immunosuppression, 
Roelants and Pinder (1984) suggested that both cell types are important. The finding in 
the present study that the production of IL-10 and IFN-y (both of which can be 
immunosuppressive) by spleen cells from infected mice requires cooperation between 
adherent Thy 1.2+ and Thy 1.2' cells fiuther supports the reports of Corsini et al. (1 978) and 
Pearson et a1 (1978a; 1979) and the suggestion of Roelants and Pinder (1984) that both T 
cells and macrophages are important in trypanosome-induced immunosuppression. 
Suppressor T cells could alter (via cell to cell contact or cytokines) macrophage functions 
and cytokine patterns, thereby rendering them suppressive. On the other hand, 
macrophages could become suppressive after interaction with trypanosomes or their 
products and such suppressive activity may be transferred to T cells during antigen 
presentation. 
What marker(s) distinguish these Thy1.2TD4-8' adherent-like cells from 
conventional T cells and what is the nature of the trypanosomal antigen that they 
recognize? These questions were not addressed in this work but it is conceivable that 
these were NK I' T cells. NKI + T cells, which can either be Thy 1 -2TD4'8- (60%) or 
Thyl.2-CD4-8' (40%), can secrete large amounts of IL-4, IL-10 and IFN-y upon 
appropriate stimulation, and comprise about 0.5 - 1% of splenocytes fiom normal mice 
(Bendelac, 1995; Vicari and Zlotnik, 1996; Bendelac et al., 1997). Their activation is 
restricted by the CDI molecule and they recognize both hydrophobic peptides and lipid 
antigens presented in association with CDI (Porcelli et al.. 1992; Bendelac et al., 1997). 
Double negative NKI.1' T cells that recognize a lipid antigen derived fiom the 
lipoarabinomanan of M. tuberculosis have been reported (PorcelIi et al., 1992). The 
variant surface glycoprotein of African trypanosornes is inserted into the plasma 
membrane via the glycosyl phosphatidylinositol (GPI) similar to the lipoarabinomanan of 
M. tuberculosis (Ferguson et al., 1985; 1988; Ferguson, 1997). It is conceivable that 
similar antigen processing and presentation of lipid antigens derived fiom the GPI anchor 
of the VSG to Thy1.2TD4-8' cells could well occur during infections with T. congolense. 
What advantages could the induction of Thyl.2TD4-8- cells confer to the 
trypanosomes in the infected host? The answers to this question are all purely speculative. 
Clearly, the copious secretion of large amounts of IL- 10 and IFN-y by these cells mediates 
immunosuppression within the host (discussed in section 7.2). The induction of 
immunosuppression might prevent effective immune responses by the host and thus delay 
the clearance of the parasite from the circulation, thereby allowing additional t ine  for new 
variants to arise. It has been reported that IFN-y has a growth-stirnulatory effect for T. 
brucei (Olsson et al., 1991), although we have tested this and been unable to demonstrate 
such an effect with T. congolense (Kaushik et al., 1997). However, it is not unlikely that 
under certain conditions, such an effect could occur. In such conditions, the activation of 
Thy 1.2TD4-8- cells would be advantageous for the parasite's survival. 
7.4 The role of IL-10 and IFN-y in susceptibility to T. congolense infections 
A role for IL-10 and IFN-y in the enhanced susceptibility of BALBlc mice to T. 
congolense infections was clearly demonstrated. Whereas in vivo administration of anti- 
IL-10 antibodies to BALB/c mice early during infection moderately but significantly 
prolonged their survival period, the administration of anti-IFN-y antibodies dramatically 
shifted the phenotype o f  most of these highly susceptible mice to a resistant-like 
phenotype. Overall, the anti-IFN-y-treated mice expressed low and undulating 
parasitemias and had a greater than 300% increase in the mean survival period. The anti- 
IFN-y treatment was associated with a dramatic decline in the plasma levels of IL-10 as 
well as a reduction in both the spontaneous and Con A-induced secretion of IL-I0 by 
splenocytes From the infected mice. 
Based on the in vitro results in which anti-IL-10 antibody treatment completely 
reversed the suppression of Con A-induced splenocyte proliferation, a much longer 
survival periods for the anti-11-10-treated T. congolense-infected mice was anticipated 
than were observed. An explanation for this low impact of anti-IL-10 antibody in vivo 
could potentially be related to the IgM isotype of the antibodies. While IgG antibodies 
penetrate relatively easily through the capillary wall and into the tissues, the much larger 
IgM antibodies do not and thus are restricted much more to the intravascular compartment 
(Nakamura et al., 1968. Spiegelberg, 1974). Consequently, these antibodies would not be 
available at optimal concentrations within the interstitial tissues, where cytokines would 
predominantly mediate their local effects. It is proposed that an IgG anti-IL-10 antibody 
would present better effects in vivo than those obtained in the present study. An 
alternative approach to further investigate the role of IL-10 would be the use of IL-10 
gene-knock out mice. 
It is conceivable that the beneficial effects of in vivo neutralization of IL-10 and 
IFN-y relate more to the reversal of immunosuppression associated with the infections 
which would then allow the infected animals to mount efficient and effective immune 
responses against the parasites. IL-10. formerly known as cytokine synthesis inhibitory 
factor (Mosmann et al., 1990) indirectly inhibits, via its effects on the antigen presenting 
cells, proliferation and cytokine production by THl cells (Mosmann and C o h a n ,  1989; 
Moore et al., 1993). THI cells and their cytokines promote B cell growth and production 
of IgGZa and IgG3 antibodies (Boehm et al., 1997) which would mediate a different kind 
of adherence of trypanosomes to macrophages via the Fcy receptors (see section 7.5). 
Thus. the inability observed in this study of infected BALBIc mice to make antibodies of 
these isotypes may be associated with the production of high amounts of IL-10 by 
splenocytes fiom these mice. 
On the other hand, neutralization of IL-10 and IFN-y might enhance the 
production of TNF-a and NO by macrophages (Kupffer cells). Both NO (Vincendeau et 
al., 1992) and TNF-a (Magez et al., 1993; Lucas et al., 1994) are trypanostatic for African 
trypanosomes. IL- 1 0 inhibits IFN-y-mediated NO and TNF-a production by macrophages 
(Fiorentino, et al., 199 1; Gazinelli, et al., 1992; Moore et al., 1993). Thus, the high level 
production of IL- 10 by infected BALBIc mice relative to that observed in C57BLl6 mice 
in this study may be responsible for the lower levels of TNF-a found in the plasma of the 
BAL,B/c mice. Consistent with this, we observed that the administration of anti-IFN-y 
antibodies to T. congoiense-infected BALBIc mice resulted in a dramatic decrease in IL- 
10 and a subsequent increase in NO production by splenocytes from these mice. Also. 
IFN-y-primed bone marrow-derived macrophages from BALBIc mice pulsed with T. 
congolense lysate produce more IL-10 but less TNF-a than similar cells from C57BL/6 
mice (Kaushik et al., manuscript in preparation). Thus, an effective suppression of NO 
and TNF-a production by the high levels of IL-10 in the BALB/c mice could prevent the 
trypanostatic and trypanolytic effects of NO and TNF-a, thereby allowing the parasites to 
multiply rapidly. In contrast. the production of low levels of IL-10 within infected 
C57BL/6 mice would facilitate the production of high levels of NO and TNF-a which 
would be beneficial for parasite control. 
How do the anti-IFN-y antibodies abolish IL-10 synthesis by splenocytes of T. 
congolense-infected mice? In the LPS model of macrophage activation, IFN-y inhibits IL- 
10 synthesis (Moore et al., 1993) via inhibition of IL-10 gene transcription (Shakhov et 
al., 1996); but, in macrophages pulsed with T. congolense lysate, IFN-y actually up- 
regulates IL-10 production. Specifically, priming with IM-y prior to interaction with T. 
congolense lysates leads to 2-Mold increases in IL-10 production by bone marrow- 
derived macrophages of BALBIc but not C57BLl6 mice (Kaushik et al., manuscript in 
preparation). Thus, during infection, T. congolense alters the behavior of macrophages 
fiom BALBIc mice such that their responses to IFN-y are skewed towards IL-10 
production. It is possible that this differential response of macrophages from BALB/c and 
CS7BL/6 mice to T. congolense might be one of the genetic factors controlling the 
differential resistance of the two mouse strains to infections with T. congolense. 
7.5 Antibody response to T. congolense in BALBIc and C57BL16 mice 
Infected BALBIc mice mounted earlier IgM antibody responses to the purified 
VSG and fixed VSG as well as to the whole T. congolense lysate than did the CS7BW6 
mice. In contrast, BALB/c mice failed to mount any detectable IgG2a and IgG3 antibody 
responses to these antigens whereas infected C57BL/6 mice made vigorous and sustained 
IgG responses that peaked at the time of control of parasitemia. 
Detailed analyses of the roles of anti-VSG antibodies in resistance to T. brucei 
rhodesiense infections in mice showed that there is no correlation between the production 
of specific IgM antibodies and resistance (DeGee and Mansfield, 1984; 1988). The 
present work further supports these reports. since highly susceptible BALBIc mice 
mounted earlier and initially higher IgM responses to the various antigens of T. 
congolense than did the resistant C57BLl6 mice. On the contrary, the data suggest that 
IgG2a and IgG3 antibodies to the cryptic epitopes of the VSG and whole trypanosome 
lysate may be associated with control of parasitemia and enhanced resistance to T. 
congolense infections in mice, since significantly higher levels of these antibodies were 
made by the resistant C57BL/6 than the susceptible BALB/c mice. In cattle. superior IgG 
antibody responses against the invariant antigens of 7'. congolense have been associated 
with trypanotolerance (Authie et al., 19934b; Authie 1994; Agur and Meher, 1997). 
How could IgG anti-trypanosome antibodies mediate better protection than IgM 
antibodies? Clearly, the mechanism can not be through enhanced phagocytosis, since both 
IgM and IgG antibodies mediate comparable uptake of trypanosomes by macrophages 
(Ngaira et el., 1983; Kaushik et ai., unpublished data). It is speculated that the difference 
lies in the differential capacities of these antibodies to mediate adherence of trypanosomes 
to rnacrophages during the early phases of the antibody response. Such adherence would 
facilitate the exposure of the trypanosomes to the direct static and lytic effects of NO and 
TNF-a being produced by the macrophage (see section 7.4 above). Binding of IgM 
antibodies to the VSG induces shedding of the VSG from the parasite (H. Tabel, personal 
communication) thereby exposing the carbohydrate residues on the VSG as well as the 
underlying plasma membranes, leading to rapid phagocytosis via the carbohydrate 
receptors on the macrophages (Mansfield, 1990). In contrast, binding of the few available 
molecules of IgG antibodies to the trypanosomes during the initial phases of the antibody 
response could conceivably result in a prolonged Fcy receptor-mediated adherence but 
only minimal phagocytosis by macrophages. 
There was no correlation between the cytokines produced by the splenocytes of 
infected mice and the isotypes of antibodies against the various antigens of the parasite. 
The fact that BALB/c mice were unable to make IgG2a and IgG3 antibodies despite the 
secretion of high amounts of IFN-y by their splenocytes suggests that the measured IM-y 
was not produced by conventional T helper cells. Indeed, it was shown in this study that 
most of IL-I 0 and E N - y  produced by splenocytes from infected BALBlc mice arises from 
small numbers of Thy1.2CD4-8- cells that are plastic-, nylon wool- or Sephadex G-10- 
adherent. On the other hand, the fact that strong IgG2a and IgG3 antibodies were made by 
the C57BL/6 mice suggests that some of the IFN-y measured in those mice might have 
been produced by THl cells. Such a lack of correlation between the high levels of IFN-y 
secretion and an IgG2a isotype response to the VSG has also been reported in mice 
infected with T. brucei rhodesiense (Mansfield, 1994). 
Differences in IL-I0 and IL-12 production by macrophages from BALB/c and 
C57BL/6 mice following their interaction with trypanosomes may be responsible for the 
differential antibody isotype production in these mice. As noted previously, IFN-y-primed 
bone marrow-derived macrophages from BALB/c mice pulsed with T. congolense lysate 
secrete significantly more IL-10 than do those from C57BL/6 mice. In contrast, the 
secretion of IL-12 p40 by these macrophages was significantly greater in the C57BL/6 
than in the BALB/c mice. IL- 10, a potent down-regulatory cytokine (Moore et al., 1993), 
mediates a suppression of splenocyte proliferative responses to Con A and an enhanced 
susceptibility to T. congolense infections in BALB/c mice (see section 3). IL-I0 also 
inhibits cytokine synthesis by THl cells (Mosmann et al., 1990). Thus, the production of 
high levels of IL-10 by infected BALB/c mice might be expected to down-regulate THI- 
dependent B cell responses, leading to lower IgG2a and IgG3 antibody responses as 
observed in this study. On the contrary, the high level production of IL-12 by 
macrophages from the resistant mice would favor THl cell development (Trinchieri, 
1995) and thereby IgG2a and IgG3 isotype production (Boehm et al., 1997). These 
antibodies might, in turn, mediate an adherence of trypanosomes to macrophages that 
enhances the cytostatic effects on trypanosomes of NO and TNF-a produced by the 
macrophages. It is hypothesized that control of parasitemia and increased survival in mice 
infected with T. congofense is mediated by a THl cell response. 
7.6 Future directions 
The studies presented in this thesis have brought up many questions that, if answered, 
would shed more light on the mechanisms mediating the pathogenesis and enhanced 
resismce to T. congolense infections. These questions include the following: 
1) By what mechanism(s) does in vivo neutralization of IL-10 and IFN-y enhance the 
resistance of the highly susceptible BALB/c mice to T. congolense infections? Clearly, it 
was shown in this report that IL-10 and IFN-y are involved in trypanosome-induced 
suppression of splenocyte proliferative responses. I t  was therefore suggested that 
neutralization of these cytokines abrogated trypanosome-induced immunosuppression, 
thereby enabling these mice to make an effective immune response. This suggestion is 
based on the premise that the degree of immunosuppression in different strains of mice 
infected with African trypanosomes is correlated with the degree of susceptibility 
(Morrison et al., 1978; Roelants and Pinder, 1984; Pinder et al., 1986). However, an 
alternative hypothesis could be formulated based on the inhibitory effects of IL-10 on NO 
and TNF-a production by macrophages (Fiorentino et al., 1991, Gazinelli et al., 1992). 
NO is cytostatic for T. b. rhodesiense in vitro (Vincendeau et al., 1992) and TFN-a has 
both static and lytic effects on T. brucei in vitro and in vivo (Magez et al., 1993; 1997; 
Lucas et al., 1994). It is conceivable that the high levels of IL-I0 in the susceptible 
BALBk mice potently inhibit the production of these molecules and consequently their 
static and lytic effects, thereby allowing the parasites to fkrther multiply unchecked. 
Further studies are needed to dissect the mechanisms by which anti-IL-10 and anti-IFN-y 
antibody treatments in BALBlc mice are beneficial. 
2) It was clearly shown that splenic adherent Thy1.2TD4-8- cells are the major T cells 
involved in the production of IL-4. IL-I0 and IFN-y in BALB/c mice infected with T. 
congolense clone TC13 and that these cells could mediate suppression of T and B cell 
responses to mitogens and unrelated antigens. By what mechanism(s) are these cells 
activated? Are they activated by trypanosomal antigen(s)? If  so, what is the nature of the 
antigen(s)? How is this trypanosomal antigen(s) processed and presented? What is the 
antigen-presenting cell(s)? What is the restricting element(s)? These are very interesting 
and mind-searching questions that require answers in order to hlly understand and 
appreciate the pathogenesis of African trypanosomiasis. 
3) It was not tested whether IL-4-, IL- 10- and IFN-y-secreting adherent Thyl.Z'CD4-8- 
cells were NKl+ T-cells. NK14 T cells, which can either be Thy1.2TD4'8' (60%) or 
Thy 1.2TD4-8- (40%), are known to secrete large amounts of IL-4, IL- 10 and IFN-y upon 
appropriate stimulation, and comprise about 0.5 - 1% of splenocytes from normal mice 
(Vicari and Zlotnik, 1996; Bendelac et al., 1997). Their activation is restricted by the 
CDl molecule and they recognize both hydrophobic peptides and lipid antigens presented 
in association with CDI molecules (Porcelli et al., 1992; Bendelac et d., 1997). Double 
negative NKI .I T cells have been reported to act as suppressor cells in hemopoesis (Kikly 
and Dennert, 1992), tumor development (Tamada et al., 1997) and autoimmunity (Sumida 
et al., 1995; Meiza et al., 1996). It will be highly desirable to know whether the 
Thy1 .TCD433' cells of this investigation are indeed NKl -1 T cells. 
4) Most of the studies reported in this thesis were done in the highly susceptible BALB/c 
mice. This choice was guided, in part, by the findings that the patterns of early responses 
may influence the overall outcome of the disease (Ogunrerni and Tabel, 1995). It will be 
desirable to study the involvement of the adherent Thy1.2TD4I3- cells in the secretion of 
IL- 10 and IFN-y in infected relatively resistant C57BL/6 mice. Trypanosoma congolense- 
infected C57BU6 mice produce very low amounts of IL-10 and IFN-y, yet they are 
immunosuppressed (albeit to a relatively lesser degree than BALBk mice). It will be 
desirable to investigate the roles of IL-10 and IFN-y in this suppression in order to 
determine whether other mechanisms, such as NO-mediated suppression. operate in these 
mice. 
5) It is hypothesized that effective control of parasitemia and increased survival periods in 
T. congolense-infected mice are correlated with THI cell responses to variant and 
invariant antigens. The present study suggested that IgM anti-VSG antibodies may not be 
associated with resistance, as was previously reported (DeGee and Mansfield, 1984). 
Rather, IgG2a and IgG3 antibodies against the cryptic epitopes of the VSG and whole 
parasite lysate were higher in the resistant C57BL/6 mice and the levels of these 
antibodies peaked during the period of control of first wave of parasitemia. It would be 
desirable to measure the cytokine and antibody isotype responses to the variant and 
invariant parasite antigens in the few C57BL/6 mice that self cure. It is predicted that 
IgG2a and IgG3 antibodies against the invariant antigens wiI1 be high in the plasma of 
these mice. 
8.0 CONCLUSIONS 
The main objectives of this study were to study the patterns of cytokine secretion and the 
role of cytokines in resistance to T. congolense employing highly susceptible BALB/c and 
relatively resistant C57BL/6 mice. The kinetics and patterns of appearance of IL-4, IL- 
10- and IFN-y-secreting cells in the spleens of infected mice were essentially similar. 
However, a dramatic difference was observed in the secretion of cytokines in cultures. 
The infected BALB/c mice produced higher levels of these cytokines than infected 
C57BL/6 mice. The production of high levels of IL-4, IL-10 and IFN-y was restricted 
mainly to a Thy1.2TD4'8- splenocyte population that are plastic-, nylon wool- or 
Sephadex G- 1 O-adherent and which require some interaction with Thy 1.2- cells to produce 
these cytokines. These cells effectively suppressed Con A-induced proliferation of 
splenocytes fiom uninfected mice as well as B cell responses to SRBC. 
Both endogenously produced IL-lO and IFNy mediate suppression of splenocyte 
proliferative responses to Con A and enhanced susceptibility to the infection. 
Neutralization of these cytokines in vivo enhanced the resistance of the highly susceptible 
BALBlc mice to T. congolense infection. The beneficial effect of anti-IFN-y was 
associated with the reduction of IL- 10 production. 
There was no correlation between the production of high levels of cytokines and 
production of antibodies against various antigens of T. congolense. Infected BALBlc mice 
made earlier IgM antibody responses but were unable to produce IgGZa and IgG3 
antibodies to these antigens. In contrast, the production of IgG2a and IgG3 antibodies was 
correlated with the control of parasitemia in C57BL/6. It is hypothesized that enhanced 
resistance (effective control of parasitemia and increased survival period) to T. congoleme 
infection in mice is correlated with a THI cell response. 
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10.0 APPENDIX 
10.1 Restoration of Con .&induced proliferative response of spienocytes from T. 
congolense-infected BALBlc mice following treatment with Berenil. 
Table 1. Berenil treatment" reverses suppression of Con A-induced proliferation of 
splenocytes from infected miceb 
DAYS POST- ABSORBANCE (595 nrn) + SD 
NFECTION Untreated Berenil-treated 
a I& cted mice were treated with Berenil ( 1 4 mgkg) on days 6 and 7 post-infection. 
Cultures of splenocytes ( 10' cells/well) from uninfected or T. congolense-infected 
BALBk mice were stimulated with 5 p / m l  Con A. After 72 hr, proliferative response 
was measured by the MTT dye incorporation assay. Data are presented as mean 2 
standard deviation. ND = Sot  done. 
10.2 Con A-induced secretion of IL-4 by splenocytes h m  T. cungo~ense-infected 
BALB/c and C57BLJ6 mice, 
Days post infection 
Figure 1. Con A-induced secretion of IL4 by splenoctyes he. 
congolemeinfected BALB/c and C57BU6 mice. 
10.3 Con A-induced secretion of by splenocytes from T. wngoiem~ehfected 
BALB/c and C57BU6 mice. 
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Figure 2. Levels of IFNq in culture fluids of Con A stimuiated spienocytes 
f h m  T. congohe-infected BALB/c and C57BU6. 
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Figure 3. Production of nitric oxide by splenocytes from T. congoleme-infected 
mice. Splenocytes from infected BALB/c and C57BU6 mice were cultured in the 
presence of 5 pgld Con A. After 48 hr, the supernatant fluids were collected and the 
level of nitrite in the fluids was determined by the Griess reaction. 
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